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Introduction Générale
Les acides nucléiques aptamères sont des oligonucléotides en série ADN ou ARN 
qui ont été sélectionnés pour leur capacité à reconnaitre une (des) cible(s) 
pre-déterminée(s) par la méthode in vitro nommée SELEX (pour Systematic 
Evolution of Ligands by EXponential enrichment). De par leurs caractéristiques, les 
acides nucéliques aptamères peuvent être considérés comme des « anticorps 
chimiques » et, par conséquent, ont été et sont encore très largement employés comme 
outils potentiels en thérapeutique et diagnostic. 
La majeure partie des outils analytiques à base d’aptamères rapportés à ce jour est 
dédiée à la détection de cibles protéiques. En règle générale, les performances 
analytiques des aptacapteurs à protéines sont supérieures à celles des aptacapteurs 
pour petites espèces chimiques. Les constantes de dissociation observées pour les 
complexes aptamère-protéine sont communément plus faibles que celles obtenues 
pour les complexes aptamère-petite molécule et les systèmes de transduction sont 
habituellement de mise en œuvre plus aisée. 
L’objectif de ce travail était d’établir de nouvelles approches analytiques à base 
d’aptamères pour la détection de petites espèces chimiques (adénosine, tyrosinamide 
et argininamide en tant que composés modèles). 
Trois types de méthodologies ont été explorés dans ce travail, basés sur des 
approches par électrophorèse capillaire (EC), par colorimétrie et par 
polarisation/anisotropie de fluorescence. Ce manuscrit se subdivise en trois chapitres 
comme suit :
Le chapitre I correspond à une analyse bibliographique qui regroupe deux parties. 
La première décrit les caractéristiques générales des aptamères et les méthodes de 
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sélection par le processus SELEX (et dérivés). La seconde partie introduit les 
différentes stratégies adoptées pour le développement de méthodes de dosage à base 
d’aptamères. Les approches de transduction sont également abordées. 
Le chapitre II décrit l’ensemble de la partie expérimentale, les résultats et la 
discussion sous forme de publications. Après une introduction sur l’objectif général 
du travail, les trois parties sont abordées relativement à la méthodologie générale 
employée.
Le premier objectif du travail était de développer une nouvelle méthode de 
détection de petites molécules par EC couplée à une détection par fluorescence induite 
par laser (FIL) en utilisant, comme sondes, des oligonucléotides marqués par un 
fluorophore. Ce travail a fait l’objet d’une publication dans Analytical Chemistry, 
2010, 82, 4613-4620. La stratégie d’analyse était fondée sur le concept de 
« structure-switching » de l’aptamère. Celui-ci repose sur la formation d’un duplex 
entre l’aptamère et un brin complémentaire (BC) de celui-ci. En présence de la cible, 
la formation du complexe aptamère-cible entraine la libération du brin 
complémentaire qui peut-être corrélée à la concentration de la cible dans le milieu de 
réaction. Deux configurations ont été décrites. La première, dédiée à la détection d’un 
seul composé, utilise un aptamère marqué par un groupement cholesteryl (Chol-Apt) 
en tant qu’élément de reconnaissance et un BC marqué par la fluorescéine (BC*) en 
tant que sonde. En conditions de chromatographie électrocinétique micellaire (en 
présence de micelles neutres dans le capillaire), la fraction libre de BC* a été 
efficacement séparée de sa fraction liée à l’aptamère. En présence de cible, la forme 
hybridée est déstabilisée, entrainant une diminution de l’intensité du pic du duplex et 
une augmentation de celle du pic du BC*. Le second format, spécifiquement 
développé pour une détection de plusieurs cibles dans un même capillaire, a utilisé 
des aptamères de taille différente marqués par la fluorescéine à une extrémité et un 
groupement cholesteryl à l’autre. La séparation électrophorétique des aptamères, sous 
forme libre et hybridée, a été démontrée, permettant de suivre les variations de 
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l’intensité des différents pics en fonction de la concentration des cibles ajoutées dans 
le milieu. Bien que cette approche permette une analyse « multiplexée » (adénosine et 
tyrosinamide en seule analyse dans un même capillaire), elle souffre d’un certain 
nombre d’inconvénients. Elle nécessite l’emploi d’un matériel sophistiqué et couteux
et le temps d’analyse s’avère être relativement long.
Afin de remédier à ces problèmes, la deuxième étude s’est focalisée sur le 
développement d’un aptacapteur colorimétrique simple, rapide et peu coûteux, qui 
utilise le concept général de protection enzymatique de l’aptamère et les 
nanoparticules d’or en tant que système de transduction. Ce travail a fait l’objet d’une 
publication dans Analytica Chimica Acta, 2011, 706, 349-353. En absence de cible, 
l’aptamère est hydrolysé par la phosphodiestérase I en mononucléotides et petits 
fragments d’ADN. De par leur taille réduite, ceux-ci peuvent s’adsorber à la surface 
des nanoparticules d’or (non modifiées), entrainant leur stabilisation électrostatique et 
leur capacité à rester dispersées dans des conditions de force ionique importante 
(couleur rouge). A contrario, la présence de la cible dans le milieu induit un 
changement de conformation/structure de l’aptamère qui protège, au moins en partie, 
l’aptamère de l’attaque enzymatique. Dans ces conditions, l’oligonucléotide, de 
longueur plus importante, n’est plus capable de s’adsorber efficacement sur les 
nanoparticules d’or qui s’agrègent à force ionique élevée, avec changement de couleur 
(violet-bleu). La détection de la cible a été effectuée en suivant les rapports 
d’absorbance à 650 et 520 nm de la solution colloïdale. Cette méthodologie a été 
appliquée, suivant le même protocole, à la détection de deux cibles différentes 
(tyrosinamide et adenosine). L’inconvénient majeur de cette approche est lié au fait 
qu’elle est très difficilement applicable à l’analyse de composés en milieux réels 
complexes.
Dans ce contexte, nous nous sommes orientés vers la mise en œuvre d’aptacapteurs 
employant un système de transduction par polarisation/anisotropie de fluorescence, 
une technologie qui est très fréquemment utilisée pour le dosage d’espèces bioactives 
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dans des matrices biologiques. Ce travail a fait l’objet de deux publications dans 
Analytica Chimica Acta, 2011, 707, 191-196 et dans Analytical Chemistry, 2012, 
sous presse. La première étude, fondée sur la stratégie « structure-switching »
préalablement utilisée en électrophorèse capillaire, a consisté en l’évaluation des 
paramètres critiques impliqués dans la performance de l’aptacapteur. Dans cette 
configuration, BC est marqué par un fluorophore (BC*). En absence de cible, le 
duplex formé limite la rotation du fluorophore et entraine une anisotropie de 
fluorescence élevée. Lorsque le complexe aptamère-cible se forme, BC* est libéré du 
duplex avec, comme conséquence, une diminution du signal. Les effets de la 
composition et du pH du milieu réactionnel, de la température, de la stœchiométrie, de 
la nature du fluorophore et de la longueur du brin complémentaire sur la sensibilité de 
la méthode ont été appréhendés, permettant de définir les conditions optimales pour la 
détection de la cible tyrosinamide. L’un des problèmes de la méthode par 
« structure-switching » est lié à la faible variation du signal d’anisotropie de 
fluorescence obtenu (0,04). Pour pallier à cet inconvénient, une nouvelle approche a 
été proposée. Elle est basée sur l’utilisation de la protéine SSB (pour Single-Stranded 
Binding protein) en tant qu’outil amplification du signal. L’aptamère est marqué par 
un fluorophore. En absence de cible, la protéine SSB fixe la sonde aptamérique de 
telle sorte qu’une très forte augmentation de taille est obtenue, induisant une intense 
variation du signal d’anisotropie de fluorescence. En présence de cible, la formation 
du complexe aptamère-cible est responsable du déplacement de l’oligonucléotide de 
son complexe formé avec la protéine. Ce phénomène se traduit par une diminution 
drastique du signal (0,120 pour l’adénosine). Cette méthode a été utilisée avec succès 
dans le cas d’une autre cible (argininamide) et d’un autre strategie de biocapteur. 
Enfin, des expériences en conditions de sérum humain dilué semblent indiquer que 
cette approche pourrait être utilisée en milieux complexes. 
Enfin, le chapitre III correspond à la conclusion générale de cette étude 
accompagnée d’une discussion sur les perspectives envisagées.
Chapter I: Literature Review
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I.1 Aptamers and SELEX
I.1.1 Introduction
Molecular recognition plays a very important role in the nature. There are different 
kinds of biomolecular pairs in biological systems, including antibodies and antigens
[1], hormones and hormone receptors [2], DNA promoters and transcription factors
[3], enzymes and substrates [4], etc. Most of these biomolecular pairs present high 
binding affinity and specificity and their interactions are widely investigated. They are 
of great interest for different biological and biomedical applications, one of which 
being biosensing. A variety of biosensors have been developed since the design of the 
first enzyme-based biosensor over 40 years ago [5]. However, challenges exist when 
using these kinds of natural biomolecular systems under the experimental conditions.
For example, many biomolecules (e.g., enzymes and antibodies) have unstable 
functional structures. When they are placed in an environment that is different from 
their ideal conditions they can be easily denatured and lose their initial biological 
function. Therefore, these molecular pairs have limited analytical applications in 
many situations. Clearly, it is of particular interest and importance to explore 
synthetic ligands which not only have high binding affinity and specificity towards
target molecules, but also have special features such as tolerance to rigorous chemical 
and biological environments. Aptamers were developed to respond to these 
requirements, the following chapter concisely describes aptamers and the related 
SELEX technique.
I.1.2 Selection of aptamers
Aptamers are oligonucleic acid or peptide molecules that bind to a specific target 
molecule. Ever since the concept of aptamer was first proposed by Ellington [6] and 
Gold [7] and the technology of Systematic Evolution of Ligands by EXponential 
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enrichment (SELEX) was developed for isolation of nucleic acid aptamers in 1991 [8],
more and more different aptamers have been reported, which could specifically bind
to various target ligands. Aptamers are also termed “chemical antibodies” because of 
their artificial in vitro selection process based on Systematic Evolution of Ligands by
EXponential enrichment (SELEX). Unlike the preparation of antibodies, which 
depends on induction of an animal immune system, the SELEX process enables the
preparation of aptamers for non-immunogenic and toxic targets which is otherwise 
impossible to obtain by the immune system [9]. Moreover, it is also possible to 
produce aptamers to specific regions of targets, which is sometimes difficult for 
antibodies, since the animal-immune system inherently contains epitopes on target 
molecules. Until now, aptamers have been selected toward a broad range of targets, 
including ions (e.g., K+, Zn2+ and Ni2+), small organic molecules (e.g., amino acids, 
nucleosides/nucleotides, drugs, vitamins, organic dyes and toxins), peptides and
proteins (e.g., thrombin, growth factors and HIV-associated peptides) and even whole 
cells or microorganisms (e.g., bacteria, viruses) [10-19]. Significantly, the availability 
of such a large pool of aptamers makes it possible to explore novel bioassay tools 
covering various areas including diagnostics, anti-bioterrorism, and environmental 
and food analysis [20].
I.1.2.1 General Scheme of SELEX
Figure 1-1 shows a typical SELEX process. The process begins with the generation 
of a random library that contains up to 1013̢1015 single-stranded DNA or RNA 
oligonucleotides. The oligonucleotides are synthesized by a combinatorial chemical 
synthesis technique. These oligonucleotides are comprised of N random nucleotides 
in the middle of their sequences, flanked by a primer-binding region at each end. 
During the selection of aptamers, target molecules are incubated with the library to 
enable molecular recognition between the target molecules and the oligonucleotides. 
Theoretically, the aptamers will tightly bind to the target molecules while the other 
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oligonucleotides will stay in solution. Because the aptamer-target complexes and the 
free oligonucleotides in the binding solution should exhibit different physical 
properties, they can be separated with a partitioning method or tool. After separation, 
the sequences bound to the target molecules will be amplified by polymerase chain 
reaction (PCR) to generate a new library for further selection. This process is usually 
repeated for 8-12 cycles.
Figure 1-1: Scheme for the Systematic Evolution of Ligands by EXponential (SELEX) enrichment 
process [21]. A random nucleic acid library is incubated with a target molecule, and 
unbound molecules are separated from bound molecules. Bound nucleic acids are eluted, 
amplified by PCR and serve as an enriched library for the next cycle. For each target, 
8–12 consecutive cycles are performed and the final enriched library is cloned and 
sequenced.
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I.1.2.2 Different Methods of SELEX
The most critical step of SELEX is the separation of bound oligonucleotides from 
the unbound ones. Nitrocellulose filtration is the most commonly used technique [6, 
7]. As aptamer-related research grew at an increasing pace within the past few years, 
numerous separation techniques have been used to improve aptamer selection, 
including affinity surfaces (e.g., affinity magnetic beads [22], titer plates [23], and 
affinity chromatography [24, 25]), gel mobility shift [26], immunoprecipitation [27],
density-gradient centrifugation [28], and tailored SELEX [29]. These techniques are 
promising to improve aptamer selection. In addition to the development of separation
techniques for improving the separation efficiency, other SELEX techniques such as 
photo-SELEX [30], evolution mimicking algorithm-based SELEX [31], and 
molecular beacon-based SELEX [32] have been developed to improve the selectivity 
of the aptamer. To further advance the breadth of aptamer selection, cell-SELEX [33]
and tissue-SELEX [34] have recently been studied. These methods have the potential 
to identify aptamers that can recognize cancer cells or tumor tissues for cancer 
therapy and diagnosis. However, the aptamer selection process is iterative. It can be 
very time-consuming, requiring several months or longer to complete. To overcome 
this problem, automated SELEX [35, 36] and microarray-based SELEX [37] have 
been developed. These new methods are promising to improve the speed of 
aptamer-based research.
The Krylov group [38] has developed nonequilibrium capillary electrophoresis of 
an equilibrium mixture (NECEEM) approach, which can screen aptamers with much 
fewer rounds of selection and can also determine accurate binding parameters. They 
further utilized NECEEM in the repetitive partitioning step to improve the affinity of 
a DNA library by more than 4 orders of magnitude [39, 40]. Recently, the same group 
used the NECEEM method to screen aptamers against a target protein from a cell 
lysate without any prior purification of the target protein and subsequently utilized the 
developed aptamers for protein isolation from the same cell lysate [41]. This 
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technique was demonstrated to be useful for the selection of aptamers for certain 
proteins that do not have intrinsic DNA-binding characteristics [42].
CE-based separation methods have greatly accelerated the selection efficiencies 
due to the fast separation ability based on the differences of electrophoretic mobility 
between protein-aptamer complexes and free oligonucleotides. However, the 
approach is limited to mainly proteins, because small species typically do not allow
the detectable electrophoretic mobility shift. Magnetic bead-based selection methods, 
where molecular targets are first immobilized on a magnetic bead surface, show wider 
applications to any kind of molecules or species. However, the efficiency of magnetic 
selection techniques is significantly lower than CE. The Soh group, thus, developed a
platform that combines magnetic bead-assisted SELEX with microfluidics technology 
(M-SELEX) to take advantage of robust and efficient features of both separation 
approaches [43]. This procedure improves the aptamer selection by enabling highly 
stringent selection conditions through the use of very small amounts of target 
molecules. The separation of the magnetic bead is based on the magnetic field 
gradients generated by ferromagnetic patterns imbedded in the microfluidic channel.
The M-SELEX could provide a highly efficient, low-cost, and automated system with 
high-throughput capabilities. In a follow-up work, the Soh group further improved the 
M-SELEX method using a disposable microfluidic chip to rapidly generate aptamers
with high affinity and specificity [44]. In the experiments, picomolar amounts of 
target molecule bound to beads were recovered with high efficiency. The procedure 
was performed for both the positive selection toward streptavidin and negative 
selection against bovine serum albumin (BSA), which greatly increased the selection 
specificity. 
A particularly interesting aptamer selection approach was introduced by Mi et al.
[34] who questioned whether the in vitro SELEX procedure is effective enough for
subsequent in vivo target detection, principally because the environments during
selection and application are not identical. To address this potential issue, an in vivo 
aptamer selection approach was created using intrahepatic colorectal tumor-bearing 
mice (Figure 1-2). During their procedure, the tumor-bearing mice were injected with 
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a random library of RNA sequences. After harvesting the tumors, RNA sequences 
were extracted and amplified with RT-RCR. The resulting RNA pool was again 
reintroduced into mouse tumors. After this repeated procedure, the resulting RNA 
molecules demonstrated increasing affinity towards the colorectal tumor protein 
extract compared to normal tissue cells. The generated aptamers were confirmed to 
have exceptional in vivo selectivity towards the targeted cancerous mouse tissue.
Figure 1-2: In vivo selection of aptamers [34]. Tumor-bearing mice are intravenously injected with a 
random library of RNA sequences. After harvesting the tumors and extracting and 
amplifying the bound RNA molecules, the reinjection procedure is repeated several more 
times, resulting in increasing specificity of the bound aptamers. The selected RNA 
aptamers can finally be used for in vivo tumor imaging.
Besides common molecules such as small organics, peptides, and proteins, whole 
intact cells or viruses have been increasingly used as targets for the selection of 
aptamers, since the prior precise knowledge of target molecules is not required 
[45-48]. The resulting aptamers can be used for cancer cell detection, although the 
knowledge of exact targeted molecules on the surface of the cells may not be totally 
clear. Cell-SELEX has become one of the most widely used methods for screening 
cells. A number of aptamers targeting different cancer cells have since been 
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developed. Most recently, Li et al. [49] reported a slide-based SELEX strategy for in 
situ selection of tissue samples. They demonstrated the effectiveness of their approach 
by generating an aptamer with high affinity toward infiltrating ductal carcinoma 
tissues. Similarly, another aptamer system was developed by Wan et al. [50] to 
capture and enrich EGFR-expressing glioblastoma cells. The cancer is known for its 
ability to infiltrate human brain regions, and the inability to detect glyoblastoma 
renders it surgically incurable. The fluorophore-labeled aptamer probe was 
immobilized on the glass slides and then applied to successfully capture targeted
cancer cells with high efficiency and selectivity. Overall, new developments and 
improvements in the aptamer selection process have made the generation of aptamers 
a more straightforward and routine practice, leading to greater impact of aptamers and 
their broader applications in biochemical and medicinal fields.
I.1.3 Aptamer characteristics
I.1.3.1 The length of Aptamers
The aptamers identified by the selection procedure (i.e., full-length aptamers) are 
usually 80̢100 nucleotides (nt) long. However, not all of the nucleotides in a 
full-length aptamer play a critical role in the binding to its target. A full-length
aptamer usually has three functional regions. The region that plays the role of 
contacting the target is approximately 10̢15 nt long [51]. Another region contains 
nucleotides that do not directly contact the target but play an important role in
supporting the interactions between the contacting nucleotides and the target. The 
nucleotides that either bind to the target or facilitate aptamer binding are the essential 
nucleotides required for a functional aptamer. In general, the number of essential 
nucleotides is approximately 25̢40 nt [52]. The third region comprises the 
nucleotides that do not bind to the target nor support the binding of the contacting
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nucleotides to the target. They are regarded as nonessential nucleotides. It is always 
desirable to truncate the aptamer to eliminate the nonessential nucleotides after the 
upstream aptamer-selection process (i.e., downstream truncation) for several reasons. 
Firstly, in some cases, elimination of nonessential nucleotides can increase the
binding functionality of the aptamer [53] presumably because of reduced steric
hindrance. Secondly, the smaller aptamers can provide more freedom and space for 
constructing novel nanostructures with smaller, more desirable dimensions, which is 
required to develop tiny, more sensitive biosensing devices [54]. Thirdly, although the 
chemical synthesis of an oligonucleotide is a well-established technique, the synthesis 
of aptamers longer than 60 nt is still more expensive and difficult to perform.
I.1.3.2 Structural Features of Aptamers
A distinguishing feature of aptamers is their ability to form pronounced secondary 
structure. This structure is the result of a combination of hydrogen bonding, 
electrostatic and van der Waals interactions, Watson-Crick and non-canonical base 
pairing, and stacking of aromatic rings [55, 56]. It has been shown in many cases that 
unpaired sites in the oligonucleotide structure are most important for the specific 
interaction with targets, whereas sites with stable secondary structure are necessary to 
maintain the proper spatial arrangement of the recognition elements [57, 58]. This is 
confirmed by the fact that many aptamer sites are non-structured in the free state (like 
loops in hairpins) and acquire a stable conformation only after binding to the target 
[58-60].
Usually one or two structural motifs comprise the basis of an aptamer. Most 
frequent are the following structural elements (Figure 1-3).
1. Hairpins of different structures. It is one of the most widespread secondary 
structure motifs occurring both in RNA and DNA aptamers.
2. Pseudoknots. The pseudoknot structure is formed as a result of complementary 
interactions of the sequence located to the right or to the left of a hairpin with the 
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sequence of the hairpin loop. Pseudoknots are most characteristic of RNA aptamers, 
but they occur in DNA sequences as well [57, 61, 62].
3. Four-stranded structures (quadruplexes). As a rule, the quadruplex cross section 
is formed by four guanine nucleotides (G-quartet). Each guanine base in the G-quartet 
forms hydrogen bonds with two adjacent bases. Usually in a quadruplex there are 2 or 
3 G-quartets stacked in succession. Such structures exhibit very high stability 
compared to simpler structural motifs. The quadruplex is additionally stabilized in the 
presence of K+ ions coordinated between planes of two neighboring G-quartets [63].
The G-quartet structures appeared to be typical of DNA aptamers, although in some 
cases they were also found in RNA ligands [64-70]. It is supposed that in all cases the 
structural motif of the G-quartet is the architectural basis of the aptamer, whereas 
nucleotides in variable loops between quadruplex strands are involved in protein 
recognition.
Figure 1-3: Scheme for 3 basic structure of aptamer [58-60]: A. hairpin; B. pseudoknots; C. 
quadruplexes
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I.1.3.3 Aptamer-Target Molecular Recognition
In many ways, aptamers can be considered as nucleic acid-type antibodies with 
properties comparable with or even superior to conventional antibodies. The binding 
of an aptamer to its target is very specific. Interactions occurring between aptamers 
and their molecular targets are usually so specific that even tiny variations in the 
target molecule may disrupt aptamer binding (e.g., aptamers for theophylline and 
L-arginine can discriminate closely related chemical structures by factors as high as 4 
orders of magnitude [71, 72]). In addition to this high selectivity, aptamers bind to 
their targets with high affinity, particularly with macromolecules (e.g., proteins), 
which often possess remarkable dissociation constants (Kd) ranging from picomolar to
nanomolar [71]. For small molecules, Kd range commonly from nanomolar to 
millimolar [73] (Table 1).
Aptamers were first described in 1990 by two separate groups targeting either an 
organic dye [6] or a DNA polymerase [7]. Since the inception of the technology, 
aptamers have been selected for a vast range of targets including metal ions, small 
organic molecules, nucleotides and derivatives, cofactors, nucleic acids, amino acids, 
carbohydrates, antibiotics, peptides, proteins, whole cells, viruses and virus infected 
cells and bacteria (Table 1).
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Table 1: Aptamer selected in vitro for different targets
Target Type Kd References
Ions
Zn2+ 
Ni2+
Nucleotides 
ATP / adenosine
ATP
Cofactors
Riboflavine
NAD
Biotin
FAD and FMN
Amino acids
L-arginine
L-citrulline
L-histidine
L-isoleucine
L-valine
L-tyrosine
L-tyrosinamide
D-tryptophan
RNA
RNA
RNA
DNA
RNA
RNA
RNA
RNA
RNA
RNA
RNA
RNA
DNA
RNA
RNA
RNA
RNA
RNA
DNA
RNA
1.2 mM
0.8-29 µM
0.7-50 µM
6 µM
4.8-11 µM
1-5 µM
2.5 µM
5.7 µM
0.5-50 µM
1 mM
56 µM
330 nM
2.5 mM
62-68 µM
8-54 µM
200-500 µM
12 mM
35-743 µM
45-80 µM
18 µM
[74]
[75]
[73]
[76]
[77]
[78]
[78]
[79, 80]
[81]
[82]
[83]
[72]
[84]
[83]
[85]
[86]
[87]
[88]
[89]
[90]
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Table 1: Aptamer selected in vitro for different targets (continued)
Target Type Kd References
Antibiotics
Tobramycine RNA 2 -3 nM [91]
Lividomycine RNA Q0 [92]
Kanamycine A RNA nM [93]
Kanamycine B RNA 180 nM [94]
Neomycin B RNA 100 nM [95]
Carbohydrates
Cellobiose DNA 1-100 µM [96]
Lipids
Cholic acids DNA 6.4-67.5 µM [97, 98]
Peptides
Substance P RNA 190 nM [24]
RNA 40 nM [99]
Vasopressine DNA 1.2 µM [100]
RNA 1 nM [101]
Neuropeptide Y DNA 0.3-1 µM [102]
Proteins
Antibodies
Anti-NES Ab RNA 0.1 µM [103, 104]
MAb G6-9 RNA 2 nM [105]
Ig E RNA 30 nM [106]
DNA 10 nM [106]
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Table 1: Aptamer selected in vitro for different targets (continued)
Target Type Kd References
Cell surface 
proteins
ȕLQWHJULQ/)$-1 RNA 0.5-1 µM [107]
L-selectin DNA 1.8-5.5 nM [108]
Enzymes
Reverse DNA 5 nM [61]
transcriptase of 
HIV-1
RNA 1 nM [62]
Complex targets
Ribosome RNA 4-5 nM [57]
Leukemia cells DNA 0.8-229 nM [33]
I.1.3.4 Advantages of Aptamers Compared to Antibodies
Compared with conventional recognition elements like monoclonal antibodies, 
aptamers present similar or even better characteristics [21, 109, 110]:
¾ Aptamers possess extremely high affinity and specificity for related ligands as 
well as for some ligands which could not be recognized by antibodies, such as 
ions, non-immunogenic and toxic targets, indicating that employing aptamers 
as recognition components may significantly expand the applications of the 
corresponding biosensors.
¾ Once selected, aptamers could be massively synthesized by chemical process, 
which is more convenient than the production of antibodies which require the 
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induction of animal immune system. As a result, the cost for fabrication of 
aptamer-based biosensors could be largely cut down. 
¾ Aptamer can be easily modified by different functional groups at critical, 
precise locations in order to increase stability or allow signaling using 
electrochemical probes, fluorophores and quenchers.
¾ Aptamers are more stable at elevated temperatures, and thermal denaturation 
of aptamers is reversible, while, as proteins, antibodies are more thermally 
sensitive, and denaturation of antibodies is usually irreversible. Thus use of 
aptamers offers a wide range of assay conditions.
¾ The binding of aptamers with their targets usually relies on specific 
conformations, such as G-quaduplex, hairpin etc... The conformational 
variations trigged by the formation of aptamer-ligand complexes offer a great 
possibility and feasibility for the construction of aptamer-based biosensors. 
¾ Owing to their oligonucleotidic nature, they could interact with other DNA or 
RNA molecules, such as DNAzymes, allowing designing versatile 
oligonucleotide machines for either biosensing or clinical applications. 
¾ Nucleic acid aptamers can hybridize with their complementary sequences, 
which can be used to create antidotes or structure-switching biosensing 
platform.
¾ Aptamers can function both inside and outside cells whereas antibodies 
usually only work outside cells to target secretory proteins or cell surface 
receptors.
¾ For therapy, aptamers have shown no intrinsic toxicity and immunogenicity
but antibodies, even humanized, could induce immunogenicity.
Due to the above advantages, aptamers are considered as promising alternatives to 
antibodies in bioassay related fields and have been applied in bio-molecule detection, 
cell collection and detection [111, 112], imaging [33], or other clinical treatments 
[109]. The applications of aptamers remain very dynamic, with increasing 
explorations in the field of biosensing, diagnosis, and therapeutics (some 
aptamer-based applications are illustrated in Figure 1-4). 
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Figure 1-4: Widespread use of aptamers for various analytical and biological applications.
Bioanalytical applications of aptamers are highlighted in red [113].
I.1.3.5 Aptamer Modifications
Although aptamers have significantly broadened the utility of nucleic acids as 
molecular recognition elements (MREs), standard unmodified DNA and RNA 
aptamers do not have inherent properties with which a convenient method can be 
adopted to report an aptamer–target interaction. Therefore, to take full advantages of 
aptamers as bioassay probes, it is necessary and important to find ways to link the 
excellent molecular recognition capability of aptamers to a signal production process
which is simple (without the need of a complicated modification to an aptamer for 
signal generation), universal (no matter what characteristics an aptamer and its target 
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exhibit), and convenient to use (with minimal sample operating during the signal 
generating process). Phosphoramidite chemistry enables easy functionalization of the 
oligonucleotide sequence at the 3' or 5' end, or in the middle of the sequence. 
Functional groups, such as biotin, amino, thio, carboxyl, sulfhydryl and a wide range
of fluorophores, can all be incorporated during the chemical synthesis of 
oligonucleotides [114-117]. The modifications can be introduced either during 
SELEX or after SELEX or both. 
The pharmacokinetics of aptamers is determined by their various properties 
including nuclease-resistance, uptake and distribution in tissues and circulation 
half-life in the blood of organisms. Modifications of aptamers can help to improve 
their pharmacokinetics for therapy and in vivo diagnosis.
Modifications such as 2’-NH2, 2’-F, 2’-OCH3 and 4’-SH were introduced to 
increase the nuclease resistance of aptamers. The half lives of natural RNAs in human 
serum are from seconds to hours but those of modified aptamers are days (e.g. >> 96 
hr for the 2’-OCH3-VEGF aptamer). In addition to nuclease resistance, these 
modifications also increase the affinities of aptamers by increasing their 
thermostability and chemical diversity [118, 119]. In one study, post-SELEX 
modification of an NF-țB aptamer in stem I and in loop region increased the 
aptamer’s thermostability (Tm from 34.8 Ԩ to 45.7 Ԩ). At the same time, the 
nuclease resistance of the aptamer was increased by three-fold [115]. Capping at the 5’ 
and 3’-termini can also increase resistance of aptamers to exonucleases. The 
degradation of aptamers in human blood is largely due to exonucleases from 
3’-termini to 5’-termini. A commonly used 3’-capping of aptamers is an inverted 
thymidine (3’-idT), which creates an additional 5’-end without a 3’-end. The
3’-capping with 3’-idT can greatly increase aptamer stability in an organism’s blood. 
The half-life of a platelet-derived growth factor (PDGF) DNA aptamer modified with 
2’-F, 2’-OCH3 and 3’-capping by 3’-idT was increased from 0.6 h to 8 h in 85% rat 
serum [120].
Nuclease-resistance is only one part of the aptamer pharmacokinetics. Uptake and
distribution in tissues and circulation half-lives of aptamers are other important 
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aspects of aptamer pharmacokinetics. Aptamers are relatively small (10-15 kDa, 
30-45 nt) and can be easily cleared from human blood through the kidney and liver. 
To increase the circulation half lives of aptamers, tagging aptamers at the termini is 
often used. The most commonly used tag is polyethylene glycol (PEG). Pegylation 
usually has little effect on the affinities of aptamers but it can dramatically increase 
the circulation half lives of aptamers, thus enhancing in vivo aptamer activity. In 
addition, pegylation can affect the tissue distribution of aptamers. Tagging with lipids 
may also increase the circulation half lives of aptamers and tagging with 
cell-penetrating peptides may help tissue uptake of aptamers.
Some multifunctional aptamers have been developed. A thrombin aptamer, a
L-selectin aptamer and a DNA element conjugated to biotin or fluorescence were 
linked together through duplex linkers or three way junctions. The resulting 
multivalent aptamers had multiple functions including anticoagulation activity and 
application as biosensors [121, 122]. Another bifunctional aptamer could sense either 
AMP or cocaine. The AMP and cocaine aptamer was linked into one piece, which 
was hydridized to another piece of DNA. Either AMP or cocaine could compete with 
the hybridized sequence and release it to give colorimetric or electric signal for 
detection [123]. Another bivalent aptamer was also reported to bind simultaneously to 
the HIV transactivation responsive element (TAR) and the dimerization initiation site 
(DIS) in the 5’ untranslated region. The two aptamers were linked through a PEG 
linker. The resulting bifunctional aptamer showed about 10 times higher affinity for 
HIV RNA 5’-untranslated region compared with those of individual aptamers. The 
enhanced affinity was due to a slower dissociation rate [124].
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I.2 Aptamers-based Bioanalytical Assays
I.2.1 Introduction
Aptamers are strong and powerful tools as molecular recognition elements for 
analytical applications. Researchers have made considerable efforts in recent years to 
take advantage of the unique features of aptamers to design appropriate strategies to 
effectively and efficiently use aptamers for biological agent recognition, identification, 
characterization and quantification.
Generally, a biosensor is a device that comprises two or more of the following parts: 
recognition component, linker, localization component, signal receptor, signal 
amplification component and signal transducer, etc. Among them, at least two parts 
are unavoidable: one is the recognition part, which could specifically recognize and 
identify target, and the other is the signal transduction part, which could transform the 
analyte signal into some detectable signal. Recognition components, typically 
enzymes, antibodies or nucleic acids, directly determine the stability, selectivity, 
sensitivity, as well as application prospects of biosensors. 
In addition to the inherent advantages of biosensors, aptamer-based biosensors 
offer the advantage of reusability over antibodies. Furthermore, their smaller size and 
versatility allow efficient immobilization at high density, which is essential in 
multiplexing miniaturized systems (e.g., bioarrays or biochips). In this chapter, 
aptamer-based biosensors were classified into three basic modes: target-induced 
conformation change mode, complementary strand displacement mode, sandwich or 
sandwich-like mode. Based on these three basic strategies, aptamer-based affinity 
separation and purification and various detection methods for aptamer-based assays 
were also discussed.
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I.2.2 Basic Strategies for Aptamer-Based Assays
I.2.2.1 Target-induced conformation change mode (Direct mode)
In this mode, the targets directly bind to their aptamers, coupled with the 
corresponding conformational change of aptamers to specific patterns instead of 
random structures, and this event subsequently leads to the “changes” of detectable 
properties. These kinds of “changes” include the quantity, position or status of the 
signal moieties (which are covalently bound to the end of aptamers or adsorbed on the 
aptamers via electrostatic force, stacking, hydrogen bond, etc.), the size or weight of 
aptamers, along with the formation of aptamer-target complexes and other properties 
of aptamers, such as the ability to stabilize gold nanoparticles (AuNPs). Each of the 
“changes” described above could lead to an alteration of signal which implies a 
potential opportunity for the design of direct aptamer-based biosensors. 
I.2.2.1.1 Electrochemical detection
The analytical applications of aptamers are rapidly moving towards electrochemical 
strategies, not only because electrochemical techniques have high sensitivity but also 
because the instrumentation is simple, low cost, and can be readily miniaturized.
Various electrochemical detection methods have now been utilized with aptamers 
based on the direct mode, such as the aptamer beacon [125, 126] and 
target-responsive electrochemical aptamer switch (TREAS) [127]. Upon the binding 
of the targets to the aptamers immobilized on the surface of electrodes, aptamers 
change from random flexible conformations into three-dimensional structures such as 
G-quaduplex. Such conformational changes would alter the relative positions of 
signal moieties which are covalently linked to the end of aptamers towards the 
electrodes, leading to the changes of electrochemical signal. Based on such mode, 
several electrochemical aptamer-based biosensors have been designed. A redox 
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probe-labeled, signal-off electrochemical biosensor was first developed in 2005 for 
thrombin detection [128]. Before the binding of thrombin, the electrochemical active 
redox moiety, methylene blue (MB) which was covalently labeled at the end of 
aptamer, could transfer electron with the electrode surface due to the flexible 
conformation of the aptamer. However, once thrombin was captured by the aptamer 
and the G-quaduplex structure was formed, the MB moiety was kept away from the 
electrode surface, resulting in the electrochemical signal-off (Figure 1-5). The main 
disadvantage of such design is negative signal.
Figure 1-5: Design of a signal-off electrochemical aptamer biosensor for thrombin detection [128].
After binding to thrombin, the aptamer probe self-assembles into a G-quadruplex 
structure and keeps MB away from electron-transfer (eT) communication with the 
electrode, leading to a negative signal.
To circumvent this problem, several signal-on electrochemical biosensors were 
developed. In a typical work in 2006, thrombin-binding aptamer immobilized on 
polycrystalline gold electrode was covalently attached with ferrocene (Fc) at the other 
end [125]. The electrode surface was further blocked by 2-mercaptoethanol. No signal 
was obtained before the binding of thrombin, because the flexible unfolded aptamer 
led to the large electron-tunneling distance between Fc moiety and the electrode. In 
the presence of thrombin, the formation of a thrombin-aptamers complex made the 
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G-quadruplex aptamer configuration rigid and resulted in the turning of the ferrocene 
units towards the electrode (Figure 1-6). This led to electron-transfer between the 
electro-active ferrocene units and the electrode, and produced a positive signal. 
However, the flexibility of aptamers immobilized on electrode surface could bring 
high background signals and influence the reproducibility of biosensors.
Figure 1-6: Design of a signal-on electrochemical aptamer biosensor for thrombin detection [125].
The formation of a thrombin-aptamers complex makes the G-quadruplex configuration 
rigid and results in the orientation of the ferrocene units towards the electrode, leading to 
easy electron transfer between the electro-active ferrocene unit and the electrode,
producing a positive signal.
Detection in the femtomolar range was achieved with aptamer capture of a protein 
target followed by electrochemical impedance spectroscopy (EIS) [129] and chemical 
amplification (10 fM) [130]. However, most of these detection methods were limited 
to DNA aptamers, and the first example of a RNA aptamer–based electrochemical 
sensor has been reported by Ferapontova et al. in 2008 [131]. For these direct 
electrochemical aptamer-based sensors, their electroactive reporters such as 
methylene blue (MB) [132], ferrocene [133], ferrocene-bearing polymers [134],
ruthenium complexes [135], and Fe(CN)6
4íí [136] were used for signal transduction.
These reporters were covalently conjugated to the aptamer itself [132, 133, 137], or 
indirectly complexed with aptamers [134]. Based on the incorporation of an 
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electrochemical reporter, detection can be either “signal on” or “signal off,” 
depending on how the redox reporter was shielded from the electrode.
Most of these electrochemical biosensing methods were based on a large
conformational change of the aptamer which upon binding of the protein targets, and 
the preparation of aptamer-modified electrodes could be laborious and timeconsuming.
Recently, Limoges et al. reported a new electrochemical methodology for monitoring 
in homogeneous solution the enantiospecific binding of a small chiral analyte to an 
aptamer [138]. The principle relied on the difference of diffusion rates between the 
targeted molecule and the aptamer/target complex, and thus on the ability to more 
easily electrochemically detect the former over the latter in a homogeneous solution
(Figure 1-7).
Figure 1-7: General principle of the homogeneous electrochemical aptamer-based enantioselective 
binding assay involving an electrodetectable small target [138].
I.2.2.1.2 Fluorescence/quantum dot detection
Besides electrochemical biosensors, target-induced conformation change mode 
could be utilized to design optical biosensors. The most important and widely used 
optical aptamer sensors are based on fluorescently labeled aptamers. Indeed, 
fluorescence technique is highly compatible with nucleic acid aptamers [139]: firstly,
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there are a large number of well-characterized fluorophores and quenchers that can be 
used to modify nucleic acids during the automated synthesis or using simple 
post-synthesis chemistries; secondly, fluorophore-dressing of nucleic acids eliminates 
the need of target-labeling and therefore it can be universally applied to any 
aptamer–target pair; thirdly, fluorescence offers a very convenient way to report 
molecular interactions because the detection can be carried out in real time without 
the need for the separation of target–probe complexes from unbound probes. 
Furthermore, the availability of many different fluorophores with different excitation 
and emission wavelengths makes it feasible to conduct multiplexed assays with which 
several targets within the same sample can be assessed at the same time without cross 
interference. Since aptamers can be readily modified with fluorescence tags, different
approaches have been focused on how to generate fluorescence-labeled aptamers and 
how to detect fluorescence signal changes in response to aptamer binding to its target 
[140-150].
As various fluorophores and aptamer modifications have become commercially 
available, several design strategies have been developed, one of which is based on 
fluorescence resonance energy transfer (FRET). The simplest format is to label 
aptamers with a quencher and either one or two fluorophores, enabling both 
quenching and “light-up” strategies (Figure 1-8). An anti-cocaine DNA aptamer [151]
and an anti-PDGF aptamer [152] were destabilized by truncating one of the stems of a 
three-way junction and labeling the termini with a 5’ fluorophore and a 3’ quencher. 
Ligand binding stabilized the engineered stem and brought the quencher and 
fluorophore in close proximity, resulting in a fluorescence decrease (Figure 1-8a).
However, a potential problem with quenching aptamer beacons is that there are a
variety of ligands or solvents that may interfere with quenching, leading to a false 
positive signal. To overcome this problem, beacons can rely upon FRET to signal. For 
example, in 2002 Tan’s group [153] has noted that in the absence of the protein target,
an equilibrium existed between the random coil state and the quadruplex states of an 
anti-thrombin aptamer. By incorporating two fluorophores, coumarin (donor) and 
fluorescein (acceptor), at the two termini of the aptamer, thrombin binding could be 
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monitored. In this study, the apparent dissociation constant (Kd) and limits of 
detection for the two-fluorophores aptamer beacon were 4.87 ± 0.55 nM and 429 ± 63 
pM, respectively. The FRET beacon gave a ѝ14-fold signal-enhancement factor (the 
ratio of acceptor to donor intensity before and after binding). FRET-type aptamer 
beacons may prove to be particularly useful for real-time analysis of proteins and may 
be used in living specimens in conjunction with ratiometric imaging. Such beacons 
have already been used for the detection of angiogenin in serum samples from healthy 
and lung cancer patients [154]. Aptamers could also be engineered to refold, rather 
than fold. In one experiment [155], sequence was added to an anti-thrombin DNA 
aptamer that fixed it in a molecular beacon–like hairpin structure. Upon the addition 
of thrombin, the conformational equilibrium was shifted from the quenched hairpin to 
the thrombin-bound quadruplex, resulting in dequenching of the fluorophore and the 
creation of an optical signal (Figure 1-8b).
Figure 1-8: Schemes for the target-induced conformation change based quenching and “light-up”
aptamer beacons. (a) Quenching aptamer beacon: Target binding brought the quencher 
and fluorophore in close proximity, resulting in a fluorescence decrease [151, 152] (b) 
“Light-up” aptamer beacon: Upon the addition of thrombin, the conformational 
equilibrium was shifted from the quenched hairpin to the thrombin-bound quadruplex, 
resulting in dequenching of the fluorophore and the creation of an optical signal [155].
Another aptamer-fluorescent biosensor for intact cell detection was created by the 
Jaykus group in 2010 which purified a DNA aptamer with high affinity to pathogenic
Campylobacter jejuni cells through the cell-SELEX approach [156]. In another report, 
a homogeneous label-free quantitation was achieved through measuring fluorescence 
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decrease of crystal violet via the specific interaction between TBA and thrombin 
[157]. A highly sensitive aptasensor was also developed by Chang et al. in 2010 [141]
via the utilization of FRET as the mode of detection on a graphene surface 
immobilized with thrombin selective aptamer. In the resting state, fluorescence was
quenched by the dye-linked aptamer, followed by fluorescence recovery after the 
introduction of thrombin into the system and complex formation.
Besides the common organic fluorescent dyes, quantum dots (QDs) have also been
developed as labels for the sensitive detection [158]. Compared to organic fluorescent 
dyes [159], QDs are highly photostable and the wavelength of the emitted light can be 
controlled by changing the size and composition of the materials. Furthermore, QDs
have a very broad excitation range with sharp emission, making it possible to excite 
different QDs with a single wavelength, while still resulting in a variety of emission 
wavelengths. Dong et al. [160] created a platform that combined aptamer-based 
molecular sensor beacons and a QD-based FRET system in 2010.
Aptamer-functionalized quantum dots interact with graphene oxide, thus resulting in 
fluorescence quenching due to FRET. After the addition of the aptamer-specific target, 
the binding to the aptamers causes an increase in QD-graphene oxide distance, 
inhibiting FRET and enabling fluorescence detection. Such an ability to sensitively 
detect even minor changes in binding could be particularly useful for many 
applications. 
I.2.2.1.3 Chemiluminescence detection
Chemiluminescence detection has been widely applied in various fields, since it 
does not require external light source like fluorescence to produce light signal and 
offers simplicity, low cost, and high sensitivity. It is not surprising that 
chemiluminescence-based aptasensors have recently become a popular field [161, 
162]. Taking advantage of this detection approach, a chemiluminescence system was 
constructed in 2011 on the basis of the lysozyme (LYS) induced fluorescence 
enhancement of aptamer-grafted single-walled carbon nanotubes (SWNTs) and the 
Eu3+ complex (Figure 1-9) [163]. In the absence of LYS, the SWNTs were wrapped 
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by the ssDNA, so that they were well dispersed and remained in the supernatant, 
providing the quenching substrate for the Eu3+ chelates. While in the presence of LYS, 
interaction of the aptamer with LYS made it unable to disperse the SWNTs, after 
centrifugation to separate the SWNTs, BHHT/Eu3+ in solution emitted a strong 
luminescence. 
Figure 1-9: Schematic representation of luminescent biosensor [163]. In the absence of target, the 
SWNTs are in complex with the present aptamers, resulting in the quenching of the 
luminescence signal from the chelated Eu3+. After the addition of the target LYS, which 
binds with the aptamers, the SWNTs aggregate and can be easily removed, resulting in 
the strong unquenched luminescence signal from the added Eu3+.
6LPLODUO\GHWHFWLRQRIRWKHUSURWHLQV OLNHĮ-fetoprotein (AFP), has been reported 
with a sensitivity limit of 5 pg /mL, which was much lower than the classical 
enzyme-linked immunosorbent assay (ELISA). In a report by Ahn et al. in 2009 [164]
an aptamer nanoarray chip-based chemiluminesce immunosorbent assay was 
developed for sensitive detection of severe acute respiratory syndrome (SARS) 
coronavirus nucleocapsid protein. Such a sensitive detection approach could be highly 
valuable for the virus detection, particularly in the light of SARS disease outbreaks a 
few years ago.
Chemiluminescence was also used for the detection of ions like Pb2+ [165]. In a 
particularly interesting report in 2010, Li et al. [166] used isoluminol isothiocyanate
(ILITC) as a chemiluminescent tag on an aptamer, which was then used in a CE-based 
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method to detect the interacting targets. Such an approach has demonstrated the 
capability to calculate the dissociation constant (Kd) and the number of binding sites.
I.2.2.1.4 Fluorescence polarization (FP) detection
The theory of fluorescence polarization is based on the observation that fluorescent 
molecules in solution, excited with plane-polarized light, will emit light back into a 
fixed plane if the molecules remain stationary during the excitation. FP detection 
works particularly well for binding interactions that lead to significant change in the 
size of the molecular system that is associated with a reporter fluorophore. Labeling 
can make use of conventional and readily obtained organic dyes such as fluorescein, 
Texas Red, and carboxytetramethylrhodamine (TAMRA). There is no need for
separation steps to purify complexes from unbound interacting partners, and this 
offers opportunity to determine parameters such as the dissociation constant by 
titration. Various classes of binding agents have been identified including aptamers. 
The molecular size of an aptamer, the availability of functional groups for
fluorescence tagging, and the ability to serve as a binding agent or a displacement 
agent, combine to offer opportunities when considering use of FP to study binding, 
and to develop diagnostic methods and biosensors.
Numerous aptamer-based FP methods targeting small molecules, peptides and 
proteins have been developed in the past few years. The aptamer based FP analysis of 
macromolecules such as proteins is quite simple, and is related to the molecular 
volume change of the aptamer probe upon macromolecular target complexation. In 
1998, Hieftje’s group first developed a FP method for the real-time detection of 
thrombin using aptamer [167]. In a model system, an anti-thrombin DNA aptamer 
was fluorescently labeled and covalently attached to a glass support. Thrombin in 
solution was selectively detected by following changes in the 
evanescent-wave-induced fluorescence anisotropy of the immobilized aptamer. The 
new biosensor can detect as little as 0.7 amol of thrombin in a 140-pL interrogated 
volume, had a dynamic range of 3 orders of magnitude, had an inter-sensing-element 
measurement precision of better than 4% RSD over the range 0-200 nM, and required
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less than 10 min for sample analysis. Since then the FP method has been further 
extended to the detection of other proteins, such as human neutrophil elastase [9],
oncoprotein PDGF [168], IgE [169], angiogenin [170], and lysozyme [171].
In contrast, the FP sensing of a small target appears much more complicated as the 
target binding does not significantly change the size of the labeled functional nucleic 
acid. The former FP-based analysis of small molecules mainly relied on a competitive 
format. In 2009, our group has reported a noncompetitive FP technique dedicated to 
the small molecule sensing [172] (Figure 1-10). This approach was based on the 
unique induced-fit binding mechanism of nucleic acid aptamers which was exploited 
to convert the small target binding event into a detectable fluorescence anisotropy 
signal. An anti-L-tyrosinamide DNA aptamer, labeled by a single fluorescent dye at 
its extremity, was employed as a model functional nucleic acid probe. The DNA 
conformational change generated by the L-tyrosinamide binding was able to induce a 
significant increase in the fluorescence anisotropy signal. The method allowed 
enantioselective sensing of tyrosinamide and analysis in practical samples. The 
methodology was also applied to the L-argininamide detection, suggesting the 
potential generalizability of the direct FP-based strategy. Such aptamer-based assay 
appeared to be a sensitive analytical system of remarkable simplicity and ease of use.
However, this method was confined to certain aptamer system which had a significant 
conformational change upon target binding. 
Figure 1-10: Schematic representation of the noncompetitive FP strategy for the design of the small     
molecule aptasensor [172]. Double arrows represent the possible local and global 
motional contributions to the variation of the fluorescence anisotropy signal.
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In order to generalize the direct approach, our group then established a rational FP 
sensor methodology by engineering instability in the secondary structure of an 
aptameric recognition element [173]. The anti-adenosine DNA aptamer, labeled by a 
single fluorescein dye at its 3’ extremity, was employed as a model functional nucleic 
acid probe. The terminal stem of the stem-loop structure was shortened to induce a 
destabilized/denatured conformation which promoted the local segmental mobility of 
the dye and then a significant depolarization process. Upon target binding, the 
structural change of the aptamer induced the formation of a stable stem-loop structure, 
leading to the reduction of the dye mobility and the increase in the fluorescence 
anisotropy signal. This reasoned approach was applied to the sensing of adenosine 
and adenosine monophosphate and their chiral analysis (Figure 1-11).
Figure 1-11: Proposed representation of the dye local segmental motion contribution (arrow) to the 
variation of the fluorescence anisotropy signal in relation to the aptamer probe structure. 
rf is the fluorescence anisotropy in the absence of analyte [173].
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As a complement to the direct method, our group reported a FP biosensor based on 
an aptamer enzymatic cleavage protection strategy in 2011 [174]. The 
nuclease-mediated size variation of a dye-labeled aptamer induced by the target
binding can be effectively monitored through the analysis of the fluorescence 
anisotropy signal change of the fluorescent probe.
I.2.2.1.5 Mass Sensitive detection
A mass-sensitive biosensor is defined as any device that measures the property that 
scales proportionally to mass associated with or bound to its sensitive surface 
assembled with capture probes. Mass sensitive detection has the advantage of 
recording mass changes on the sensor surface, requiring no additional reagents for the 
labeling. More importantly, these detection methods can be used for the real-time
detection. However, a number of drawbacks are associated with the mass 
change-based sensing, and therefore, it is normally more applicable for the detection 
of large analytes like proteins or cells but typically not for small molecules.
Frequently used mass-sensitive techniques include surface plasmon resonance (SPR) 
[175], quartz crystal microbalance (QCM) [176] and surface acoustic wave device 
(SAW) [177] (Figure 1-12). In an aptamer-based gold nanoparticle (AuNPs) enhanced 
SPR detection, AuNPs, the SPR signal enhancer, was immobilized via DNA 
hybridization with the aptamer sequence. Like the target-responsive electrochemical 
aptamer switch (TREAS) strategy mentioned above, the binding of ATP led to 
formation of tertiary structure between aptamer and the AuNPs tagged 
complementary ssDNA, which finally resulted in the decrease of the SPR signal 
[175].
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Figure 1-12: Mass-sensitive aptasensors. (A) SPR-based aptasensor [175]; (B) QCM-based 
aptasensor [176]; (C) SAW-based aptasensor [177]; and (D) micromechanical 
cantilever-based aptasensor [178, 179].
SAW devices work because mass changes on the surface lead to a change in the 
propagation velocity of acoustic waves, resulting in a reduction in resonance 
frequency or an alteration of the phase shift between the input and output signals. A 
special type of SAW sensor, the Lovewave sensor (which uses horizontal waves 
guided in a layer on the surface of the sensor to reduce energy dissipation of the 
acoustic wave, thereby increasing surface sensitivity), was combined with aptamers 
by Schlensog et al. [177] for the detection of thrombin and a HIV-1 Rev peptide. The 
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detection limits for thrombin and HIV-1 Rev peptide were 72 pg cmí2 and 77 pg cmí2,
respectively. Like SAW, QCM employs piezoelectric quartz crystals, but the latter is a 
simpler and more cost-efficient technique. Aptamers using QCM technique have been 
used for the detection of thrombin (LOD < 1 nM) (96) and HIV-1 Tat protein (LOD 
RISSPȝ/í1 and a dynamic range of 0.25 to 2.5 ppm) [180] by measuring 
the gravimetric resonance frequency change. Aptazymes may be useful for changing 
the relative mass present on a QCM. Knudsen et al. [181] have adapted the catalytic 
activity of both ligation and cleavage aptazymes to the detection of a HIV-1 Rev 
peptide (ligation) or theophylline (cleavage). The catalytic activities of immobilized 
aptazymes on the sensor surface were observed in real time by monitoring changes in 
QCM frequency.
A final example of the use of piezoelectric quartz crystals is the construction of 
microcantilevers that operate in a vibrational mode. Binding is measured by 
monitoring the differential bending between reference (random DNA) and sensor 
(aptamer) cantilevers. Taq DNA polymerase [178] and hepatitis C virus [179] were 
detected using DNA and RNA aptamers with LOD of 15 pM (Kd) and 2.1 pM, 
respectively.
I.2.2.2 Complementary strand displacement mode (or target-induced 
structure switching mode)
The most common design strategy reported in the literature is related to the 
complementary strand displacement approach [137, 182-187]. The fabrication of 
those aptamer-based biosensors is highly depending on the unique conformations of 
aptamers (such as G-quaduplex or hairpin conformation) or the specific 
target-aptamer complex structures. However, in the design of some biosensors, a
complementary strand displacement mode, which belongs to a structure-independent 
strategy, has been proposed [186]. This strategy is related to the unique ability of 
nucleic acids to form duplex structures with their complementary sequences (CS). In 
Chapter I: Literature Review
38
the absence of target, base pairing between the aptamer and complementary sequences
is favored. When the target binds to the aptamer, the hybridization is disrupted,
leading to the release of the complementary strand. Therefore, via adequate labeling 
of the CS and/or the aptamer, the molecular recognition event can be effectively 
converted into a detectable signal. Because of its great simplicity and its very broad 
applicability, the duplex-to-complex change concept has been successfully exploited 
in the design of various aptamer-based assays.
I.2.2.2.1 Electrochemical detection
The electrochemical aptamer sensors based on complementary strand displacement 
strategy can be further classified into signal-off mode [137, 182, 183], signal-on mode 
[184, 186] and label-free mode [185, 187], as shown in Figure 1-13. In signal-off 
mode, the presence of targets can be determined from the signal suppression due to 
the release of redox-tagged aptamer from the electrode into solution. As an example, 
signal-off design for ATP and thrombin assay [137], the redox-tag attached aptamers 
was confined near the electrode surface through the hybridization with their thiolated 
complementary sequence, which was self-assembled on the gold electrode. In the 
absence of targets, the redox-tag gave electrochemical signals. When targets were 
added, the redox-tagged aptamers were released and the electrochemical signals were 
greatly reduced (Figure 1-13A). Signal-on strategy has also been developed. In the 
construction of an ATP biosensor [186], the aptamer hybridized with its thiolated 
complementary sequence which was immobilized on the gold electrode via Au-S
bond. As the target ATP was added, the aptamer sequence was released from double 
strands to form target-aptamer complex. The remained complementary sequence was 
further hybridized with another Fc-moiety modified ssDNA, resulting in the 
appearance of electrochemical signal (Figure 1-13B). Furthermore, label-free 
displacement strategy was also raised. In a faradic impedance spectroscopy (FIS) for 
lysozyme assay [187], the aptasensor was fabricated by self-assembling the partial 
complementary single strand DNA (pcDNA)–lysozyme binding aptamer (LBA) 
duplex on the surface of a gold electrode. To measure lysozyme, the change in 
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interfacial electron transfer resistance of the aptasensor using a redox couple of 
[Fe(CN)6]
3íí as the probe was monitored. The introduction of target lysozyme
induced the displacement of the LBA from the pcDNA–LBA duplex on the electrode 
into the solution, decreasing the electron transfer resistance of the aptasensor, which 
was utilized to quantify the concentration of lysozyme (Figure 1-13C).
Figure 1-13: Schemes for the target-induced complementary strand dissociation/displacement 
strategies. A. signal off mode [137]; B signal-on mode [186]; C label-free mode [187].
I.2.2.2.2 Fluorescence detection
Besides electrochemical biosensors, the complementary strand displacement mode 
has also been widely employed in fluorescence detection biosensors. In the Nutiu and 
Li strategy for the sensing of ATP and thrombin [188] in 2003, a two-stem duplex 
assembly was designed using fluorophore (F) containing DNA at the 5’ end (FDNA) 
and quencher (Q) containing DNA (QDNA) at the 3’ end. The aptamer was linked at 
the 5’ end with a 15-mer sequence complementary to FDNA. QDNA was
complementary to the 5’ end of the aptamer. The length of QDNA was optimized to
meet the requirements of fluorescence quenching and restoration. When all the 
sequences were in complex, the dabcyl quencher was brought into sufficient
proximity to quench the fluorescence signal on FDNA. Upon introduction of the 
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aptamer target, the aptamer–target complex caused QDNA to dissociate from the 
complex, thus restoring fluorescence (Figure 1-14a). The displacement mechanism 
was tested with signals associated with different temperatures as well as the 
introduction of aptamer targets, such as ATP and non-cognate molecules, such as CTP, 
UTP and GTP. The engineering strategy was further expanded to a variety of
modifications, and all yielded similar results. The generality of this design was further 
evaluated for protein detection. Here, the 15-mer thrombin aptamer was engineered to 
generate the required sensor similar to the ones obtained for ATP. By using both ATP 
and thrombin as targets for these sensors, the versatility of these designs to produce 
significant signals for real-time detection, irrespective of the binding affinity or size 
of the aptamer, was demonstrated.
The application of this strategy was further expanded by Yoshida and Yokobayashi
in 2007 [189]. They constructed a pair of DNA-based logic gates that could sense the 
presence of targets to induce a fluorescence signal according to the Boolean logic 
functions AND and OR. Molecular logic gates based on nucleic acids have many 
potential advantages. For instance, the straightforward hybridization rules enable 
convenient interfacing with other molecular computation devices based on DNA and 
RNA. In addition, both DNA and RNA are known to possess catalytic and molecular 
recognition abilities which can be used to provide amplification and sensor functions.
Boolean logic gates have been constructed using organic molecules, peptides, 
proteins, and oligonucleotides. An AND Boolean logic gate was constructed in which 
there was an output only when all of the inputs were present, whereas an OR logic 
gate produced a signal when at least one of the inputs was present. The AND Photonic 
Boolean logic gate was engineered by fusing the adenosine and the thrombin DNA 
aptamers with 11-mer linkers which have a fluorescein conjugation in the middle 
(Figure 1-14b (i)). Two short DNA sequences complementary to part of the aptamers 
and the linkers were conjugated at the 5’ and 3’ ends with quenchers. The binding of 
these two sequences with the linked aptamers bought the two quenchers in close 
proximity to the fluorescein, thereby quenching the fluorescence signal. The
introduction of either adenosine or thrombin, with the concomitant dissociation of one 
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of the quencher sequences, did not restore the fluorescence signal since the remaining 
quencher was strong enough to exert its effect. However, addition of both adenosine 
and thrombin led to the displacement of both quencher DNA sequences, resulting in 
enhanced fluorescence signal. A similar construct was designed for the OR logic gate 
with the following modification. The 11-mer linker lacked the fluorescein conjugation, 
while one of the short DNA strands was modified with fluorescein at the 5’ and the 
other with quencher at the 3’ end (Figure 1-14b (ii)). Here again, the structure of the 
complex quenched the fluorescence signal. Unlike the AND gate, the addition of 
either adenosine or thrombin restored the fluorescence signal with the dissociation of 
either the QDNA or FDNA.
Figure 1-14: (a) The aptamer (blue) is linked at the 5’ end with 15 mer sequence (orange) 
complementary to the fluorophore-labeled strand (green) FDNA, while the quencher 
strand (grey) QDNA, can hybridize with the aptamer. The introduction of the target 
(purple), results in the release of the QDNA from the complex, and the fluorescence
signal is restored [188]. (b) Schemes for the DNA logic gates. The AND logic gate (i) 
is activated only when both targets (purple and brown) of the two aptamers bind, 
causing the release of the quencher sequences from the fluorophore. An OR logic gate 
(ii) can be activated with just one of the aptamer targets [189].
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I.2.2.2.3 Colorimetric detection
Colorimetric assays are another popular optical detection technique. In recent years, 
gold nanoparticles (AuNPs) have been widely used in optical biosensor design, due to 
their unique characteristic spectroscopic changes during target-induced aggregation or 
dispersion. Researchers discovered that adsorption of single-stranded DNA (ssDNA) 
on AuNPs can effectively stabilize the colloid against salt-induced aggregation while 
the double-stranded DNA (dsDNA) has no such function [190-192]. Then 
colorimetric aptamer-based biosensors were developed based on this principle in 2007 
[193]. When the target ATP was absent, the aptamer hybridized with its 
complementary sequence to form a rigid duplex, which could not prevent AuNPs 
from aggregating as salt was added into the system. However, as ATP was present, 
the duplex structure would switch to ATP-aptamer complex coupled with the release 
of its complementary sequence, which could stabilize AuNPs and showed high 
resistance to salt-induced aggregation (Figure 1-15). The changes of solution color 
caused by AuNPs aggregation could be easily observed by naked eyes. And the 
corresponding changes in UV-visible spectra could be used to in a quantitative assay 
for ATP. Similarly, another research indicated that the AuNPs modified by 
target-binding folded aptamer showed higher stability towards salt-induced 
aggregation than the AuNPs modified with unbinding aptamer. A colorimetric 
biosensor was developed for the assay of ATP or K+, according to this target-induced 
structure switching of the aptamer modified on the surface of AuNPs [194].
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Figure 1-15: Scheme for the target-induced structure switching and salt-induced AuNPs aggregation 
[193]. When the target ATP was absent, the duplex structure could not prevent AuNPs
(circles) from aggregating as salt was added into the system. However, as ATP was 
present, the duplex structure would switch to ATP-aptamer complex coupled with the 
release of its complementary sequence, which could stabilize AuNPs and show high 
resistance to salt-induced aggregation.
Thiolated aptamer probes can readily self-assemble at the surface of AuNPs via the 
well-established Au–S chemistry. These AuNP–aptamer conjugates possess a heavily 
loaded DNA monolayer (e.g. over 200 probes on a 13 nm AuNP [195]), with aptamer 
molecules protruding into the solution. Such nanoprobes were extremely stable in 
solutions of high ionic strength since DNA polyelectrolytes bring high-density 
negative charges to the surface. These interesting findings formed the basis of 
biomolecular detection by using AuNPs–aptamer conjugates [196-198].
Lu and coworkers developed a series of methods to detect small molecules based 
on target-induced conformational change in aptamers and disassembly of AuNP 
aggregates [199-202]. In their design, AuNP aggregates were prepared by employing 
a DNA strand containing an aptamer sequence and complementary sequences that 
crosslinked AuNPs. In the presence of the specific target, the target–aptamer binding 
displaced the complementary sequences, which altered the crosslinking state and 
disassembled the AuNPs aggregates. In their experiments, they could detect target 
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molecules (e.g. adenosine and cocaine) from the purple-to-red colour change within 1 
min (Figure 1-16A). Importantly, this strategy can be easily extended to the detection 
of a variety of targets including DNA, protein, small molecules and ions.
Figure 1-16˖Colorimetric detection based on AuNPs/Aptamer conjugate crosslinking nanoprobes (A)
The AuNPs aggregates containing aptamer linkers were used to detect target with 
specific binding with aptamer and disassembled the purple aggregates [199].
Colorimetric detection based on AuNPs/Aptamer conjugate non-crosslinking 
nanoprobes. (B) The aptamer–target binding leads to disassociation from AuNPs surface, 
and a red-to-purple colour change [203].
The non-crosslinking aggregation mechanism by controlling the DNA structure and 
conformation on the AuNPs’ surface has been proposed as an alternative way to 
perform DNA-based sensing. It is well known that DNA strands loaded at the surface 
of AuNPs stabilize AuNPs against high salt concentrations due to the heavy negative 
charge of the DNA polymers [204-206]. However, it was found that the 
conformational change in tethered DNA might significantly alter the stability of 
AuNPs–DNA conjugates against salt induced aggregation. This non-crosslinking 
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system has its own merits. It is a rapid process and is usually much simpler than the 
crosslinking system. Moreover, the accessibility of binding sites is usually higher than 
those encapsulated within aggregates. As a result, the non-crosslinking system has 
been extensively employed to detect analytes such as small molecules, proteases and 
their inhibitors.
In 2008, Zhao et al. proposed a displacement-based adenosine-sensing assay in 
which the addition of adenosine caused displacement of DNA aptamers from the 
AuNP surface, which resulted in the aggregation of AuNPs in salt solution [203]
(Figure 1-16B). Such a structure-switching of DNA aptamers and the salt-induced 
AuNP aggregation formed the basis of a rapid colorimetric assay for adenosine. By 
using this method, the detection process could be completed in 1 min with sensitivity 
comparable to fluorescent assays.
Another interesting colorimetric detection approach recently introduced relies on 
the DNA base-pair recognition on agent-caging hydrogels [207, 208]. Zhu et al.
reported a colorimetric agent-caging hydrogel as a novel visual detection platform 
that relies on DNA base-pair recognition and aptamer–target interactions for simple 
and rapid target detection with the naked eye in 2010 [207] (Figure 1-17). Two pieces 
of DNA, strand A and strand B, were grafted onto linear polyacrylamide polymers to 
form polymer strands A and B (PS-A and PS-B), respectively. The sequences of DNA 
strands A and B were complementary to an adjacent area of a DNA aptamer sequence. 
When mixed in equal amounts, the polymers grafted with strand A and strand B were
in transparent liquid form. The addition of aptamer linker-Apt initiated hybridization 
of strand A and strand B with the aptamer sequence, thus cross-linking the linear 
polyacrylamide polymers. As the hybridization proceeded, the cross-linking ratio of 
polyacrylamide increased, which resulted in the increase of viscosity of the polymer 
solution. The polymer would finally transform into a gel. Upon introduction of a 
target, the aptamer would bind with it, and the gel would be dissolved as a result of 
reducing the crosslinking density by competitive target–aptamer binding. If an 
enzyme was added prior to the addition of the aptamer, the enzyme would be trapped 
inside the 3D network of the hydrogel (represented as pink symbols in Figure 1-17). 
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When target molecules were introduced to dissolve the gel, the enzyme was released 
and can take part in its catalytic role for signal amplification. A cascade of events was
thus set in motion, whereby target binding triggered an enzymatic reaction, which, in 
turn, changeed the substrate color, thus allowing visual detection. As this 
aptamer-based cross-linked hydrogel colorimetric platform can be targeted to any 
ligand for which there was a corresponding aptamer, many visual detection 
applications became possible in a wide variety of fields.
Figure 1-17: Working principle of DNA cross-linked hydrogel for signal amplification and visual 
detection [207]. Addition of the aptamer linker (green) causes the formation of the gel 
structure as a result of the linking of polymer strands A and B (PS-A and PS-B). In the 
presence of the aptamer target (purple), however, the gel will be dissolved as a result of 
reducing the crosslinking density by competitive target–aptamer binding, as a 
consequence, the trapped enzyme is released and can take part in its catalytic role for 
signal amplification.
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I.2.2.2.4 Chemiluminescence detection
The chemiluminescence detection methods based on the complementary strand 
displacement mode have also been developed, especially for small molecules like 
adenosine and cocaine [209-212]. Zhu et al. reported a highly sensitive and selective 
electrochemiluminescent (ECL) biosensor for the determination of adenosine in 2011 
[212]. The decrease of ECL intensity has a direct relationship with the logarithm of 
adenosine concentration in the range of 1.0×10í10 to 5.0×10í6 Mí1. The detection 
limit of the proposed method was 3.0×10 í11 Mí1. The developed biosensor also 
demonstrated very good reusability, as after being reused for 30 times, its ECL signal 
still kept 91% of its original state.
I.2.2.2.5 Fluorescence polarization (FP) detection
As described above, one of the important requirements for a workable FP probe is 
that the molecule being measured should induce a significant change in molecular 
mass before and after recognition. The complementary strand displacement mode, 
thus, offers great potential for the development of FP strategy for the small molecular 
detection. In 2008, Penner et al. reported one example of FP displacement assay for 
ochratoxin A (OTA) [213] based on the increase in the fluorescence anisotropy of 
aptamer when bound by a fluorescently labeled oligonucleotide.
Recently, Yang et al. developed a molecular mass amplifying strategy to construct 
FP aptamer probes for small molecule analysis in complex biological samples [214].
The design of a mass amplifying probe (MAP) is shown in Figure 1-18. Overall, the 
probe was designed in such a way that only when the target molecule bound to the 
probe did it activate its binding ability to an anisotropy amplifier (a high molecular 
mass molecule such as protein), thus significantly increasing the molecular mass and 
FP value of the complex. Specifically, the aptamer probe consisted of a targeting 
aptamer domain (blue ribbon in Figure 1-18) against the target molecule and 
molecular mass amplifying aptamer domain (purple ribbon) for binding with the 
amplifier protein. The probe was initially deactivated by a short blocking strand (cyan 
ribbon) which was partially complementary to both target aptamer and amplifier 
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protein aptamer so that the molecular mass amplifying aptamer domain would not 
bind to the amplifier protein (Scheme 18a), unless the probe has been activated by the 
small molecule target (Scheme 18b). In this way, they prepared two probes that 
constituted a target (ATP and cocaine respectively) aptamer, a thrombin (as the mass 
amplifier) aptamer, and a fluorophore. Both probes worked well against their 
corresponding small molecule targets, and the detection limits for ATP and cocaine 
ZHUH  ȝ0 DQG  ȝ0 UHVSHFWLYHO\ 0RUH LPSRUWDQWO\ EHFDXVH FP was less 
affected by environmental interferences, ATP in cell media and cocaine in urine were 
directly detected without any tedious sample pretreatment. Liang et al. have 
developed an amplified fluorescence polarization aptasensor that relied on aptamer 
structure-switching triggered nanoparticles (NPs) enhancement for biomolecules 
detection [215]. This new type of assay exhibited higher detection sensitivity over 
traditional homogeneous aptasensors by two orders of magnitude and high specificity 
for target molecules.
Figure 1-18: Working Principle of mass amplifying probe for small molecules FP detection [214].
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I.2.2.3 Sandwich or sandwich-like mode
As named, the sandwich mode devices consist of at least three parts, “a piece of 
meat” inserted within “two pieces of bread”. Some protein targets, such as PDGF and 
thrombin, have dual binding sites, which enable them to bind two recognition 
molecules and form sandwich-like complexes. Since these proteins could specifically 
bind either aptamers or antibodies, the sandwich structures have three basic formats: 
aptamer-protein-aptamer, aptamer-protein-antibody and antibody-protein-antibody. 
The first two formats have been widely used in design of aptamer-based biosensors. 
I.2.2.3.1 Electrochemical detection
In order to obtain high specificity and sensitivity, sandwich or sandwich-like mode 
is often employed in aptamer-based electrochemical bioassays. Usually, the 
biocatalytic properties of enzymes are used to detect and to amplify the analysis of 
targets with their aptamers. For example, glucose dehydrogenase (GDH) was 
employed as a biocatalytic label for the amplified amperometric detection of thrombin 
[216]. Thrombin was linked to a 15-mer thiolated aptamer linked to an Au electrode, 
and the GDH-avidin conjugate was linked to the surface by its association to the 
biotinylated 29-mer aptamer bound to the thrombin. The bioelectrocatalyzed 
oxidation of glucose in diffusional mediator enabled the amperometric detection of 
the thrombin.
In an improved approach in 2006 [217], aptamer-functionalized platinum 
nanoparticles (PtNPs) were employed as catalytic labels instead of enzymes (Figure 
1-19A). The PtNPs catalyzed the electrochemical reduction of H2O2 and amplified 
detection of thrombin with an LOD of 1 nM. This assay format is very similar to the 
biocatalytic sandwich-type analysis using GDH but improved the LOD by a factor of 
80-fold. Besides acting as catalysts, NPs (e.g., AuNPs) have also been employed as 
carriers for ultrasensitive electrochemical detection of proteins [218]. In this format,
AuNPs were functionalized with anti-thrombin aptamers containing a poly-adenine 
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(poly-A) sequence. They bound to the thrombin captured by immobilized 
anti-thrombin antibody (Figure 1-19B). The adenine nucleobases were released by 
acid or nuclease degradation and were directly detected using a pyrolytic graphite 
electrode. Because one NP carried a large number of aptamers, the thrombin-binding 
process was substantially amplified, which led to a low LOD of 2.8 pM.
In another sandwich-type electrochemical bioassay, instead of using carriers, the 
aptamers were designed to allow rolling circle amplification (RCA) [219]. As a result,
the aptamer-primer sequence mediated an in-situ RCA reaction that generated 
hundreds of copies of the circular DNA template, leading to significant enhancement 
in the detection sensitivity (Figure 1-19C). This assay strategy produced a wide 
detection range of four orders of magnitude and an LOD as low as 10 fM. Moreover, 
the novel aptamer-primer design circumvented time-consuming preparation of the 
antibody-DNA conjugate in conventional immuno-RCA assays.
Figure 1-19: ‘‘Sandwich’’-type aptamer-based electrochemical sensors with signal amplification. (A) 
Aptamer-functionalized PtNPs were employed as catalytic labels to catalyze the 
electrochemical reduction of H2O2 and enabled the amplified detection of targets [217];
(B) AuNPs functionalized with aptamers containing poly-A were used as reporting 
probes. The adenine nucleobases released from them were directly detected to produce 
amplified signals [218]; and (C) acting as the reporter, the aptamer-primer sequence 
mediated an in-situ RCA reaction, leading to significant enhancement in detection 
sensitivity [219].
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I.2.2.3.2 Optical detection
Functionalized AuNPs with aptamers have also been used for the amplified optical 
detection of proteins in the sandwich configuration [220]. The anti-thrombin aptamer
was covalently attached to a maleimide-functionalized siloxane monolayer, and 
thrombin was bound to the interface. The same aptamer-functionalized AuNPs were 
then associated to the second thrombin binding site. The resulting AuNP interface was 
then enlarged in growth solution containing HAuCl4 and reducing agents (Figure 
1-20A). The enlargement of AuNPs significantly improved the colorimetric detection 
sensitivity, which could detect as few as 2 nM thrombin. More recently, Li et al. 
reported a similar approach that employed silver amplification [221] (Figure 1-20B). 
Their assay simultaneously employed an AuNP-aptamer and a biotin-aptamer that 
bound to the PDGF, with an extremely low LOD of 83 aM.
Figure 1-20: The ‘‘sandwich’’ type aptamer-based colorimetric bioassays with gold (A) [220] and 
silver (B) [221] amplification systems.
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I.2.3 Aptamer-Based Affinity Separation and Purification
I.2.3.1 Chromatography
Aptamers have also been employed in various chromatography techniques, such as 
liquid chromatography [222] and electrochromatograpy [223]. The advantages of 
aptamers applied in this field are obvious: wide targets enlarge the range of analytes 
that can be used; easy synthesis reduces the cost; selected as functional 
oligonucleotides decreases the adsorption (compared with antibodies); and high 
affinity guarantees a high selectivity and separation effect. Based on these advantages, 
processes such as molecular recognition [224, 225], quantitative detection [226],
analogy separation [227], and even chiral selection [228-230] have been undertaken 
using aptamer-based chromatography analysis. Chromatography techniques are also 
used to assist the SELEX procedure and exhibit increasing potential in this field.
Generally, two strategies have been described for the aptamer immobilization on 
the chromatographic surface. The first immobilization approach involves the 
non-covalent binding of the aptamer on a functionalized matrix. The second approach 
is related to the covalent immobilization of the oligonucleotide on the 
chromatographic surface. In most cases, the aptamer immobilization has been 
achieved using the well-known non-covalent biotin–streptavidin bridge. This type of 
ligand immobilization is frequently chosen because the procedure appears to be easy 
and rapid to perform. Furthermore, the biotin–streptavidin bridge is known to 
maintain efficiently the receptor (aptamer) binding ability. Immobilization of aptamer 
was commonly attained, by mixing streptavidin chromatographic support with the 
aptamer solution during some hours at 4°C or ambient temperature. About 15–20
nmol of aptamer for 100 µL of separation media are commonly bound using this 
strategy [227, 229, 231]. Despite the simplicity and the rapidity of this immobilization 
methodology, such kind of binding procedure presents, in terms of reusability and 
column lifetime, some major drawbacks for a practical chromatographic use. 
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Although the streptavidin–biotin link is very strong in solution, the magnitude of the 
streptavidin–biotin binding constant is greatly reduced when the protein is bound to a 
surface [232]. In addition, dissociation of the biotin–streptavidin complex can occur at 
relatively low temperatures, notably in nonionic aqueous solutions or in medium 
containing a low salt concentration [233]. Furthermore, as classically observed with 
proteins, the immobilized streptavidin can be also irreversibly denatured under 
standard reverse phase chromatographic conditions, for example by using a mobile 
phase containing organic modifiers [234]. Therefore, covalent immobilization 
strategies have been also described. These involve attachment of the oligonucleotide 
through the formation of amide or carbamate bonds [235-237]. These approaches 
allow working under more drastic conditions. For example, it has been demonstrated 
that the analyte separation can be performed at relatively high temperatures [237] and 
using strong proportion of organic solvent (methanol, ethanol, acetonitrile,
isopropanol) [236, 237], without alteration of binding ability of the immobilized 
aptamer. In addition, a very good stability over the time can be obtained, even under 
various conditions of use and storage [237].
A variety of aptamer-based stationary phases have been described for the 
separation and purification of small molecules and proteins using open tubular 
capillaries, packed bed columns and monolithic columns [238-240].
I.2.3.1.1 Aptamer-based stationary phases for protein separation
In 1999, Drolet et al. reported an aptamer affinity chromatography for the protein 
purification [222]. A DNA-aptamer specific for human L-selectin was immobilized 
on a chromatography support to create an affinity column. This column was 
effectively applied as either the first or second step in the purification of a
recombinant human L-selectin–Ig fusion protein from Chinese hamster ovary 
cell-conditioned medium. The fusion protein was efficiently bound to the column and 
efficiently eluted by gentle elution schemes. Application of the aptamer column as the 
initial purification step resulted in a 1500-fold purification with an 83% single step 
recovery. In 2005, Lee et al. developed a bead affinity chromatography system to 
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purify specific target proteins on a chip [241]. The microbead affinity
chromatography system, which is based on photolytic elution, was integrated into a 
glass-silicon microchip and tested by the biotin-streptavidin model system. In addition, 
they presented result of the detection of hepatitis C virus (HCV) RNA replicase from
a protein mixture using the microsystem packed with the beads immobilized with 
photo-cleavable RNA aptamer.
Taking advantage of the specific affinity of aptamers and the porous property of the 
monolith, Le’s group developed a capillary chromatography technique for the 
separation and detection of proteins in 2008 [239]. A biotinylated DNA aptamer 
targeting cytochrome c was successfully immobilized on a streptavidin-modified 
polymer monolithic capillary column. The aptamer, having a G-quartet structure, 
could bind to both cytochrome c and thrombin, enabling the separation of these
proteins from each other and from the unretained proteins. Elution of strongly bound 
proteins was achieved by increasing the ionic strength of the mobile phase. The
following proteins were tested using the aptamer affinity monolithic columns: human 
immunoglobulin G (IgG), hemoglobin, transferrin, human serum albumin, 
cytochrome c, and thrombin. Determination of cytochrome c and thrombin spiked into 
dilute serum samples showed no interference from the serum matrix. The benefit of
porous properties of the affinity monolithic column was demonstrated by selective 
capture and preconcentration of thrombin at low ionic strength and subsequent rapid
elution at high ionic strength. The combination of the polymer monolithic column and 
the aptamer affinities made the aptamer-modified monolithic columns useful for 
protein detection and separation.
I.2.3.1.2 Aptamer-based stationary phases for small molecule separation
The first aptamer affinity chromatography for small molecule separation was 
reported by Kennedy’s group in 2001 [227]. A biotinylated-DNA aptamer that binds 
adenosine and related compounds in solution was immobilized by reaction with 
streptavidin, which was covalently attached to porous chromatographic supports. The 
aptamer medium was packed into fused-silica capillaries (50-150 µm i.d.) to form 
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affinity chromatography columns. Variation of mobile-phase conditions revealed that 
ionic strength and Mg2+ level had strong effects on retention of analytes while pH and 
buffer composition had less effect. It was demonstrated that the column could 
selectively retain and separate cyclic-AMP, NAD+, AMP, ADP, ATP, and adenosine, 
even in complex mixtures such as tissue extracts. Based on this, an aptamer affinity 
chromatography for rapid assay of adenosine in microdialysis samples collected in 
vivo was also developed in 2003 [242]. The aptamer stationary phase was the same as 
the previous one, but the mobile phase is modified to allow selective retention of 
adenosine. The adenosine assay, which required no sample preparation, was used on 
microdialysis samples collected from the somatosensory cortex of chloral hydrate 
anesthetized rats. Total analysis times were shortened enough that dialysate samples 
could be injected every 5 min.
The enantioselective properties of DNA or RNA aptamers selected against a target 
enantiomer were adopted to create a new class of target-specific chiral stationary 
phases (CSPs). The first example of aptamer-based CSP specifically designed against 
the racemate to resolve has been described by our group in 2003 using a DNA 
oligonucleotide as selective ligand. The enantiomers of arginine-vasopressin have 
been separated using an immobilized 55-base DNA aptamer known to bind 
stereospecifically the (all-D)-isomer of the oligopeptide [228]. The immobilization 
was achieved using the biotin-streptavidin interaction, as previously described by 
Kennedy and co-workers [227]. The influence of various parameters (such as column 
temperature, eluent pH and salt concentration) on the enantiomer retention has been 
investigated in order to provide information about the binding mechanism and then to 
define the experimental conditions of the aptamer column. Very important apparent 
enantioselectivity was observed, the non-target enantiomer being roughly not retained 
by the column. More, it has been shown by thermodynamic analysis that both 
dehydration at the binding interface, charge-charge interactions and adaptive 
conformational transitions contributed to the specific (all-D)-peptide aptamer complex 
formation. Furthermore, it was established that the aptamer column was stable during 
an extended period of time. In a further work in 2004, such an approach has been 
Chapter I: Literature Review
56
extended to the chiral resolution of small molecules of biological interest [231]. The 
DNA aptamers used have been selected against the D-adenosine and L-tyrosinamide 
enantiomers. An apparent enantioseparation factor of around 3.5 (at 20°C) was 
observed for the anti-D-adenosine aptamer CSP while a very high enantioselectivity 
was obtained with the immobilized anti-L-tyrosinamide aptamer. This allowed 
obtaining baseline resolution even at a relative high column temperature. The 
anti-D-adenosine aptameric stationary phase can be used for two months without loss 
of selectivity while some performance degradation was observed for the 
anti-L-tyrosinamide column over this period. As an important complement, a CSP 
based on the L-RNA aptamer was also developed by our group in 2005 [229]. It was 
shown that this approach was a very simple and powerful strategy to develop a highly 
stable stationary phase due to the intrinsic insensitivity of L-RNA to the RNase 
degradation. And this method was extended to resolution of the enantiomers of 
tyrosine and other analogues (11 enantiomeric pairs) [230].
In addition to the separation of simple targets, Tan’s group reported the selective 
capture of cancer cells from a flowing suspension on a simple square capillary by 
immobilizing aptamers in the capillary [243]. More than 90% capture efficiency can 
be obtained through this device. The method was extended to aptamer-based 
differential mobility cytometry for highly efficient enrichment of rare cells [244].
I.2.3.2 Capillary electrophoresis (CE)
For the capillary electrophoresis analysis, two areas of great importance are the 
separation of species and the characterization of affinity interactions. For the 
quantification of analytes, ligands may interact with the analyte before and/or during 
electrophoresis [245]. The analysis of preincubated target-ligand mixtures is the 
approach especially useful for quantitative measurements of analytes that form with 
high-affinity complex with the ligand. Such CE assays are based on separating the 
analyte-ligand complexes from the free analyte and free ligand by capillary 
Chapter I: Literature Review
57
electrophoresis. Both competitive and non-competitive (direct) assays can be used
[245]. In the competitive assay, the analyte is labeled and competes with the 
unlabeled solute in the sample for binding to a limited amount of the corresponding 
ligand. A CE separation of the mixture produces two distinct peaks corresponding to 
the free labeled analyte and the labeled analyte bound to the ligand, allowing the 
quantification of the target. In the direct assay, the ligand is labeled and added at a 
constant concentration to the sample for binding the target. Detection and 
quantification of the complex peak or free ligand peak is related to the amount of the 
analyte in solution. 
Various interacting systems have been studied by capillary electrophoresis using
proteins, antibodies or DNAs as specific ligands. The CE assays based on the 
formation of antigen-antibody complexes are the most frequently formats reported. In 
principle, direct assays possess several advantages over competitive assays including 
larger dynamic range, detection limits that are less dependent upon binding constant 
between the analyte and the ligand and ability to distinguish among cross-reactive 
species [226]. However, antibodies present some drawbacks for application in such 
noncompetitive approach. They are electrophoretically heterogeneous and do not 
migrate as a single sharp peak. More, the fluorescent label may interfere with binding 
if it is too close to the binding site. On the other hand, aptamers possess several
advantages over antibodies that make them especially valuable in direct affinity 
capillary electrophoresis. They are simple to fluorescently label, possess predictable 
electrophoresis properties and relatively low molecular mass which simplify the 
separation of complex from free aptamer.
I.2.3.2.1 Aptamer-based capillary electrophoresis for protein detection
Affinity probe capillary electrophoresis (APCE) refers to a collection of techniques 
in which high-affinity binding is used in conjunction with CE separation to determine 
analytes. Combined with laser-induced fluorescence (LIF) detection, this technique
has demonstrated potential for rapid determination of trace levels of analyte in 
complex mixtures. In 1998, Kennedy et al. reported the first application of aptamers 
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to noncompetitive APCE [226]. A DNA aptamer against IgE was labeled with 
fluorophore and used as a selective fluorescent tag for determining IgE by capillary 
electrophoresis with laser-induced fluorescence detection. CE-LIF separations of
samples containing fluorescently labeled aptamer and IgE were complete in less than 
60 seconds and revealed two zones, one corresponding to free aptamer and the other 
to aptamer bound to IgE. The free aptamer peak decreased and bound aptamer peak 
increased in proportion to the amount of IgE in the sample so that IgE could be 
detected with a linear dynamic range of 105 and a detection limit of 46 pM. The assay 
was highly selective as aptamer was unaffected by the presence of IgG and IgE did 
not bind other DNA sequences. IgE was determined in serum samples with similar 
analytical figures of merit. Similar conditions using a thrombin aptamer allowed 
detection of thrombin. In a further work, Tan et al. reported the investigation of 
protein-protein interactions using molecular aptamers with affinity capillary 
electrophoresis (ACE) [246]. This assay has been applied to quantify 
thrombin-anti-thrombin III interaction and to monitor this reaction in real time. And 
this assay can be an effective approach for studying protein-protein interactions and 
for analyzing binding site and binding constant information in protein-protein and 
protein-DNA interaction studies.
In 2003, Krylov’s group proposed a new method that allowed the use of low
affinity aptamers as affinity probes in quantitative analyses of proteins [247]. The 
method was based on nonequilibrium capillary electrophoresis of the equilibrium 
mixture (NECEEM) of a protein with its fluorescently labeled aptamer. The 
NECEEM method was applied to the analysis of thrombin using a fluorescein-labeled 
aptamer under the conditions at which the protein-aptamer complex completely 
decayed during the separation. They demonstrated that, despite the decay, as few as 4 
×106 molecules of the protein could be detected with NECEEM without sacrificing
the accuracy. This sensitivity was comparable with that reported by others for the 
aptamer-based equilibrium method. Thus, the proposed NECEEM-based method
allows the use of aptamers for highly sensitive affinity analysis of proteins even when 
protein-aptamer complexes were unstable.
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In a separate study, Girardot et al. [248] applied CE to study the interaction 
between lysozyme and aptamer mediated by both monovalent and divalent cations. 
They found that the binding between an aptamer and its target was highly dependent 
on the conformation of the aptamer molecule. The experimental setup allowed them 
to calculate apparent binding constants for divalent cations. Zhang et al. [249]
introduced another CE technique based on a tunable aptamer for the separation and 
detection of platelet derived growth factor (PDGF) isomers and their receptors in 
diluted serum samples. The aptamer can form a stable complex with the B chain but 
not with the A chain of PDGF, resulting in the difference in electrophoretic mobilities 
of PDGF isomers. 
Methods of kinetic capillary electrophoresis (KCE) facilitated highly efficient 
selection of DNA aptamers for protein targets. The inability to detect native proteins 
at low concentrations in capillary electrophoresis created, however, a significant 
obstacle for many important protein targets. Krylov et al [250] suggested that protein 
labeling with new Chromeo dyes can help to overcome this obstacle. By labeling a 
number of proteins with Chromeo P503, the labeling procedure enabled accurate 
detection of proteins in CE without significantly affecting their electrophoretic 
mobility or their ability to bind DNA. Protein adsorption to inner capillary walls 
created a major obstacle in all applications of capillary electrophoresis involving 
protein samples. Recently, Krylov et al. [251] introduced a simple pressure-based 
method for the qualitative assessment of protein adsorption that can facilitate the 
direct antiadhesive ranking of several coatings toward a protein of interest.
I.2.3.2.2 Aptamer-based capillary electrophoresis for small molecule detection
Compare to the protein analysis, small molecule detection by aptamer-based CE is 
more complicated as the electrophoretic mobility of aptamer-target complex and free 
aptamer is similar. New strategies have been developed to circumvent this problem. 
For example, some intrinsic properties of the target molecules could be beneficial for 
the development of a new label-free aptamer-base CE method. Cocaine contains a 
tertiary amino group and can generate strong electrochemiluminescence (ECL) 
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emission on a platinum electrode in the presence of tris(2,2’-bipyridyl)ruthenium(II) 
[Ru(bpy)3]
2+. Arginine can be electrochemically oxidized on a copper electrode to 
generate strong electrochemical (EC) signal; the derived argininamide also possesses 
a high EC activity. However, when the targets are bound to aptamers, they show no 
luminescent or electrochemical activity. Based on specific chemical and physical 
properties of these small target molecules, Deng et al. reported a novel label-free 
method for the investigation of the adaptive recognition of small molecules by nucleic 
acid aptamers using capillary electrophoresis analysis in 2007 [252, 253].
Aptamer-based capillary electrophoresis was also applied to design a highly 
enantioselective tool for the trace enantiomer detection. In 2006, our group reported
the chiral resolution of arginine using an anti-arginine L-RNA aptamer chiral selector 
in partial-filling CE [254]. The effects of the capillary temperature, sample load, and 
aptamer plug length on the enantiomeric separation were assessed. In a further work
in 2007, an aptamer-based stereoselective assay was developed using an affinity 
capillary electrophoresis-based competitive, homogeneous format and an on-capillary
mixing approach [255]. Detection of as low as 0.01% of the minor enantiomer in a 
nonracemic mixture can be achieved, in a short analysis time (<5 min). To improve 
the assay sensitivity, a “hybrid” strategy was developed by our group in 2008 [256]
which based on a pre-incubation/on-capillary mixing format using an enantioselective 
aptamer as affinity ligand. And in 2009, our group also developed an 
aptamer-modified micellar electrokinetic chromatography methodology which
focused on the specific shift of the aptamer mobility in the presence of a nonionic 
micellar phase [257]. The general principle is illustrated in Figure 1-21.
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Figure 1-21: Principle of the aptamer-modified MEKC mode [257]. (a) A PVA-coated capillary 
is prefilled with three different plugs, (i) a plug containing a quasi-immobile 
nonionic micellar phase, (ii) a plug containing the cholesteryl-tagged aptamer, and 
(iii) a plug containing the AMP sample. (b) When the electric field is applied, the 
mobility of Chol-Apt is strongly reduced in direct relation to its partitioning into the 
micellar pseudophase so that the AMP enantiomers pass through the 
micelle-anchored aptamer zone. (c) The stereoselective interaction between AMP 
and the micelle-interacting aptamer zone led to the chiral separation. Arrows 
indicate the migration direction of the interacting species when the electric field is 
applied, and their respective lengths represent the expected velocity magnitude.
This work reported a new enantioselective aptamer-based CE mode where an 
aptamer-modified pseudostationary phase was created during the run by an 
on-capillary mixing approach and served as the active chiral discriminating zone in a 
partial-filling format. Such an approach allowed extending the use of the CE aptamer 
to enantioseparation of an anionic target which displayed an electrophoretic mobility 
identical to that of the selector. The separation window width, selectivity, resolution, 
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and analysis time can be efficiently modulated by varying some critical 
electrophoretic factors such as the concentration and the nature of the surfactant, the 
applied voltage, or the capillary temperature. Moreover, such aptamer-modified 
MEKC mode could be also find applications in the achiral analysis field for the 
development of affinity CE assays dedicated to small negatively charged analytes or 
for the separation of small anionic targets and analogues on the basis of their 
respective binding affinity for the aptamer ligand.
I.2.3.3 Microfluidics
For the last few years, increasing efforts have been made to combine aptamers with 
microfluidics technique. Microfluidics integrates one or several laboratory procedures, 
such as sample preparation, reaction, separation, detection on a single chip, ranging 
from millimeters to a few square centimeters in size. The introduction of aptamers on 
a microchip has been expected to bring several advantages to the field, such as 
reduced reagent and sample consumption, simplicity, automated processing, faster
separation, high throughput, and portability. In 2009, Tan’s group [258] immobilized
aptamers in a microfluidic channel to capture rare cells to achieve a rapid assay 
without any pretreatment (Figure 1-22). Their device has demonstrated both 
outstanding enrichment purity (97%) and over 80% capture efficiency. They were 
able to further extend the utility of their microfluidic device to simultaneously sort, 
enrich, and then detect multiple types of cancer cells in a complex sample [259].
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Figure 1-22: Aptamer-based capture and enrichment [258]. Immobilized sgc8 aptamer was used to 
capture its target cells. (A) Schematic representation of the aptamer immobilization and 
target capture. (B) Specific capture of the target cells using the sgc8 aptamer. (C) 
Representative capture of the control cells using the sgc8 aptamer. (D) Capture of the
target cells using immobilized random DNA sequence. (E) Capture of the control cells 
using immobilized random DNA sequence.
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As another example of the use of aptamer microfluidic devices for bioanalysis, Reif 
et al. [260] have designed a microfluidic device for the simultaneous capture and
induction of apoptotic cells in Jurkat cells, providing a tool for the study of the 
mechanisms and temporal dynamics of apoptosis. The Soper group [261] has also 
utilized an aptamer-immobilized microfluidic device to selectively capture low 
abundant cancer cells. In their study, aptamers recognizing prostate-specific
membrane antigen (PMSA) were selected and immobilized onto the surface of a 
microchip and fabricated into a high-throughput microsampling unit. Such 
combination of sensitive technology and selective aptamer binding resulted in the 90%
recovery rate of rare circulating prostate tumor cells from a peripheral blood matrix.
As another interesting development in aptamer-based microfluidics, Soh et al. [262]
introduced the microfluidic electrochemical aptamer-based sensor (MECAS) chip by 
integrating target-specific DNA aptamers that can generate an electrochemical signal 
through conformational changes in response to the analyte binding. The system was 
applied to achieve continuous, real-time monitoring of cocaine in blood serum at the 
physiologically relevant concentration and with physiologically relevant time 
resolution. In another study in 2010, Huang et al. [263] have combined flow 
cytometry with aptamer-functionalized magnetic microparticles for the detection of
adenosine in serum.
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I.2.4 Conclusions
Due to their excellent characteristics of high affinity and selectivity, aptamers have 
been considered as one of the most promising molecular recognition elements in 
biosensor fabrication. This chapter covered recent research progress in the 
development of aptamer-based or aptamer related biosensing systems and the 
aptamer-based biosensors were classified into three basic modes: target-induced 
conformation change mode, complementary strand displacement mode, sandwich or 
sandwich-like mode. Based on these three basic strategies, aptamer-based affinity 
separation and purification and various detection methods for aptamer-based assays 
were also discussed. Taking into account that such aptasensors emerged only about 10 
years ago, it is clear that significant progress has been made in employing nucleic acid 
aptamers for biosensing applications.
However, several challenges still remain. First, only a small range of targets have 
already been detected using aptamer-based biosensors, and the total number of nucleic 
acid aptamers discovered so far is still much less than that of antibodies. It is thus 
highly desirable to create new, easy and universal methodology for aptamer discovery. 
Second, up to now, most of the aptamer-based assays are confined to standard 
samples, only a few of them have been applied in detection of real samples, such as 
serum or blood, great challenges still remain for the future clinical applications in the 
sophisticated physiological environment. In addition, in comparison with the 
conventional bioassay method (such as ELISA), many elegant aptamer-based 
biosensing systems are still not highly sensitive, which implies that plenty of work 
could be done to make aptamer-based biosensors to be well-established bioanalytical 
tools. 
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II.1 Objective of the work
Although aptamers have been extensively used in many analytical applications as reviewed 
in chapter I, there are still plenty of potentials to explore for aptamer-based assays. One major 
challenge is that most of the assays are confined to macromolecules such as proteins since the 
binding event leads to a significant structure change which can be easily converted into a 
detectable signal. Aptamer-based small molecule detections are not widely investigated. 
Furthermore, compare to the conventional bioassay method (such as ELISA), many 
aptamer-based biosensing systems are still not highly sensitive, which limits the application of 
aptamers in sophisticated physiological environment. In such circumstances, to explore rapid, 
sensitive and signal amplification strategy for small biomolecule analysis would be highly 
valuable.
The objective of the present work is to establish novel methodologies of aptamer-based 
assay for the small biomolecule detection, using model targets such as adenosine, 
tyrosinamide and argininamide. According to the different experimental methods, three major 
works will be described in this chapter: aptamer-based capillary electrophoresis, gold 
nanoparticle colorimetric and fluorescence polarization assays.¾ Our group has already reported aptamer-based CE assay dedicated to small molecule. 
However, the method is confined to a single analyte detection [257]. In order to 
develop a multiplexed format, a novel structure-switching aptamer-based micellar 
electrokinetic chromatography (MEKC) methodology has been designed.¾ Taking advantages of specific DNA discriminating feature of AuNP, various 
aptamer-based gold nanoparticle colorimetric assays have been already developed. In 
order to increase both simplicity and general applicability, a label-free, homogeneous 
aptamer-based sensor strategy for the facile colorimetric detection of small target 
molecules has been described.¾ Fluorescence polarization/fluorescence anisotropy (FP/FA) is a versatile and 
powerful technique that has been widely used to study biomolecular binding
interactions. However, FP aptamer-based small molecule detection remains a 
challenge as their molecular masses are relatively too small to produce observable 
FA value changes. To circumvent this problem, a complementary strands (CS) 
displacement strategy and a single-stranded DNA binding protein (SSB)-assisted 
strategy have been developed.
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II.2 Multiplexed detection of small molecules by aptamer-based capillary 
electrophoresis
II.2.1 Introduction
II.2.1.1 General description of capillary electrophoresis
Separation of components in analytical chemistry is of great importance in qualitative and
quantitative analysis. Due to attractive analytical features such as low sample and reagent 
consumption, short analysis time, high separation performances, ease of automation, and the 
possibility of probing molecular interactions under physiological conditions, the capillary 
electrophoresis (CE) constitutes one of the most powerful separation techniques. CE has been
widely used in several major fields, such as food analysis [264], pharmaceutical and 
biomedical analysis [265], clinical and forensic analysis [266], environmental samples [267],
and biotechnology [268]. The present focus of CE has been on method development and 
applications of CE to a large variety of analytical problems. 
Capillary electrophoresis comprises a family of techniques that have dramatically different 
operative and separative characteristics. The techniques are:
Capillary zone electrophoresis (CZE) is the simplest and most common mode of CE. In 
CZE, analytes are free to move under an applied voltage depending on their individual 
structure and the interactions with the uniform buffer.
Capillary gel electrophoresis (CGE) is useful for separations of nucleic acids, proteins and
carbohydrates, because CGE is based on differences in solute size as analytes migrate through 
the pores of the gel-filled column.
Capillary isoelectric focusing (CIEF) is used for the separation of amphoteric analytes. The 
principle of CIEF is based on the electrophoretic mobility changes of analytes at a pH 
gradient in a capillary.
Micellar electrokinetic chromatography (MEKC) has the capability of separating both
charged and neutral compounds based on the partitioning of analytes into micelles. It is a 
significant extension of the CE method
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II.2.1.2 Instrumentation
The system for capillary electrophoresis experiments mainly consists of four parts:
capillary, high-voltage power supply, sample injection system and detection devices. A 
voltage is applied to two separation-buffer vials across the capillary through platinum
electrodes. Sample solution is introduced into one end of the capillary under a pressure or 
electric field. The high-voltage power supply and the detector are controlled by a computer. 
Data are recorded and processed with software. In commercially available CE systems, a 
cooling system is often integrated to thermostat the capillary during separation.
The core of a CE system is the capillary in which separation is performed. Fused silica is 
the most commonly-used capillary substrate. Advantages of fused silica include excellent 
transparency, high thermal conductance and feasible fabrication with various diameters. The 
internal diameter (I.D.) varies between 10-100 ȝm and the outer diameter (O.D.) ranges from 
190 to 366 ȝm. The length of capillary is selected as needed, generally from 20-100 cm. 
Fused silica is fragile. Therefore, a layer of polyimide is coated on the outer surface. This 
coating provides capillary with flexibility and durability. Polyimide is non-transparent and 
shows high absorptivity in UV. Therefore, a small part of the polyimide coating is removed 
by burning for the detection window. Capillaries are generally provided without internal 
coating and have bare internal walls. The internal walls of a capillary can be modified to 
adjust electroosmotic flow (EOF) and reduce adsorption of analytes [269]. Therefore, internal 
walls can be chemically or physically coated with polymers or surfactants. The 
commonly-used detection methods in CE include UV-VIS absorbance, fluorescence and 
laser-induced fluorescence (LIF), and electrochemical detection.
II.2.1.3 Electroosmosis
Electroosmotic flow (or electro-osmotic flow, often abbreviated EOF; synonymous with 
electroosmosis or electroendosmosis) is the motion of liquid induced by an applied potential 
across a porous material, capillary tube, membrane, microchannel, or any other fluid conduit. 
Because electroosmotic velocities are independent of conduit size, as long as the double layer 
is much smaller than the characteristic length scale of the channel, electroosmotic flow is 
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most significant in small channels. EOF is an essential component in capillary electrophoresis
and it can occur in natural unfiltered water, as well as buffered solutions.
Figure 2-1: Schematic diagram of electroosmotic flow (EOF) [62].
The principle of electroosmosis is based on the double-layer formation close to the
capillary inner wall as shown in Figure 2-1. For a silica capillary, silanol groups ionize when 
they are exposed to the buffer solution. The extent of silanol ionization depends notably on
the pH of buffer. The higher the pH is, the more extensive the ionization will be. The 
negatively charged capillary wall attracts a layer of cations from the bulk buffer solution. This 
layer is essentially static and called the Stern layer. The outer edge of the Stern layer is called 
the outer Helmholtz plane (OHP). Immediately adjacent to the OHP, a diffuse layer is formed 
with cations exponentially distributed according to the distance from the capillary wall. There 
is a layer defined as the shear plane at which hydrodynamic motion becomes possible, and the 
]HWDSRWHQWLDO ȗ LV WKHSRWHQWLDODW WKLV shear plane [270, 271]. When a potential is applied 
across the buffer-filled capillary, cations in the diffuse layer move to the cathode and anions 
to the anode. The moving ions produce bulk flow due to the water of hydration that is carried 
with them. The magnitude (Veo) of EOF is determined by Equation 1[270].
(1)
Chapter II: Experiments and Reslutls
96
ZKHUHİ LV WKHGLHOHFWULFFRQVWDQWSHUPLWWLYLW\RI WKHEXIIHUȗ LV WKH]HWDSRWHQWLDOȘLV WKH
viscosity of the buffer, and E is the applied electric field strength in V/cm. The factor in 
Equation 1 LVGHILQHGDVHOHFWURRVPRWLFPRELOLW\ȝeo) as shown in Equation 2.
(2)
7KH]HWDSRWHQWLDOȗLVUHODWHGWRWKHVXUIDFHFKDUJHGHQVLW\ıFKDUJHSHUXQLWVXUIDFHDUHD
as shown in Equation 3.
(3)
where įLVWKHGRXEOH-layer thickness. By substituting Equation 3 into Equation 2, the
electroosmotic mobility is expressed as in Equation 4.
(4)
The magnitude of electroosmotic mobility is commonly determined using a neutral marker,
which is carried by the background buffer and migrates at the mobility of EOF. Mobility is 
the migration velocity under unit electric field strength. The migration time (to) of the neutral 
marker can be determined through electropherograms. The applied voltage (U), the total (L)
and the effective (l) lengths of the capillary are known as the running conditions. Therefore, 
ȝeo can be easily determined according to Equation 5.
(5)
Mobilities are usually expressed in the unit of cm2/Vs. The magnitude of ȝeo typically
ranges from 10-6 to 10-4 cm2/Vs. Reproducible EOF is highly desirable for identification and
quantitation of analytes, because the area of peaks is dependent on the residence time of 
analytes in the detection window. In addition, uniform EOF produces good precision.
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II.2.1.4 Electrophoretic migration
Electrophoretic migration is a kind of ion movement that is caused by the electric force 
when exposed to an electric field. The magnitude of the electrophoretic migration is often 
reported as electrophoretic mobility (cm2/Vs) or electrophoretic velocity (cm/s) in a specific 
electric field in a buffer (Figure 2-2).
This electrokinetic phenomenon was observed for the first time in 1807 by Reuss (Moscow 
State University), who noticed that the application of a constant electric field caused clay 
particles dispersed in water to migrate. It is ultimately caused by the presence of a charged 
interface between the particle surface and the surrounding fluid.
Figure 2-2: Scheme of electrophoretic migration [60].
When a compound is dissolved in buffer, it may ionize and exist in several forms at 
equilibrium. At an infinitely diluted solution, the ionic interactions are negligible. Under an 
applied voltage across the solution, an electric field is produced across the
solution-boundary-defined container, such as a capillary. Ions in the electric field will be
accelerated by electric force (fe) and reach a steady migration velocity relative to the solution. 
The hydrodynamic buffer is viscous and produces a frictional force (fd) which hinders the 
movement of ions. When the ion is accelerated to a specific magnitude, the frictional force (fd)
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will be equal to the magnitude of fe. Under these conditions, the ion migrates at a constant 
electrophoretic velocity in the homogenous electric field. 
The situation about the electrophoretic mobility discussed above is at an ideal condition in
which no electrostatic interaction exists at infinite dilution. This situation produces the 
so-called ‘absolute electrophoretic mobility’, which is proportional to the equivalent 
conductance at infinite dilution. In practical applications, analyte ions are surrounded by 
many counterions present in the buffer solution. These counterions form a so-called ionic 
atmosphere that causes retardation and relaxation to the ions centered in it. Therefore, the 
charge (ze0) on the ion needs to be replaced by the smaller effective charge (qeff) and the 
radius (r) by the larger hydrodynamic radius (R) that includes the ionic atmosphere [272].
(6)
where ȝep is defined as the effective electrophoretic mobility. Factors affecting the magnitude 
of ȝep include temperature, components and ionic strength of the buffer. As can be seen from 
Equation 6, the electrophoretic mobility of an ion is directly related to the ratio of the charge 
and its size (qeff/R) if the viscosity of the buffer is constant. The magnitude of ȝep is 
determined indirectly using ȝeo as expressed in Equation 6 and the apparent mobility of ȝa ,
which can be directly obtained by Equation 7,
(7)
where tm is the migration time of the species of interest. Then, ȝep can be calculated by
Equation 8.
                                           
              (8)
,IȝHS!ȝHSLVLQWKHVDPHGLUHFWLRQRI(2)RWKHUZLVHLWLVLQWKHRSSRVLWHGLUHFWLRQRI
EOF.
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II.2.1.5 Separation and resolution
Separation of analytes in CE is obtained on the basis of the differences in effective
electrophoretic mobilities of analytes. As shown in Equation 7, ȝep is determined by the ratio 
of qeff/R. Therefore, charged analytes are separated with some degree of resolution, while 
neutral analytes appear as one peak without separation in capillary zone electrophoresis. The 
efficiency of an electrophoretic system is characterized by the number of theoretical plates (N)
which is borrowed from chromatography. N can be determined experimentally from an 
electropherogram with Equation 9.
(9)
where w1/2 is the peak width at the half of the peak height.
The resolution (Rs) of two peaks shows the extent of the separation and can be calculated 
according to Equation 10.
                      (10)
where t1 and t2 are migration times, w1 and w2 are peak widths of analytes 1 and 2 on the
baseline, respectively.
II.2.1.6 Micellar electrokinetic chromatography (MEKC)
Micellar electrokinetic chromatography, first developed and introduced by Terabe [273, 
274], is suitable for the separation of uncharged as well as charged analytes. It is a significant 
extension of the CE method.
The principle of MEKC is based on the partitioning of analytes between the micellar and
the aqueous phases [274].When the surfactant in aqueous solution is above the critical micelle
concentration (CMC), surfactant molecules aggregate to form micelles. Hydrophobic analytes
may join the micelles in the core and migrate with micelles under an applied voltage. Anionic
surfactants form micelles with negative charges migrating to the anode. Cationic surfactants 
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form positively charged micelles moving to the cathode. For neutral analytes, the 
electrophoretic PRELOLW\ȝ0ep) is determined by Equation 11.
                        (11)
where k’ is the capacity factor (i.e. retention factor) of the analyte, and ȝ mc ep is the
electrophoretic mobility of the micelle. Because k ' is identical for each analyte, their
electrophoretic mobilities are different. Therefore, neutral analytes can be separated from one
another. For charged analytes, the electrophoretic mobility ȝiep) is determined by Equation 12
                                     (12)
where ȝiep is the electrophoretic mobility of the charged analyte into the aqueous solution free 
of surfactant.
The capacity factor of an analyte, the ratio of analytes in the micellar phase to those in the
aqueous phase, can be determined using migration times as shown in Equation 13
(13)
where tt, teo, tmc are the migration times of the analyte, the EOF marker and the micelle marker, 
respectively. The EOF marker, such as methanol, should not interact with the micelles. The 
micelle marker, such as Sudan III, should be completely associated with the micelles. The
capacity factor of an analyte increases with the increase of the surfactant concentration in the
separation buffer. 
Several surfactants can be selected for MEKC according to the physicochemical nature of
the analytes. Sodium dodecyl sulfate (SDS), an anionic surfactant, is the most commonly used
micellar phase for neutral and cationic analytes [275]. Cetyltrimethylammonium chloride 
(CTAC), a cationic surfactant, is useful for large molecules and neutral or anionic analytes. 
Other surfactants, such as non-ionic, zwitterionic, polymer and mixed surfactants, also have 
been used in different applications [276, 277].
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II.2.2 Experimental Section
The objective of the work is to develop a new methodology for small molecule detection by 
aptamer-based capillary electrophoresis. Our lab has previously reported four examples of the 
use of aptamer as additive in the electrolyte background for the small target separation, (see 
literature review in chapter I). However, all of these methodologies are dedicated to the single 
cationic or anionic compound analysis during the run. My work was focused on the following 
two aspects:
¾ To generalize a rationalized aptamer-based assay for small molecule detection 
(regardless of the charge of the target in the electrolyte background)¾ To establish a predictable methodology for the simultaneous detection of multiple 
small analytes in a single capillary
In order to achieve these goals, a structure-switching concept was utilized for the design,
the complementary sequences of aptamers, instead of aptamers themselves, are employed as 
tracer to be detected. After incubation with targets, the formed target-aptamer complexes will 
be liberated into the solution, which leads to the changes of detectable signals. Similar to the 
previous experiment [257], cholesteryl tag is also labeled to aptamer under MEKC conditions, 
two assay configurations were designed according to the position where cholesteryl tag was 
connected: The first one, developed for the single-analyte determination, was based on the use 
of a cholesteryl-tagged aptamer (Chol-Apt) and its fluorescein-labeled complementary strand
(CS*) as the tracer. The second format, especially designed for multianalyte sensing, 
employed dually cholesteryl- and fluorescein- labeled complementary strands (Chol-CS*) of
different lengths and unmodified aptamers (Apt). This method could expand significantly the 
potential of small biomolecule analysis in terms of simplicity, adaptability, generalizability, 
and high-throughput analysis capability.
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Affinity probe capillary electrophoresis (APCE) assays,
combining the separation power of CE with the specificity
of interactions occurring between a target and a molecular
recognition element (MRE), have become important ana-
lytical tools in many application fields. In this report, a
rationalized strategy, derived from the structure-switching
aptamer concept, is described for the design of a novel
APCE mode dedicated to small molecule detection. Two
assay configurations were reported. The first one, devel-
oped for the single-analyte determination, was based on
the use of a cholesteryl-tagged aptamer (Chol-Apt) as the
MRE and its fluorescein-labeled complementary strand
(CS*) as the tracer (laser-induced fluorescence detection).
Under micellar electrokinetic chromatography (MEKC)
conditions, free CS* and the hybrid formed with Chol-
Apt (duplex*) were efficiently separated (and then quanti-
fied) through the specific shift of the electrophoretic
mobility of the cholesteryl-tagged species in the presence
of a neutral micellar phase. When the target was intro-
duced into the preincubated sample, the hybridized form
was destabilized, resulting in a decrease in the duplex*
peak area and a concomitant increase in the free CS* peak
area. The second format, especially designed for multi-
analyte sensing, employed dually cholesteryl- and fluo-
rescein-labeled complementary strands (Chol-CS*) of
different lengths and unmodified aptamers (Apt). The size-
dependent electrophoretic separation of different Chol-
CS* forms from each other and from their corresponding
duplexes* was also accomplished under MEKC condi-
tions. The simultaneous detection of multiple analytes in
a single capillary was performed by monitoring accurately
each target-induced duplex-to-complex change. This
method could expand significantly the potential of small
solute APCE analysis in terms of simplicity, adaptability,
generalizability, and high-throughput analysis capability.
By virtue of its homogeneous format, high resolving capability,
short analysis time, advanced instrumentation, minute sample
requirements, and sensitivity and selectivity of detection, the laser-
induced fluorescence-coupled affinity probe capillary electrophore-
sis (APCE-LIF) technique, using antibodies and more recently
nucleic acid aptamers as specific molecular recognition elements
(MREs), constitutes a very interesting alternative to the conven-
tional heterogeneous antibody- or aptamer-based assay methods
in a variety of application fields, including clinical, biochemical,
and environmental areas.
For the APCE-LIF assays dedicated to protein analysis,1-11
both competitive and noncompetitive (direct) formats can be used.
In the direct assay, the MRE is fluorescently labeled and added
at a constant concentration to the sample for binding to the target.
After incubation, detection of the complex peak or free MRE peak
is related to the amount of the target in solution. In the competitive
assay, the protein is labeled and competes with the unlabeled
target in the sample for binding to a limited amount of its specific
MRE. A CE separation of this preincubated mixture produces two
distinct peaks corresponding to the free labeled protein and the
labeled protein bound to the MRE, allowing the quantification of
the target.
In contrast with the protein analysis, the small molecule
detection by the APCE-LIF technique relies, except in rare specific
cases,12 on a competitive format because of the difficulty in
separating the target-MRE complex from the free MRE. The
typical small target APCE approach then requires the synthesis
of a fluorescent analogue of the small analyte (tracer).13-23 This
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constitutes a major limitation of the technique as the labeling step
(i) can be laborious and time-consuming,13,14,21-23 (ii) can produce
interfering byproducts,13,16,21,23 (iii) has to be adapted to each
target in relation to its specific reactive groups and its electro-
phoretic mobility,13,21 and (iv) can profoundly affect the tracer
affinity for the MRE.19
In addition, although parallel electrophoretic separations can
be accomplished by using capillary array electrophoresis and
multiple-LIF detection with different tagging of tracers is possible,
the improvement of the APCE high-throughput analysis capability
remains a challenging task.11,19 In this context, previous examples
of CE immunoassays have been reported for the simultaneous
analysis of multiple drugs in a single capillary.13,14,16,17 However,
the described methodology does not constitute a generalizable
approach as it necessitates the careful synthetic design of the
multiple tracers to allow the electrophoretic separation of the
differentlabeledanalytesfromeachotherandfromtheantibody-target
complexes.13,16 Furthermore, the solute quantification is solely
based on the measurement of the free tracer peak change since
the distinctions between the various complexes cannot typically
be attained.13,14,17
The first objective of this work was to establish a rationalized
method for the development of a simpler, faster, and generic
APCE-LIF assay dedicated to the identification of small analytes.
The general scheme employed a nucleic acid aptamer as the MRE
and was based on the structure-switching concept initially de-
scribed by Li and colleagues.24,25 This strategy is related to the
unique ability of nucleic acids to form duplex structures with their
complementary sequences (CS). In the absence of the target, base
pairing between the complementary sequences is favored. When
the target binds to the aptamer, the hybridization is disrupted,
leading to the release of the complementary strand. Therefore,
via adequate labeling of the CS and/or the aptamer, the molecular
recognition event can be effectively converted into a detectable
signal. Because of its great simplicity and its very broad applicabil-
ity, the duplex-to-complex change concept has been successfully
exploited in the design of various fluorescence-, electrochemical-,
or nanoparticle-based aptamer assays.24-29 Herein, the structure-
switching aptamer approach was extended to the APCE-LIF
analysis. The schematic principle is presented in Figure 1. As the
migration of DNA molecules does not change appreciably with
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Figure 1. Schematic representation of the structure-switching aptamer APCE-LIF assay principle for single-analyte sensing.
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molecular weight in free solution (except in the presence of metal
ions as very recently reported),30 the free CS and the aptamer
(and then the duplex) are assumed to display a similar electro-
phoretic mobility in capillary zone electrophoresis.31,32 To over-
come this limitation, the CE analysis step of the preincubated
mixture was conducted via application of the drag tag strategy.
Classically, this approach, known as end-labeled free solution
electrophoresis (ELFSE), consists of tagging the nucleic acid
fragments with a large, neutral (or nearly neutral) molecule, i.e.,
the drag tag, to shift their electrophoretic mobility in relation to
their length.33,34 The electrophoretic mobility (µ) of a tagged DNA
molecule comprising N monomers is known to vary as follows:34
µ ) µ0( NN + R) (1)
where µ0 is the free solution electrophoretic mobility of the
unlabeled DNA and R the hydrodynamic drag dependent on
the drag tag employed. Thus, the electrophoretic mobility in
the ELFSE increases as the DNA becomes larger. Alternative
approaches, based on a similar concept, have been also
described.32,35 Notably, a simpler method, involving the use of
neutral surfactant micelles as drag tags, has recently been
employed.35,36 The transient association of hydrophobic group-
tagged DNA strands into nonionic micelles, in a micellar electro-
kinetic chromatography (MEKC) mode, was able to modulate
their electrophoretic mobility with an R value similar to that
reported for covalently attached drag tags.35 In this context, the
CS of the aptamer was end-labeled with a fluorescein dye (CS*),
and the aptamer was end-modified with a lipophilic cholesteryl
moiety (Chol-Apt). We, therefore, expected that the duplex* and
the CS* species could be separated by MEKC through the specific
shift of the mobility of the cholesteryl-tagged species in the
presence of the neutral micellar phase.35-37 This would allow us
to monitor the duplex-to-complex change induced by the small
target binding to the aptamer (Figure 1).
The second goal of this work was to adapt this strategy to the
design of a predictable methodology for the simultaneous detec-
tion of multiple small analytes in a single capillary. In such a case,
the assay configuration was modified. Cholesteryl-tagged and
fluorescein-labeled CS (Chol-CS*) were employed as tracers,
whereas unmodified aptamers were used as the MRE (Figure 2).
We proposed that the MEKC separation between Chol-CS* and
duplex* of multiple aptamers could be rationally attained by
modulating the length of Chol-CS*. The introduction of a poly(T)
tail of an adequate length at one extremity of a complementary
strand was predicted to increase significantly the electrophoretic
mobility of both the Chol-CS* and its corresponding duplex* in
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Figure 2. Schematic representation of the structure-switching aptamer APCE-LIF assay principle for multiplex sensing.
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relation to their size (eq 1). This would provide the electrophoretic
separation of the different Chol-CS* species from each other and
from the associated duplexes* and thus the multiple-target
detection via the analysis of each duplex-to-complex change
(Figure 2).
In the first step, the feasibility of the structure-switching
aptamer-based APCE-LIF mode (Figure 1) was established by
employing the adenosine monophosphate (D-AMP) and its cor-
responding DNA aptamer38 as a model system. Titration curves
with increasing D-AMP concentrations were constructed, and the
analytical performances were subsequently analyzed. In the
second step, the proof of concept of the approach dedicated to
multiplex analysis (Figure 2) was demonstrated for dual-analyte
sensing by using two different recognition systems, i.e., D-AMP
with the anti-D-AMP DNA aptamer and L-tyrosinamide (L-Tym)
with its specific DNA aptamer.39
EXPERIMENTAL METHODS
Chemicals and Oligonucleotides. Natural â-D-adenosine (D-
A), â-D-adenosine 5′-monophosphate (D-AMP), and â-D-guanosine
5′-monophosphate (D-GMP) nucleotides and L-tyrosinamide (L-
Tym) were obtained from Sigma Aldrich (Saint-Quentin, France).
â-L-Adenosine 5′-monophosphate (L-AMP) was synthesized, puri-
fied, and characterized as previously described by Pe´rigaud and
co-workers.40 Polyoxyethylene(23) lauryl ether (Brij 35), polyoxy-
ethylene(9) dodecyl ether (Thesit), polyoxyethylene(10) octyl
phenol ether (Triton X-100), and tris(hydroxymethyl)aminomethane
(Tris) were purchased from Sigma Aldrich. HCl, NaCl, and
MgCl2 ·6H2O were supplied by Prolabo (Paris, France), Chimie-
Plus laboratoires (Bruye`res de Pouilly, France), and Panreac
Quimica (Barcelona, Spain), respectively. Water was obtained
from a Purite Still Plus water purification system fitted with a
reverse osmosis cartridge. The normal and modified oligo-
nucleotides listed in Table 1 were synthesized and HPLC-purified
by Eurogentec (Angers, France). The identity of the oligonucle-
otides was confirmed by MALDI-TOF mass spectrometry.
Sample Preparation. The incubation buffer consisted of a
buffered solution [20 mM Tris-HCl (pH 7.50), 50 mM NaCl, and
5 mM MgCl2] containing a neutral surfactant (2.5 or 25 mM in
relation to the assay configuration). The analyte stock solutions
(D-A, D-AMP, L-AMP, D-GMP, and L-Tym) were dissolved in
pure water and stored at 4 °C. The aptamer and complementary
strand stock solutions were prepared in pure water and stored
at -20 °C. Samples were daily prepared by dilution of the stock
solutions in a concentrated incubation buffer with surfactant.
The samples were composed of Chol-Apt or Apt and CS* or
Chol-CS* oligonucleotides at a final concentration of 250 nM
each for D-AMP sensing and 250 and 500 nM, respectively,
for L-Tym sensing. For the titration curve, the analyte concen-
tration varied from 0 to 3 mM in the surfactant-containing
incubation buffer. The sample solutions were heated at 90 °C
for 5 min, left to stand at room temperature for 10 min, and
kept at 4 °C for at least 30 min to attain equilibrium of the
mixture prior to the CE injection.
Capillary Electrophoresis Experiments. An Agilent capillary
electrophoresis system (Agilent Technologies, Waldbronn, Ger-
many) equipped with a ZETALIF Discocery laser-induced fluo-
rescence detector (Picometrics, Toulouse, France) adapted for a
diode laser source (DPSS Laser Kyma 488 nm, Melles Griot, or
SDL-473-030T, Shanghai Dream Lasers Technology) was used
throughout. A 50 µm inner diameter (i.d.) and 362 µm outer
diameter (o.d.) uncoated fused-silica capillary (total length, 59 cm;
effective lengths, 19 cm for the single-analyte format and 40 cm
for the multiplex format), with a specific Discocery cell including
an ellipsoid lens for the “on-capillary” collection of the emitted
light, was employed (Picometrics).41 Before being used, the
capillary was daily treated at 1000 mbar with 1 M NaOH for 10
min and rinsed first with pure water for 15 min and then with
running buffer for 30 min. This consisted of 20 mM Tris-HCl (pH
8.75), 65 mM NaCl, and 25 mM neutral surfactant for the single-
analyte sensing format or 20 mM Tris-HCl (pH 8.50), 65 mM NaCl,
and 2.5 mM neutral surfactant for the multiplex sensing format.
To ensure repeatability, the capillary was conditioned at the
beginning of the run with 1 M NaOH and pure water for 1 min at
1000 mbar. Prior to injection, the capillary was filled with the
surfactant containing running buffer (1000 mbar for 3 min). All
experiments were conducted in cationic mode. Samples were
injected hydrodynamically at -50 mbar for 8 s into the capillary
in triplicate. During the run, the capillary ends were kept in the
surfactant containing running buffer. The injected solution volume
(38) Huizenga, D. E.; Szostak, J. W. Biochemistry 1995, 34, 656.
(39) Vianini, E.; Palumbo, M.; Gatto, B. Bioorg. Med. Chem. 2001, 9, 2543–
2548.
(40) He, J.; Roy, B.; Pe´rigaud, C.; Kashlan, O. B.; Cooperman, B. S. FEBS J.
2005, 272, 1236.
(41) Rodat, A.; Kalck, F.; Poinsot, V.; Feurer, B.; Couderc, F. Electrophoresis
2008, 29, 740.
Table 1. Oligonucleotides Utilized in the Structure-Switching Aptamer-Based APCE-LIF Assaysa
Single-Analyte Format
AMP Sensing System
Chol-Apt-A (32-mer) 5′-Chol-AGAGAACCTGGGGGAGTATTGCGGAGGAAGGT-3′
CS-A* (12-mer) 5′-CCCAGGTTCTCT-F-3′
Multiplex Format
AMP Sensing System
Apt-A (32-mer) 5′-AGAGAACCTGGGGGAGTATTGCGGAGGAAGGT-3′
Chol-CS-A* (12-mer) 5′-F-CCCAGGTTCTCT-Chol-3′
Tym Sensing System
Apt-Ty (38-mer) 5′-TGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC-3′
Chol-CS-Ty* (50-mer) 5′-F-CACATCAATCCA-(T)38-Chol-3′
a Abbreviations: Chol, cholesteryl tag; F, fluorescein label. Complementary bases are shown in bold type.
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was determined under the experimental conditions from the time
required for CS-A* introduced into the prefilled capillary under a
constant pressure of -50 mbar, to reach the detection window.
For example, a hydrodynamic injection of 8 s at 25 mM Brij 35
corresponded to ∼7 nL which was not affected by the presence
of Apt and 3 mM analyte. Moreover, the interday variation of the
injected volume was not significant since the relative standard
deviation accounted for 3% (n ) 8). Between runs, the capillary
was cleaned with running buffer solution for 5 min. All solutions
were filtered prior to use through 0.20 µm pore size membranes.
Calculation Methods. The titration curves were obtained by
plotting the ratio of the area of the peak of the free Chol-CS* (ACS*)
to the peak areas corresponding to both the duplex* and the
Chol-CS* dissociated from the duplex (Aduplex*)
8 versus the
target concentration in the preincubated samples (peak areas
corrected by the migration time of each species).
The following modified one-phase exponential association
equation was employed to estimate the apparent dissociation
constant (Kd):
42
Y ) (ACS*/Aduplex*) - (ACS*/Aduplex*)f ) [(ACS*/Aduplex*)b -
(ACS*/Aduplex*)f](1 - e
-kX) (2)
where (ACS*/Aduplex*)f is the signal in the absence of target, (ACS*/
Aduplex*)b the response of the maximally target-associated aptamer,
X the concentration of the target molecule, and k a fit parameter.
The nonlinear regression of Y versus X plots, where (ACS*/
Aduplex*)b and k constituted the adjustable parameters, was achieved
using Table curve 2D (Systat Software Gmbh, Erkrath, Germany),
and the apparent Kd value was determined from the midpoint of
the equation, i.e., -ln(0.5)/k.
RESULTS AND DISCUSSION
Single-Analyte Sensing Format. To evaluate the feasibility
of the structure-switching aptamer-based APCE-LIF strategy
dedicated to single-analyte sensing (Figure 1), we first used the
adenosine monophosphate (D-AMP) target and its DNA aptamer38
as a model system. The sequence of the complementary strand
utilized in this study has been previously described for the
development of a structure-switching aptamer-based electrochemi-
cal sensor.28
In initial experiments, the CE-LIF analysis of CS-A* alone and
the analysis of a mixture of Chol-Apt-A and CS*-A (in the absence
of target) were compared under MEKC conditions (applied
voltage, -23 kV; capillary temperature, 12 °C; effective length,
19 cm). A running buffer [20 mM Tris-HCl (pH 8.75) and 65 mM
NaCl] containing 25 mM Brij 35 neutral surfactant (critical micelle
concentration of ∼40-100 µM)37 was used. The addition of Chol-
Apt-A to CS-A* in the preincubated sample (optimized stoichiom-
etry of 1:1) resulted in a strong reduction in the peak area of the
free CS* and the concomitant appearance of a new peak at a lower
migration time (compare panels a and b of Figure 3). This latter
corresponded to the duplex-A* species that migrated faster than
CS-A* as the result of its anchoring into the neutral micelles.35-37
Such data demonstrate that the MEKC mode was able to separate
(42) Perrier, S.; Ravelet, C.; Guieu, V.; Roy, B.; Perigaud, C.; Peyrin, E. Biosens.
Bioelectron. 2010, 25, 1652–1657.
Figure 3. Representative electropherograms of the APCE-LIF assay for single-analyte (D-AMP) sensing. Preincubated samples: (a) CS-A*
(250 nM), (b) CS-A* (250 nM) and Chol-Apt-A (250 nM), and (c) CS-A* (250 nM), Chol-Apt-A (250 nM), and D-AMP (2 mM). MEKC conditions:
running buffer, 20 mM Tris-HCl (pH 8.75), 65 mM NaCl, and 25 mM Brij 35; capillary, 50 µm i.d.; effective length, 19 cm; uncoated, fused silica
capillary with LIF detection; applied voltage, -23 kV; sample injection, -50 mbar for 8 s; capillary temperature, 12 °C.
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the duplex* from the free CS-A*, with an exploitable resolution
between the two fluorescent species. The influence of the nature
of the neutral surfactant on the MEKC-mediated separation of the
CS-A* and duplex-A* components was also considered. A similar
resolution between the duplex-A* and CS-A* species was achieved
using Thesit or Triton X-100 micelles [25 mM in the same running
buffer, with other conditions identical (Figure S1 of the Supporting
Information)].
The ability of this approach to monitor the target-induced
duplex-to-complex change was evaluated under the MEKC operat-
ing conditions reported above. In the absence of target, the ACS*/
Aduplex* ratio was ∼0.4 (Figures 3 and 4). From the respective
peak areas of the CS-A* and duplex-A* components, we estimated
that the fraction of the hybrid form of CS-A* was ∼70%. The
addition of the D-AMP target at a concentration of 2 mM in the
preincubated sample produced a significant increase in the ACS*/
Aduplex* ratio of a factor of ∼4 (Figures 3 and 4). This result is
consistent with the structure-switching mechanism; the formation
of the target-aptamer complex caused the hybridization disrup-
tion leading to the release of the free CS-A* component (Figure
1). The signal generation, i.e., the increase in the ACS*/Aduplex*
ratio in the presence of the target, was found to be particularly
dependent on the preincubation of the sample with the neutral
micellar phase. In fact, when the sample was not preincubated
with the micelles, a fraction of the duplex-A* that did not bind
to the pseudostationary phase35-37 comigrated with the free CS-
A* and then yielded a lower sensitivity.
The target titration curves were established by plotting the
ACS*/Aduplex* ratio versus the D-AMP concentration (varying
from 0 to 3 mM) in the preincubated mixture (Figure 4). The
APCE-LIF assay displayed linearity up to 200 µM, and the
detection limit was estimated to be 30 µM through the statistical
analysis of the regression function. The average standard deviation
was lower than 4%, demonstrating the reproducibility of the assay.
The analysis was also performed successfully with another target
of this aptamer, i.e., D-adenosine (D-A).37 The representative
titration curve can be found in the Supporting Information (Figure
S2). A similar linear range was obtained with a detection limit of
10 µM. Such results are comparable with those reported with
other homogeneous format-based aptasensors previously designed
for the detection of the same targets.24,42-49 The apparent
dissociation constant (Kd) for the targets was estimated using
eq 2. The Kd values ranged between 100 and 300 µM for the
two analytes, i.e., 270 ± 12 µM for D-AMP and 126 ± 6 µM for
D-A. The apparent binding affinity appeared to be significantly
reduced relative to that retrieved with the original aptamer (by
a factor of ∼20-30).38 Such data are in agreement with those
reported by Nutiu and Li, who showed that the blockage of
the aptamer target-binding site by the complementary strand
alters the binding affinity.24 The target specificity behavior is
in accordance with that observed for the unmodified aptamer;38
i.e., D-AMP displayed a lower apparent affinity than D-A in this
system.
The selectivity of the APCE-LIF assay was subsequently
evaluated. As shown in Figure 4, the guanosine monophosphate
(D-GMP) compound did not induce a significant response over
the same concentration range, in accordance with previous
results.38 The development of enantioselective assays constitutes
one attractive application of the aptamers in the small molecule
sensing field. To date, various aptamer-based chiral analysis
approaches have been described.37,42,45,49-51 To investigate the
potentiality of the current methodology to allow the enantiose-
lective sensing of AMP, the binding curves were also constructed
with increasing concentrations of the L-enantiomer of this species.
L-AMP did not cause any significant response over the tested
concentration range (Figure 4). Such a result confirms the strong
AMP stereoselective properties recently reported for the anti-AMP
aptamer.37,42 This suggests that the APCE-LIF procedure pre-
sented here could provide the detection of an enantiomeric
impurity down to approximately 1% in a nonracemic sample.
Multiplex Sensing Format. To perform the simultaneous
detection of multiple analytes in a single run, we designed a
different assay format (Figure 2). In the single-analyte scheme
described above, the tracer was not tagged with cholesteryl.
Therefore, multiple free CS* forms of different analyte sensing
systems could not be differentiated under such conditions as they
would display an identical electrophoretic mobility.31,32 On the
other hand, the configuration employing a dually cholesteryl-
tagged and fluorescein-labeled complementary strand as the tracer
could permit the distinction between multiple pairs of free Chol-
CS* and duplex* of different lengths, through the size-dependent
shift of their electrophoretic mobility (eq 1). Thus, this option
was predicted to allow a more accurate measurement by monitor-
(43) Merino, E. J.; Weeks, K. M. J. Am. Chem. Soc. 2005, 127, 12766–12767.
(44) Lin, D.; Shlyahovsky, B.; Willner, I. J. Am. Chem. Soc. 2007, 129, 5804–
5805.
(45) Urata, H.; Nomura, K.; Wada, S.; Akagi, M. Biochem. Biophys. Res. Commun.
2007, 360, 459–463.
(46) Li, N.; Ho, C. M. J. Am. Chem. Soc. 2008, 130, 2380–2381.
(47) Tang, Z.; Mallikaratchy, P.; Yang, R.; Kim, Y.; Zhu, Z.; Wang, H.; Tan, W.
J. Am. Chem. Soc. 2008, 130, 11268–11269.
(48) Cheng, X. H.; Bing, T.; Liu, X. J.; Shangguan, D. H. Anal. Chim. Acta 2009,
633, 97–102.
(49) Null, E. L.; Lu, Y. Analyst 2010, 135, 419–422.
(50) Turney, K.; Drake, T. J.; Smith, J. E.; Tan, W.; Harrison, W. W. Rapid
Commun. Mass Spectrom. 2004, 18, 2367–2374.
(51) Ruta, J.; Perrier, S.; Ravelet, C.; Fize, J.; Peyrin, E. Anal. Chem. 2009, 81,
7468–7473.
Figure 4. Titration curves obtained for D-AMP (O) and L-AMP (b)
enantiomers and D-GMP (2) over a concentration range of 0-3 mM.
The solid line was created from eq 2. The inset shows the linear assay
response for D-AMP at low concentrations (0-200 µM) in the sample.
CS-A* and Chol-Apt-A concentrations of 250 nM. Error bars represent
standard deviations (n ) 3). The curves were constructed by plotting
the ratio of free CS-A* peak area (ACS*) to the peak areas corre-
sponding to duplex-A* and CS-A* dissociated from duplex-A* (Aduplex*),
corrected by the migration time of each species, vs ligand concentra-
tion. MEKC conditions are given in the legend of Figure 3.
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ing the target-induced changes of both the free and bound Chol-
CS* peaks. In addition, it was more convenient to modulate the
length of the shorter interacting partner (Chol-CS* in the multi-
analyte design scheme) than that of the larger one (Chol-Apt in
the single-analyte design scheme) to enlarge the separation
window, i.e., the absolute difference in migration time between
the cholesteryl-tagged components and an untagged DNA species.
The ability of such an assay configuration to assess the sensing
of a single analyte was first evaluated using the anti-D-AMP
aptamer system. To facilitate the size-dependent separation of
Chol-CS-A* from duplex-A* and improve the peak spacing, we
partly modified the MEKC experimental conditions relative to
those employed above. The surfactant concentration was reduced
to 2.5 mM,35 the capillary effective length increased to 40 cm,
the running buffer pH set at 8.50, and the applied voltage reduced
to -12 kV.34 Under such conditions, the two species of interest
were well-resolved (Figure S3 of the Supporting Information). As
predicted by eq 1, Chol-CS-A* displayed a lower migration time
than duplex-A* because of its smaller size (12 bases vs 12 + 32
) 44 bases). The hybridized form was found to be less stable
than for the precedent configuration (ACS*/Aduplex* ratio of ∼0.6).
This could result from a lower accessibility of the micelle-
anchored Chol-CS-A* or some steric hindrance effects for Apt-
A. The introduction of D-AMP (2.5 mM) into the preincubated
sample generated the Chol-CS-A* peak increase and the
concomitant reduction in the magnitude of the duplex-A* peak
(Figure S3). The ACS*/Aduplex* ratio increased by a factor of ∼5.5
upon addition of target, higher than the assay response
exhibited with the previous format (Figure 4). As the hybrid
structure displayed a lower stability, Chol-CS-A* was expected to
be dissociated more easily from Apt-A in the presence of
D-AMP.24,25 The apparent dissociation constant, calculated from
the titration curve (not shown), was found to be 193 ± 34 µM. A
linear range up to 200 µM and a detection limit of 15 µM were
obtained. These data demonstrate that the target-induced duplex-
to-complex change can be efficiently monitored with the current
format. It also appears that the structure-switching aptamer
principle can be successfully adapted to diverse APCE-LIF assay
configurations.
The proof of principle of the multiplex approach was evaluated
for a dual-analyte sensing system by using both the anti-AMP and
anti-Tym DNA aptamers as MREs. To date, in contrast with the
AMP aptamer, no structure-switching aptamer-based Tym sensor
has been reported. Therefore, a fluorescence polarization (FP)
approach was performed in initial experiments to determine a
suitable cDNA.52 Details of the FP experiments are presented in
the Supporting Information. Two complementary sequences of
Apt-Ty were tested for their ability to be displaced from the
aptamer by L-Tym binding. One complementary strand of 12-mer
was found to respond satisfactorily to the formation of the
target-aptamer complex (Figure S4 of the Supporting Informa-
tion). For the multiassay, Chol-CS-A* was utilized as the D-AMP
tracer. The choice of the length of the modulator charge tail,
introduced at the 3′-extremity of the L-Tym complementary strand,
constituted the following key step. A poly(T) sequence of 38 bases
was chosen to design a Chol-CS-Ty* tracer of a (12 + 38) 50-base
total length. It was therefore expected that Chol-CS-Ty* could be
differentiated from the 44-base duplex-A* species in size (eq 1).
This was illustrated in Figure S5 of the Supporting Information.
Under the MEKC experimental conditions previously used for the
D-AMP analyte, Chol-CS-Ty* appeared to migrate more slowly
that duplex-A* because of its larger size (compare Figures S3 and
S5). As expected, the injection of the mixture of Chol-CS-Ty* and
Apt-Ty (optimized stoichiometry of 2:1) into the capillary resulted
in the appearance of a new peak at a higher migration time, which
corresponded to the larger duplex-Ty* component (50 + 38 ) 88
bases). The introduction of L-Tym into the incubated solution (2.5
mM) was responsible for consistent changes in the peak areas
for the two fluorescent species (Figure S5). However, in com-
parison with D-AMP sensing, a weaker assay response was
observed for L-Tym: the ACS*/Aduplex* ratio was 2-fold enhanced,
varying from ∼0.7 in the absence of target to ∼1.5 with 2.5
mM target. This indicates that, under the experimental condi-
tions described here, L-Tym switched the duplex* into the
complex structure with a lower magnitude than D-AMP. The
use of a complementary strand that would form a less stable
hybrid structure could enhance the L-Tym assay response.24,25
Finally, the electropherograms shown in Figure 5 depict the
simultaneous dual-analysis approach. Four peaks can be visualized
when a mixture containing the Chol-CS-A*, Apt-A, Chol-CS-Ty*,
and Apt-Ty components was introduced into the capillary. In
accordance with the data reported in Figures S3 and S5, these
reflected the specific pairs of Chol-CS* and duplex* for the two
targets. The migration order was as follows: Chol-CS-A* (12 bases)
< duplex-A* (44 bases) < Chol-CS-Ty* (50 bases) < duplex-Ty*
(88 bases). Addition of D-AMP or L-Tym (2.5 mM) to the
preincubated solution produced the specific diminution of the
corresponding duplex* peak area and the increase in the associ-
ated Chol-CS* peak area (data not shown). No change in the
response was obtained for the other couple, demonstrating the
absence of cross-reactivity between the two sensing systems.
When the two targets were simultaneously added to the reaction
mixture (2.5 mM each), a variation of the Chol-CS* and duplex*
peak area consistent with the duplex-to-complex change mecha-
nism occurred concomitantly for the two pairs (Figure 5). The
assay response was identical to that reported above for the
separated analysis of each target (Figures S3 and S5), confirming
the independent performance of the two assays. Although the
proof of principle has been demonstrated for dual-analyte detec-
tion, the current method could be extended to the analysis of a
larger number of compounds by simply increasing adequately the
length of the Chol-CS* tracer for each additional sensing system.
If necessary, experiments can be performed using a capillary with
a reduced inner diameter at a higher electric field to enhance the
analysis speed.
CONCLUSION
In summary, we have demonstrated that the structure-switch-
ing aptamer concept can be successfully exploited in APCE to
establish a reasoned, simple, versatile, and generic assay for the
identification of small molecules. This greatly extends the potential
of this technique and allows the performance of predictable
multianalyte detection in a single capillary. In comparison with
the typical APCE-LIF small molecule approaches developed to
date, this methodology permits elimination of the tedious case-
to-case synthesis of the tracer and the time-consuming adjust-(52) Cruz-Aguado, J. A.; Penner, G. Anal. Chem. 2008, 80, 8853–8855.
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ments of both the chemical properties of the reagents and the
CE experimental conditions for the optimal separation of the free
and bound tracer. Unlike previously described sensors based on
the structure-switching aptamer concept,24-29,49 the method
reported here provides accurate monitoring of the changes in both
the free CS* and duplex* fractions generated by the target binding
to the aptamer. More globally, such an approach offers a
significant advantage over the existing aptamer-based sensor
platforms which are, except in very few recent reports,11,53-55
solely dedicated to single-target detection in a single solution.
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Figure 5. Representative electropherograms of the APCE-LIF assay for multianalyte (D-AMP and L-Tym) sensing. Preincubated samples of (a)
Chol-CS-A* (250 nM), Apt-A (250 nM), Chol-CS-Ty* (500 nM), and Apt-Ty (250 nM) and (b) the same as panel a with D-AMP and L-Tym (2.5 mM
each). MEKC conditions: running buffer, 20 mM Tris-HCl (pH 8.50), 65 mM NaCl, and 2.5 mM Brij 35; capillary, 50 µm i.d.; effective length, 40 cm;
uncoated, fused silica capillary with LIF detection; applied voltage, -12 kV; sample injection, -50 mbar for 8 s; capillary temperature: 12 °C.
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1. Supplemental data from the single-analyte format experiments 
Figure S-1 Representative electrophoregrams obtained using different neutral surfactants (25 
mM in the running buffer) to separate the CS-A* from the duplex-A* species. Experimental 
conditions are given in Figure 3 of the manuscript. 
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Figure S-2 Titration curve obtained for D-A over the 0–3 mM concentration range using the 
single-analyte assay format. Solid line is created from Eq. 2. Insert: linear assay response for 
the target at low concentrations (0-200 M) in the sample. CS-A* and Chol-Apt-A 
concentration: 250 nM. Error bars represent SDs (n = 3). The curves were constructed by 
plotting the ratio of free CS-A* peak area (ACS*) to the peak areas corresponding to the 
duplex-A* and the CS-A* dissociated from the duplex-A (Aduplex*), corrected by the migration 
time of each species, versus the ligand concentration. Experimental conditions are given in 
Figure 3 of the manuscript.  
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2. Supplemental data from the multiplexed format experiments 
2.1 D-AMP system 
Figure S-3 Representative electropherograms for the D-AMP assay system. Pre-incubated 
samples: Chol-CS-A* (250 nM), Apt-A (250 nM), D-AMP (2.5 mM). MEKC conditions: 
running buffer: 20 mM Tris-HCl pH 8.50, 65 mM NaCl, 2.5 mM Brij 35. Capillary: 50-µm-
i.d.; effective length, 40 cm; uncoated, fused silica capillary with LIF detection. Applied 
voltage: -12 kV. Sample injection: -50 mbar for 8 s. Capillary temperature: 12°C. 
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2.2 Fluorescence polarization (FP) approach 
A FP approach was carried out in order to find an adequate CS of Apt-Ty which could be 
released upon L-Tym binding to its aptamer. The experiments were based on the monitoring 
of the fluorescence anisotropy of a fluorescein-labeled CS probe (CS*). As previously 
described,1 the formation of the duplex* is assumed to increase the fluorescence anisotropy 
signal of the probe since the molecular mass of the hybrid is higher than that of the CS* alone. 
If the target binding to aptamer causes the displacement of the CS* from the aptamer through 
a structure-switching mechanism, the fluorescence anisotropy of the CS* probe is expected to 
decrease due to the reduction of its apparent size.1  
 4 
The two following 5’-fluorescein-labeled complementary sequences (CS-1*, 10-mer and CS-
2*, 12-mer) of Apt-Ty were synthesized (Eurogentec) and tested (complementary bases are in 
bold type):  
Apt-Ty: 5’-TGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC-3’ 
CS-1*:   3’-ACCTCGAACC-F-5’ 
Apt-Ty: 5’-TGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC-3’ 
CS-2*:           3’-ACCTAACTACAC-F-5’ 
Fluorescence anisotropy measurements were taken on a Tecan Infinite F500 microplate reader 
(Männedorf, Switzerland) using black, 96-well Greiner Bio-One microplates (ref: 675086, 
Courtaboeuf, France). Excitation was set at 485 ± 20 nm and emission was collected with a 
535 ± 25 nm bandpass filter. The binding buffer consisted of 10 mM Tris-HCl, pH 7.5, 25 
mM NaCl, 5 mM MgCl2. The different oligonucleotide solutions were prepared in water and 
stored at -20°C. The working solutions were obtained by adequate dilution of the stock 
solution in a concentrated binding buffer. The working solutions were heated at 90°C for 5 
min and left to stand at room temperature for 30 min. The L-Tym solution was prepared in 
water. All solutions were filtered prior to use through 0.20 m membranes. The Apt-Ty and 
CS* (CS-1* or CS-2*) solutions (final concentration 10 nM each) were mixed into the 
individual wells at room temperature (final volume = 100 L). Blank wells of the microplate 
received 100 L of the binding buffer. All experiments were done in triplicate. The microplate 
was placed into the microplate reader for the measurement after further incubation at room 
temperature for at least 30 min. Anisotropy (r) was calculated by the instrument software, as 
classically reported: 
vhvv
vhvv
GII
GII
r
2

   
where Ivv and Ivh are the vertically and horizontally polarized components of the emission after 
excitation by vertically polarized light. The instrumental correction factor G was determined 
from standard solutions according to the manufacturer’s instructions. 
As can be seen in Figure S4, the fluorescence anisotropy of both the CS-1* and CS-2* probes 
increased when Apt-Ty was introduced in the reaction solution. This indicates that these two 
strands can effectively hybridize with the aptamer. Upon addition of the target (2 mM) in the 
reaction mixture, the fluorescence anisotropy was strongly reduced for the CS-2* probe while 
a very slight variation was observed for the CS-1* probe. This indicates that CS-2* was 
significantly displaced from Apt-Ty by a structure-switching mechanism.1  
 5 
Figure S-4 Variation of the fluorescence anisotropy for the two CS* probes (10 nM) upon 
addition of Apt-Ty (10 nM) and Apt-Ty (10 nM) + L-Tym (2 mM) in the reaction mixture.  
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2.3 L-Tym system 
Figure S-5 Representative electropherograms for the L-Tym assay system. Pre-incubated 
samples: Chol-CS-Ty* (500 nM), Apt-Ty (250 nM), L-Tym (2.5 mM). MEKC conditions: 
running buffer: 20 mM Tris-HCl pH 8.50, 65 mM NaCl, 2.5 mM Brij 35. Capillary: 50-µm-
i.d.; effective length, 40 cm; uncoated, fused silica capillary with LIF detection. Applied 
voltage: -12 kV. Sample injection: -50 mbar for 8 s. Capillary temperature: 12°C. 
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II.2.3 Conclusions
In summary, we have demonstrated that aptamers could be successfully adopted in 
capillary electrophoresis to establish a reasoned, simple, versatile, and generic assay for the
quantification of multiple small molecules. Compared to the typical CE small molecule 
approaches, this methodology allowed elimination of the tedious case-to-case synthesis of the 
tracer and the time-consuming adjustments of both the chemical properties of the reagents and 
the CE experimental conditions for the optimal separation of the free and bound tracers. The 
method reported provides accurate monitoring of the changes in both the free CS* and 
duplex* fractions generated by the target binding to the aptamer. In addition, this method 
made it possible for the small molecule analysis of a larger number of compounds by simply 
increasing adequately the length of the Chol-CS* tracer for each additional system, which 
expanded significantly the potential of small molecule analysis.
However, it is also important to point out that some major drawbacks exist. CE analysis is a 
time consuming approach and requires sophisticated and expensive devices. Thus, it appears 
of great interest to develop a simpler, quicker and cheaper biosensing platform. In this context, 
aptamer-based gold nanoparticle colorimetric assay for small molecule detection is described
in the following part.
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II.3 Aptamer-based gold nanoparticle colorimetric assay for small 
molecule detection
II.3.1 Introduction
II.3.1.1 General description of gold nanoparticles
Recent developments in nanostructured material synthesis and engineering have made a 
huge impact on a number of fields including nanoelectronics, photonics, biology, and 
medicine [278, 279]. Gold nanoparticles exhibit several interesting physical and chemical 
properties that have made them an integral part of research in nanoscience. Due to the 
plasmon resonance of gold nanoparticles, they possess strong distance-dependent optical 
properties. As a result of these properties, many techniques have been developed based on the 
aggregation of gold nanoparticles to detect ions, genes, and proteins. In addition, gold 
nanoparticles are also important because of their biofunctionalization and biostability.
Nanotechnology is the broad field of study of the behavior of matter on the nanometer 
length scale, and tries to understand, control, and manipulate it. Nanoparticles take a very 
important place in nanotechnology since they serve as the fundamental building blocks of the 
field. The term nanoparticle refers to an object of size in the range of 1 to 100 nm at least in 
one of the three dimensions [280]. Nanoparticles can be made of metals, metal oxides, 
semiconductors, polymers, carbons, organics, or biomolecules. Nanoparticles can also be 
classified into nanospheres, nanorods, nanotubes, nanowires, nanofibers according to their 
shapes [280, 281].
Nanoparticles possess unique physical and chemical properties which are significantly 
different from those of bulk materials [280]. This is the reason why the topic of nanoparticles 
has attracted attention of so many scientists and researchers and opened up the possibility for 
numerous applications. The unique properties of nanoparticles can be explained by the high 
surface area per unit volume, the high proportion of surface atoms and near-surface atoms, 
and quantum effects that nanoparticles have. In fact, these three characteristics of 
nanoparticles arise from one feature: the nanometer length scale typical of the object. It is 
quite clear that the surface area-to-volume ratio and the proportion of surface atoms increase 
with a decrease in size. 
Chapter II: Experiments and Reslutls
117
II.3.1.2 Optical properties of gold nanoparticles
Metallic nanoparticles are of great scientific interest due to their particular optical [282] and 
electrical [283] properties. These unique physical properties originate from their finite size. 
Since the size of metal nanoparticles is only a few or tens of nanometers by definition, the 
movement of their electrons is confined in three-dimensional space. Thus, these systems
exhibit discrete energy levels, which are better described by the laws of Quantum Mechanics
[281] than by the laws of Classical Physics.
Figure 2-3: Rayleigh light-scattering of gold (Au) and silver (Ag) nanoparticles displaying various colors 
depending on the material, shape, and size [284].
One example of the extraordinary properties of metal nanoparticles is that their color 
depends on their chemistry, size, and shape. The dependence can be seen in Figure 2-3 where 
gold and silver nanoparticles of different shapes and sizes display various colors. This is 
attributed to a phenomenon known as Surface Plasmon Resonance (SPR). SPR is a 
phenomenon that occurs in selected sizes of semiconductor nanoparticles and metal 
nanoparticles (e.g., Quantum Dots) [281]. It refers to the oscillation of electrons on the 
surface of metal nanoparticles caused by the interaction between light and confined electrons 
of the nanoparticles. The process is schematically represented in Figure 2-4.
Chapter II: Experiments and Reslutls
118
Figure 2-4: Schematic illustration of Surface Plasmon Resonance (SPR) - Interaction between light and 
confined electrons of a metal nanoparticle [281].
When SPR occurs, nanoparticles absorb a specific wavelength from the light that matches 
the frequency of the oscillation, and display a color. The frequency of the oscillation depends 
on the chemistry of the material, the size and the shape of the nanoparticle, the surrounding 
medium, and even on the temperature [285-287]. Consequently metal nanoparticles of 
different properties display different colors. For aqueous solutions of gold nanoparticles of 
diameter of 9, 15, 22, 48, and 99 nm, the maximum absorbance has been observed at the 
wavelengths 517, 520, 521, 533, and 575 nm, respectively. Surface Plasmon Resonance (SPR) 
has been exploited in biosensor applications [288] and for resolution enhancement of 
spectroscopic measurements [289].
Recently, significant efforts have been made to use metal nanoparticles in biological 
applications. A typical example is gold nanoparticles used in drug delivery and biosensors. 
Gold nanoparticles are known to have excellent biocompatibility and low inherent toxicity. 
Thus they promise high expectation for possible applications in medical devices. A complex 
composed of gold and iron oxide nanoparticle can work as a platin delivery agent [290].
Platin is a therapeutic agent for breast cancer. The complex is able to detect a breast cancer 
cell and release the therapeutic agent in it. 
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II.3.1.3 Synthesis and surface functionalization
The scientific synthesis of colloidal gold can be traced back to Michael Faraday’s work in 
1857, in which the gold hydrosols were prepared by reduction of an aqueous solution of 
chloroaurate with phosphorus dissolved in carbon disulfide [291]. Later in 1951, Turkevich 
developed one of the most popular approaches for the synthesis of AuNPs, using citrate 
reduction of HAuCl4 in water [292]. In this method, citric acid acted as both reducing and
stabilizing agent and provided AuNPs with diameters of 20 nm. Further studies by G. Frens 
enabled control over AuNPs size by varying the feed ratio of gold salt to sodium citrate [293].
After Mulvaney’s initial attempt of stabilizing AuNPs with alkanethiols [294], a significant 
breakthrough in the field of AuNP synthesis was achieved by Brust and Schiffrin in 1994. 
They reported a two-phase synthetic strategy, (the Brustí6FKLIIULQPHWKRGˈutilizing strong 
thiolíJROG LQWHUDFWLRQV WR SURWHFW $X13s with thiol ligands (Figure 2-5). In this method, 
AuCl4
í is transferred from aqueous phase to toluene using the surfactant tetraoctylammonium 
bromide (TOAB) and reduced by sodium borohydride (NaBH4) in the presence of 
dodecanethiol [295]. On addition of NaBH4, a quick color change from orange to deep brown 
takes place in organic phase. The AuNPs are generated in toluene with controlled diameters in 
the range 1.5í QP 7KHVH WKLRO -protected AuNPs feature superior stability because of the 
strong thiolíJROGLQWHUDFWLRQDQGWKH\FDQEHHDVLO\KDQGOHGFKDUDFWHUL]HGDQGIXQFWLRQDOL]HG
The nanoparticles can be thoroughly dried and then redispersed in organic solvents without 
any aggregation or decomposition. Various reaction conditions, such as gold/thiol ratio, 
temperature, and reduction rate, can be used to tune the particle size [296].
Figure 2-5˖Brustí6FKLIIULQ PHWKRG IRU WZR-phase synthesis of AuNPs by reduction of gold salts in the 
presence of external thiol ligands [295].
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II.3.2 Experimental Section
Thiolated aptamer probes can readily self-assemble at the surface of AuNPs via the 
well-established Au–S chemistry. Such nanoprobes are extremely stable in solutions of high 
ionic strength since DNA polyelectrolytes bring high-density negative charges to the surface.
These interesting findings form the basis of biomolecular detection by using AuNPs–aptamer 
conjugates [196-198]. However, the reliable and bulk synthesis of such conjugates remains a 
technical challenge. 
More recently, unmodified AuNPs have been employed to probe biomolecular recognition 
based on interactions between DNA strands and AuNPs. Previous works have demonstrated 
that unmodified AuNP reporters are able to discriminate between DNA species of different 
electrostatic properties, i.e. single-stranded versus double-stranded DNA, unfolded versus 
folded DNA, short versus long single-stranded DNA. 
The objective of our work is to utilize the specific DNA discriminating feature of 
unmodified AuNP to design new aptamer based assay for the small molecule detection. 
According to the basic binding modes between aptamer and target which was introduced in 
chapter I, three design strategies could be available: direct mode, displacement mode and 
sandwich or sandwich-like mode. However, despite the simplicity of the direct mode, such a 
strategy is not generalizable as it requires a sufficiently large aptamer structural change to 
generate a detectable signal, while the displacement approach suffers from some drawbacks 
including the strong alteration of the apparent binding affinity and the careful case-to-case 
choice of a suitable complementary DNA probe. The sandwich mode necessitates the 
knowledge of both the aptamer secondary structure and the critical nucleotide positions to 
select precisely the cut site that does not impede the target binding. 
To circumvent this problem, our group designed a label-free, homogeneous aptamer-based 
sensor strategy for the facile colorimetric detection of small target molecules [297]. The 
format relied on the target-induced protection of DNA aptamer from the enzymatic digestion 
and its transduction into a detectable signal through the length-dependent adsorption of 
single-stranded DNA onto unmodified gold AuNPs. The proof-of-principle of the approach 
was established by employing the anti-tyrosinamide aptamer as a model functional nucleic 
acid and further applied to the adenosine detection.
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a  b s t  r  a c  t
A  label-free,  homogeneous  aptamer-based  sensor  strategy  was designed for  the facile  colorimetric  detec-
tion  of small  target molecules. The  format  relied  on the  target-induced  protection  of DNA  aptamer from
the enzymatic digestion and its  transduction into  a detectable  signal  through  the  length-dependent
adsorption  of single-stranded  DNA onto  unmodified  gold nanoparticles  (AuNPs).  The  proof-of-principle
of  the  approach  was  established  by employing  the  anti-tyrosinamide  aptamer as  a model functional
nucleic  acid.  In  the  absence  of  target,  the  aptamer was  cleaved  by the  phosphodiesterase  I enzymatic
probe,  leading to the  release  of mononucleotides  and short DNA  fragments.  These  governed effective
electrostatic  stabilization of AuNPs so that  the  nanoparticles  remained  dispersed  and red-colored  upon
salt addition.  Upon tyrosinamide binding, the  enzymatic cleavage  was  impeded,  resulting in the  protec-
tion  of  the  aptamer structure.  As  this long DNA  molecule  was unable  to  electrostatically stabilize AuNPs,
the resulting  colloidal  solution  turned  blue after  salt  addition  due  to the  formation  of  nanoparticle  aggre-
gates. The  quantitative  determination  of the target  can  be achieved  by monitoring  the  ratio of absorbance
at  650 and 520  nm  of the gold colloidal  solution. A  limit  of  detection  of ∼5 mM  and a  linear range up  to
100  mM were obtained.  The sensing  platform  was further applied,  through the same  experimental  proto-
col,  to  the adenosine detection  by using  its  DNA aptamer  as  recognition tool. This strategy  could  extend
the  potentialities, in terms of both simplicity  and general  applicability,  of the aptamer-based  sensing
approaches.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Gold nanoparticles (AuNPs) are  widely used as signal trans-
ducers for the development of bioassays in various application
fields including diagnostic and biochemical areas [1,2].  AuNPs have
become important reporters as the result of their high extinc-
tion coefficients and their capability of visual detection, allowing
avoiding the use of sophisticated equipments and expensive trans-
duction techniques. The working principle of the AuNP colorimetric
probes relies on the color change related to aggregation (red-to-
blue) or dispersion of  aggregates (blue-to-red) of nanoparticles.
Molecular recognition events that lead to changes in aggrega-
tion/dispersion states of  AuNPs can be thus visually detected by
a simple color change of the solution [1,2].
In this context, and owing the impressive advantages of nucleic
acid aptamers as molecular recognition tools [3–5],  numerous
AuNP-based aptamer assays have been described during the last
few years for the sensing of  a large variety of targets ranging
∗ Corresponding author. Tel.: +33 04 76 63 53 04; fax: +33 04 76 63 52 98.
E-mail address: eric.peyrin@ujf-grenoble.fr (E.  Peyrin).
from small species to whole cells [6–15].  The signal generation
depends typically on two  different systems which are  related to
interparticle crosslinking or noncrosslinking aggregation phenom-
ena [16]. The first system relies on the formation of interparticle
bonds mediated by interacting partners (aptamer and/or DNA
probe) immobilized onto the particle surface. This sensing platform
suffers from limitations such as the time-consuming function-
alization of  the nanoparticle surface and the slow interparticle
assembly phenomenon. The second system is related to the modifi-
cation of stabilizing (electrostatic and/or steric) processes, without
intervention of interparticle bond formation. In such case, the strat-
egy based on changes of electrostatic stabilization of unmodified
AuNPs constitutes a  very attractive approach due to its  rapid-
ity and its simplicity. Previous works have demonstrated that
unmodified AuNP reporters are  able to discriminate between DNA
species of different electrostatic properties, i.e. single-stranded
versus double-stranded DNA [17–19],  unfolded versus folded DNA
[20], short versus long single-stranded DNA [18,21]. Typically,
single-stranded or unfolded DNA sequences can adsorb efficiently
to citrate-capped AuNPs via facilitated DNA base-Au interactions
while double-stranded or folded DNA species bind more weakly to
the Au surface due to the limited exposure of their nucleobases.
0003-2670/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.aca.2011.08.047
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AuNPs are then electrostatically stabilized by unfolded, single-
stranded DNA molecules through the increase in their negative
surface charge density, leading to the protection of AuNPs from
the colloidal aggregation upon addition of salt [17–19].  On the
basis of such DNA discriminating feature, unmodified AuNP-based
aptasensors have been reported for the colorimetric determination
of diverse analytes including K+,  cocaine, adenosine, ATP, ochra-
toxin A, oxytetracycline or thrombin [20,22–27].  In these cases,
three different biosensor strategies involving direct, sandwich-like
or displacement mechanisms were designed. The direct strategy
implied the target-induced conformational changes of  the func-
tional nucleic acid from the unfolded to folded state [20,22,26,27].
Although of valuable simplicity, such a strategy is not generaliz-
able as it requires a  sufficiently large aptamer structural change
to generate a detectable signal [24]. The sandwich-like strategy
was based on the cutting of  the aptameric recognition element
into two separated single-stranded, unfolded DNA strands which
were able to form a  folded ternary complex in the presence of
target [24,25].  The major limitation of this approach is related to
the fact that it necessitates the knowledge of both the aptamer
secondary structure and the critical nucleotide positions to select
precisely the cut site that does not impede the target binding [24].
In the third strategy, the target binding was responsible for the
displacement of an aptamer-binding reporter, i.e. a complemen-
tary single-stranded DNA, from its duplex (double-stranded DNA)
formed with the functional nucleic acid [23]. Despites its broad
applicability, such structure-switching approach suffers from some
drawbacks including the strong alteration of the apparent bind-
ing affinity [28,29] and the careful case-to-case choice of a  suitable
complementary DNA probe [30,31].  Therefore, there is a  need for
the development of an  alternative AuNP aptasensor design which
would combine the simplicity of the direct strategy with the gen-
eralizability of the displacement approach.
Herein, a simple and generic unmodified AuNP-based aptamer
assay dedicated to the colorimetric sensing of  target molecules was
described. The general concept is illustrated in Fig. 1. The sen-
sor design was based on  the common ability of nucleic acids to
be protected, upon complexation by specific ligands, from enzy-
matic attacks [32,33].  The ligand binding protects directly (steric
hindrance to nucleases) and eventually indirectly (conformational
change) the nucleic acid structure from the enzymatic cleavage
[32,33]. Due to its universal feature, such type of protection assay
has been very widely exploited in  several works related to the
nucleic acid-related research field [34–37]. Moreover, the target-
induced resistance of aptamers against the enzymatic digestion has
been previously employed to probe the critical nucleotides implied
in the formation of the ligand–nucleic acid complex [38–40] or
to develop polymerase chain reaction (PCR)-based protein assays
PDE I
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Fig. 1.  Schematic representation of the  enzymatic cleavage protection-based
aptamer assay using unmodified gold nanoparticles as colorimetric reporters. PDE
I:  phosphodiesterase I  enzyme.
[41,42].  In this work, phosphodiesterase I  (PDE I), i.e. a venom
exonuclease that successively hydrolyzes 5′-nucleotides from the
3′-hydroxy-termini of both single-stranded and double-stranded
DNA, was  employed as an  enzymatic probe. In the absence of tar-
get, the DNA aptamer substrate was  predicted to be enzymatically
cleaved, leading to the release of mononucleotides/short single-
stranded DNA fragments (Fig. 1). Upon binding of specific analyte
to the functional DNA, the enzymatic cleavage was  expected to
be impeded, resulting in the protection of the aptamer struc-
ture. Therefore, the target-induced PDE I  cleavage protection of
the aptamer could be converted into a visual signal through the
salt-induced aggregation of  unmodified AuNPs (red-to-blue color
change) produced by the variation of  length of the functional
nucleic acid (Fig. 1), i.e. mononucleotides/short single-stranded
DNA fragments versus long single-stranded DNA [18,21,43,44].
The proof-of-principle of  the unmodified AuNP-based enzy-
matic protection assay strategy was  first evaluated by employing
the anti-tyrosinamide (Tym) DNA aptamer [45] (Apt-T) as a model
functional nucleic acid. To investigate the potential generality of the
approach, the sensing platform was further tested for the adenosine
(Ade) detection using its  DNA aptamer [46] (Apt-A) as molecular
recognition tool.
2. Materials and methods
2.1. Chemicals
l-Tyrosinamide, l-tyrosine, adenosine, inosine, tris(hydroxy-
methyl)aminomethane, phosphodiesterase I  type IV from Crotalus
Atrox (PDE I), HAuCl4 (99%) and trisodium citrate were purchased
from Sigma–Aldrich (Saint Quentin, France). NaCl and MgCl2
were purchased from Chimie-Plus laboratories (Bruyère de Pouilly,
France) and Panreac Quimica (Barcelona, Spain), respectively.
Water was purified on a  Purite Still Plus Water system (Thame, UK)
fitted with a reverse osmosis cartridge. DNA oligonucleotides were
synthesized and purified by  Eurogentec. The aptamer and control
scrambled sequences used are reported in Table S1 (supplemen-
tary content).
2.2. Instrumentation
UV–visible spectra of  the colloidal solutions were recorded
on a Shimadzu UV-1650pc spectrophotometer for wavelengths
ranging from 400 to 800 nm in  10 mm  quartz suprasil® cuvettes.
Microscopy samples were prepared by deposition of a drop of
colloidal solution onto a carbon-coated copper grid and observed
on a  JEOL1011 microscope for bright-field transmission electronic
microscopy (TEM) working at 100 kV.  The particle size was  esti-
mated manually using the ImageJ software.
2.3. Preparation of the gold nanoparticles
AuNPs were prepared by citrate reduction as previously
reported [47].  Briefly, to 20  mL of boiling HAuCl4 (1 mM in filtered
deionized water), 2 mL of trisodium citrate (38.8 mM in water) were
added. The solution was  maintained boiling under vigorous stirring
for 10  min. The color of the suspension changed from pale yellow
to dark red. The stirring was  then continued until the mixture was
cooled to room temperature (RT). The colloidal suspension was
finally filtered on PVDF-membrane filters 0.45 mm  (Roth) and left
aging for 3 days at 4 ◦C before use.
2.4. PDE I cleavage protection-based AuNP assay
A 1 mM aptamer or control scrambled oligonucleotide solution
in deionized water was  prepared daily from a  100  mM solution of
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the corresponding oligonucleotide in a  30 mM  MgCl2, 130 mM  NaCl,
10 mM Tris, pH 8 buffer which was denatured for 5 min at 80 ◦C
and then cooled to RT during 30  min. The working enzymatic solu-
tion of PDE I was prepared daily by a 1/1000 dilution of the stock
solution (2 U mL−1)  in deionized water. The 1 mM oligonucleotide
solution (5 mL) was added in an  eppendorf to the target (50 mL). The
target concentration ranged from 0 to 1 mM  for the Tym assay and
from 0 to 500 mM for the Ade assay. These mixtures were stored for
30 min  at 4 ◦C. Water (45 mL), PDE I  (50 mL, working solution) and
AuNPs (100 mL) were then added (final concentration of  0.75 and
3.25 mM for MgCl2 and NaCl, respectively). The enzymatic reaction
was performed for 15 min  at 25 ◦C.  The digestion was stopped by
heating the mixture at 90 ◦C  for 10  min. After 15 min cooling, 250 mL
of the 40 mM MgCl2,  20 mM NaCl, 40 mM  Tris buffer were finally
added to the DNA/AuNPs mixture and the absorption spectrum
of the resulting solutions was then recorded. Blank experiments
were carried out to test the stability of  the AuNPs in the presence
of target (up to 1 mM  for Tym and Tyr; up to 500 mM for Ade and
Ino) or PDE I  enzyme (working solution). Control experiments were
also performed to evaluate solely the effects of the heating proce-
dure. The titration curves were constructed by plotting the ratio of
absorbance at 650 and 520 nm (A650/A520) versus the ligand concen-
tration (c). A high A650/A520 value was associated to blue-colored
AuNP aggregates while a low A650/A520 value corresponded to
red-colored dispersed nanoparticles. The sensing platform repro-
ducibility was assessed from triplicate measurements employing
AuNP reporters arising from three different batches.
3. Results and discussion
To test the feasibility of the proposed AuNP-based enzymatic
protection assay strategy (Fig. 1), the anti-tyrosinamide DNA
aptamer (Apt-T) and its target (Tym) were firstly chosen as a model
molecular recognition system. This is characterized by a disso-
ciation constant in the 1–5 mM range under low ionic strength
conditions [48,49].  Previous aptamer-based Tym assays using flu-
orescence [50],  fluorescence polarization [49] and miniaturized
separation [51] methods have been successfully reported. Prelim-
inary experiments were carried out in order to (i) investigate the
ability of the PDE I  enzyme to cleave Apt-T in its  free form and
(ii) evaluate the potential protection effects that could be induced
by the target binding to the DNA aptamer. The PDE I-mediated
digestion patterns of Apt-T were analyzed by HPLC (supplementary
content for experimental details). Representative chromatograms
are presented in Figure S1.  The PDE I  action was responsible for
the complete degradation of free Apt-T. In presence of Tym, the
hydrolysis of the DNA aptamer was inhibited, demonstrating that
PDE I  constituted a particularly well-suited enzymatic probe for the
design of the Tym-responsive aptamer protection assay. In the sec-
ond step, PDE I  cleavage protection AuNP-based assay experiments
were performed. The features of the prepared AuNPs were initially
investigated. As typical dispersed particles, citrate-capped AuNPs
(∼14 nm,  see supplementary content)  appeared red in aqueous
solution, exhibited a surface plasmon resonance (SPR) absorption
band at ∼520 nm and was characterized by a low A650/A520 ratio of
∼0.1 (Figure S2).  The addition of an appropriate amount of salts, i.e.
20 mM MgCl2 and 10 mM NaCl in  20 mM  Tris buffer, to the colloidal
solution produced the characteristic particle aggregation by screen-
ing the electrostatic repulsion between AuNPs [17–19] and led to
a blue color change associated to a broad, red shifted absorption
spectrum (Figure S2).  A series of  experiments was subsequently
conducted through the designed format (Fig. 1)  to detect the Tym
target. The AuNP solution properties were analyzed in the presence
of Apt-T, before and after treatment by PDE I. As shown in Fig. 2, the
gold colloid containing the uncleaved Apt-T species changed, after
Fig. 2. Absorption spectra of the  AuNP solution upon salt  addition for samples con-
taining (a) Apt-T and PDE I, (b) Apt-T and  PDE I  after pre-incubation of  Apt-T with
1  mM Tym target and (c) Apt-T alone without PDE I treatment. Inset: Representative
photographs of  the  corresponding solutions. See Section 2 for details.
addition of the same amount of  salts used above, from red-to-blue
with the corresponding absorption broadened and shifted to longer
wavelength (A650/A520 ∼1.3). Such data indicate that the aptamer
sequence (38-base length) was  unable to prevent the salt-induced
aggregation of AuNPs. This is consistent with previous studies that
have demonstrated that single-stranded DNA species of length >10
bases adsorbed slowly onto the gold surface [18],  leading to a lim-
ited electrostatic stabilization effect for the unmodified particles.
On the other hand, the AuNP solution which contained Apt-T
submitted to the enzymatic attack retained, under identical salt
conditions, the red color and nearly the original band in the absorp-
tion spectrum (Fig. 2, A650/A520∼ 0.2). Such a result indicates that
the presence of  aptamer digestion products arising from the PDE
I  treatment governed an increase in the colloidal stability. Both
mononucleotides [43] and short DNA species [18,21] are known
to adsorb quickly and efficiently onto the unmodified AuNPs, pro-
viding the protection of  the gold colloids against the salt-induced
aggregation. When the Apt-T sample was pre-incubated for 30 min
at 4 ◦C with 1 mM Tym target before the PDE I  treatment, the
resulting AuNP solution turned blue upon salt addition with a
red shifted absorption band (Fig. 2, A650/A520 ∼0.8). As reported
above, the Tym binding to Apt-T was  able to prevent the PDE I-
mediated cleavage of the aptamer structure. Therefore, the long
DNA molecule could not stabilize effectively AuNPs [18,21], result-
ing in the salt-induced aggregation of the nanoparticles (Fig. 1).
TEM measurements revealed that AuNPs were mainly dispersed in
the absence of target in the sample while they aggregated signif-
icantly in  the presence of  1 mM  of Tym (Figure S3), corroborating
the color and absorption spectrum change data described above.
Control experiments were carried out to confirm that the elec-
trostatic stability changes of  AuNPs were dependent solely on the
enzymatic manipulation of the aptamer structure. In the absence
of Apt-T, the addition of  Tym or PDE I  to the colloidal solution
(absence of salt) did not modify the color and absorption spectrum
of the citrate-capped nanoparticles (Figure S4).  Similarly, the heat-
ing procedure employed to stop the enzymatic cleavage process
had no effects on the stability of the AuNP solution. Additional con-
trol experiment was  performed using a scrambled sequence DNA
in place of Apt-T. After PDE I  treatment and salt addition, the color
of the colloidal solution did not change in presence of  0.25–1 mM
Tym (Figure S4),  indicating that the assay response was specific to
the target association with Apt-T.
For the quantitative detection of Tym, the A650/A520 ratio was
monitored as a function of  the target concentration in the sam-
ple. The increase in the Tym concentration led to an enhancement
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Fig. 3. Dose-dependent enzymatic protection assay curves obtained by plotting
the A650/A520 ratio of the AuNP solution versus Tym (filled symbols) and  Tyr (open
symbols) concentration. See Section 2 for details.
of  the A650/A520 value (Fig. 3), indicating that the binding event
can be converted into  a suitable colorimetric response related to
the magnitude of the salt-induced AuNP aggregation. Although the
dissociation constant of the Tym–Apt-T complex is known to be in
the micromolar range [48,49], the half-saturation target concentra-
tion of the titration curve, i.e. the apparent dissociation constant,
appeared relatively high (∼60 mM).  The protection of the aptamer
structure was assumed to depend not only on the binding con-
stant of the target/aptamer complex but also on the enzyme probe.
As previously reported [52,53], the cleaving agent may  disturb
the target–aptamer interaction so  that a  competitive equilibrium
between PDE I and the target can occur, leading to high measured
dissociation constant [53].  In addition, a  weak sample Mg2+ amount
was used in the present work to reduce the risk to destabilize
AuNPs during the enzymatic digestion process. Previous studies
have demonstrated that a low magnesium concentration alters the
affinity of the target for the aptamer [48,49].  The limit of  detec-
tion (LOD) was experimentally estimated to be ∼5 mM,  comparable
or better to the LODs previously obtained with other AuNP-based
colorimetric small molecule aptasensors [9,12,13,23–25], and a lin-
ear range up to 100 mM was observed. Additional experiments
were performed using tyrosine (Tyr) as a non-cognate [45].  No
salt-induced red-to-blue color change was observed upon Tyr addi-
tion to the sample (Fig. 3), reflecting the selectivity of the present
methodology.
The general applicability of the AuNP-based sensor strategy was
explored using another small target/aptamer system, i.e. the adeno-
sine (Ade)/anti-Ade DNA aptamer (Apt-A, containing the minimal
functional structure of  25 nucleotides) complex that is character-
ized by a dissociation constant of about 5 mM [46,54]. The PDE
I-mediated digestion profiles of free and target-bound Apt-A were
also analyzed by HPLC (Figure S5).  Apt-A in its free form was
found to be efficiently cleaved by PDE I  and, upon target binding,
resisted, at least partially, to the enzymatic hydrolysis. This result
demonstrates the general usefulness of PDE I  as cleaving probe for
the enzymatic protection assay strategy. The Ade detection was
subsequently performed through the exactly same experimental
protocol employed above for the Tym determination. The Apt-
A/AuNP solutions were submitted to the PDE I treatment, either in
the absence or in the presence (500 mM)  of the Ade target molecule.
After salt addition, a color change from red to blue was observed
when the Ade–Apt-A complex was formed while the colloidal solu-
tion for the target-free sample retained the red color. Moreover, a
significant increase in the A650/A520 ratio by a  factor of ∼6.5 was
reported for the sample containing 500 mM of  Ade (Fig. 4). Ade
Fig. 4. The A650/A520 ratio of  AuNPs obtained for blank (0.5 mM Ade, no salt addi-
tion), assays without (0  mM Ade + Apt-A, PDE I  treatment, salt  addition) and with
adenosine (0.5 mM Ade +  Apt-A, PDE I  treatment, salt addition), control assay with
scrambled oligonucleotide (0.5 mM Ade +  control scrambled Apt-A, PDE  I  treatment,
salt  addition) and selectivity assay with inosine (0.5 mM Ino + Apt-A, PDE I  treatment,
salt addition). See Section 2 for details.
(500 mM)  was added to the AuNP aqueous solution, in absence of
Apt-T and PDE I,  to establish blank experiment (no salt addition, Fig.
4). Another control experiment using a scrambled oligonucleotide
revealed that the color of the DNA/AuNP solution, after PDE  I treat-
ment and salt addition, was  unmodified in presence of  Ade (Fig.
4). The Ade assay displayed similar linear range (up to 100 mM)
and detection limit (∼1 mM)  than those reported above for the Tym
sensing. The LOD is better than those previously reported for col-
orimetric assays dedicated to the adenosine/AMP detection [55].  As
shown in Fig. 4,  the aptasensor was able also to discriminate against
a structurally related compound, i.e. inosine (Ino), further estab-
lishing that the current sensing platform maintained the selective
properties of the recognition element.
4. Conclusion
In summary, we have described an  AuNP-based colorimetric
aptamer assay strategy that relies on  the protection of the aptamer
structure against the PDE I  enzymatic cleavage and its colorimetric
signal transduction through the ability of  gold nanoparticles to dis-
criminate between single-stranded DNA species of variable length.
To the best of  our knowledge, the present work reports the first
small molecule aptasensor based on the target-induced aptamer
enzymatic protection principle. The current approach exhibits sev-
eral attractive features. First, the biosensor functions well even with
Apt-A which is known to undergo a  limited structural change upon
target binding [54,56,57].  Second, the methodology does not neces-
sitate prerequisite aptamer structural information, as exemplified
by Apt-T for which (i) the secondary structure is unknown [45] and
(ii) none precise knowledge on the target-induced fit mechanism
is available [48]. Third, the same assay protocol can be success-
fully employed with different target–aptamer systems without the
requirement of  the case-to-case adaptation of the experimental
conditions. It is consequently expected that the simple sensing
platform reported herein could be applied to a large variety of
target-aptamer couples, expanding the potential applications of the
AuNP-based aptasensor approaches.
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Chromatographic analysis of the PDE I-mediated aptamer digestion pattern
The binding buffer consisted of 50 mM Tris-HCl pH 7.5, 5 mM NaCl and 10 mM MgCl2. The 
solutions of aptamers, analytes and PDE I were prepared in water and stored at -20 °C. 
Binding buffer and water were filtered prior to use through 0.45 µm membranes. The stock 
solutions of aptamers were first diluted to 20 µM in 2x concentrated binding buffer, heated at 
80 °C for 5 min and left to stand at room temperature for 30 min. The working aptamer 
solutions (5 or 10 µM) were obtained by the adequate dilution of the former solution mixed 
with the analyte and/or the PDE I enzyme (0.18 or 0.9 mU). Enzyme containing samples were 
incubated at 25 °C for 30 min and the enzymatic reaction was stopped by heating at 90 °C for 
10 min. The resulting solutions were centrifugated. Samples were analyzed by reversed-phase 
HPLC using an Uptisphere-WRP (5 µm, 300 Å, 250 × 4.6 mm) column purchased from 
Interchim (Montluçon, France). The HPLC system consisted of a LC Shimadzu pump 10AD 
(Sarreguemines, France), a Rheodyne injection valve model 7125 (Interchim, Montluçon, 
France) fitted with a 20 µL loop, a Shimadzu SPD-10A UV-visible detector (detection at 254 
nm) a Shimadzu SCL-10A system controller with Class-VP software (Shimadzu) and an oven 
Igloocil (Interchim). The elution of compounds was achieved at a flow rate of 1 mL/min in 
the gradient mode using acetonitrile (5% for 5 min and from 5 to 25% during 60 min) in 100 
mM NaCl and 25 mM sodium phosphate buffer at pH 6.6 (for Apt-T) or 25 mM Tris-HCl 
buffer at pH 6.4 (for Apt-A), the column being maintained at a temperature of 50 °C. 
Determination of particle size
AuNP size and concentration were characterized using spectral data (Figure S2), as previously 
described [1]. The particle size of citrate-capped AuNPs and the final molar concentration 
were found to be ~14 nm and ~2.2 nM, respectively. The particle size was confirmed (14.1 ±
2.0 nm) by transmission electronic microscopy measurements (n = 50).
Table S1. Aptamer and control scrambled sequences used in the present work.
2Anti-Tym 38-base aptamer (Apt-T) 5’-TGG-AGC-TTG-GAT-TGA-TGT-GGT-
GTG-TGA-GTG-CGG-TGC-CC-3’
Control scrambled Apt-T 5’-CGT-GTT-TGG-GGC-AAT-TTG-GCG-
GCA-GTT-GTG-GTA-GGT-CG-3’
Anti-Ade 32-base aptamer (Apt-A) 5’-AGA-GAA-CCT-GGG-GGA-GTA-TTG-
CGG-AGG-AAG-GT-3’
Control scrambled Apt-A 5’-GTG-AAA-GGG-CAA-TGG-CGC-AGT-
AGA-GGT-AGG-TG-3’
Figure S1. Chromatograms obtained from the reversed-phase HPLC analysis of samples
containing (a) Tym and Apt-T, (b) Apt-T submitted to the PDE I treatment (30 min) in the 
absence of Tym and (c) Apt-T submitted to the PDE I treatment (30 min) in the presence of 
Tym. Apt-T and Tym concentrations were 10 µM and 3.5 mM, respectively. PDE I enzyme: 
0.9 mU. The sample submitted to the enzymatic treatment in absence of Tym (b) was 
characterized by the disappearance of the aptamer peak and the appearance of four peaks, 
characterized by lower retention time (4.4, 6.5, 8.6 and 12.1 min), which corresponded to the 
digestion products. Upon target addition to the medium before the PDE I treatment (c), the 
Apt-T peak was almost similar to the control peak while the low retention time peaks 
disappeared, reflecting the ability of Tym to inhibit the PDE I-mediated hydrolysis of the 
DNA aptamer. 
Figure S2. Absorption spectra of the prepared citrate-capped AuNP solution (~2.2 nM)
before and after salt addition (20 mM MgCl2 and 10 mM NaCl in 20 mM Tris buffer).
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3Figure S3. TEM images of AuNPs for samples containing (a) Apt-T and PDE I and (b) Apt-T
and PDE I mixture after pre-incubation of Apt-T with 1 mM Tym target.
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Figure S4. The A650/A520 ratio of AuNPs obtained for blank Tym (1 mM Tym, with or 
without salt addition), blank PDE I (PDE I working solution, with or without salt addition) 
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4and control with scrambled oligonucleotide (1 mM Tym + scrambled Apt-T, with or without
PDE I treatment, salt addition).
Figure S5. Chromatograms obtained from the reversed-phase HPLC analysis of samples
containing (a) Ade and Apt-A, (b) Apt-A submitted to the PDE I treatment (30 min) in the 
absence of Ade and (c) Apt-A submitted to the PDE I treatment (30 min) in the presence of 
Ade. Apt-A and Ade concentrations were 5 µM and 3.125 mM, respectively. PDE I enzyme: 
0.18 mU.
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II.3.3 Conclusions
Gold nanoparticles have emerged as a promising material for biosensing that provide a 
useful complement to more traditional sensing techniques. The combination of low toxicity, 
high surface area, rich surface functionalization chemistry and colloidal stability allow them 
to be safely integrated into the sensor systems for detection in vitro and in vivo. However, 
optimization of parameters for the sensing systems is still required to meet the demands of
clinical diagnosis for the future development of personalized medicine. In particular, due to 
the aggregation ability of AuNPs under some high ionic strength, pH conditions, etc., the 
development of efficient sensors to detect analytes in complex biological fluids such as urine,
serum, and blood remains a challenge. Further studies on the optical properties of AuNPs as 
well as their aggregates, and interactions between AuNPs and different biomolecules may 
eventually lead to highly useful biosensors in diagnosis, environment monitoring and civil 
defence.
In order to meet the need of clinical diagnosis for the future development, it is of great 
interest and important to explore aptamer-based methodologies which could be applied in 
complicated biological environment. Furthermore, the investigation of aptamer-target binding 
interactions mechanism including the influence of the aptamer secondary structure has 
far-reaching significance. A novel rapid, homogeneous, sensitive detection method for the 
molecule interaction study becomes an urgent need, which makes fluorescence polarization 
(FP) an excellent candidate for the new aptamer-based assay.
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II.4 Aptamer-based fluorescence polarization assay for small molecule 
detection
II.4.1 Introduction
II.4.1.1 General description of fluorescence polarization (FP)
The investigation of biomolecular binding interactions remains one of the most popular 
studied topics using techniques that are based on emission of fluorescence. Several 
technologies have been successfully used including fluorescence resonance energy transfer, 
fluorescence quenching or fluorescence polarization (FP) methods. During the past few 
decades, the increase in the number and diversity of fluorescence polarization studies has 
been astonishing and the method is now extremely widespread in the clinical and biomedical 
fields. The virtual explosion of polarization studies, which began during the mid-1980s, was 
due to several factors: FP assays utilize single fluorescent label strategy and avoid the use of 
radioisotopes and filtration or separation steps. Thus, fewer reagents are generally needed, and 
the assay protocol is a simple mix-and-read (i.e., homogenous) with the assay reagents being 
overall inexpensive. Additionally, reagent equilibrium is not disturbed due to lack of 
separation step, and plates can often be repetitively measured as FP detection does not destroy 
samples.
Fluorescence polarization/fluorescence anisotropy (FP/FA) is a versatile solution-based
technique that has been widely used to study molecular interactions, enzymatic activity and 
nucleic acid hybridization. After its first theoretical description in 1926 by Perrin [298], the 
application has evolved from obtaining binding isotherms under carefully controlled settings 
to the study of small molecule-protein, antigen-antibody and hormone-receptor binding in 
miniaturized automated settings. It was not until the mid-1990s that FP was adopted in 
high-throughput screening (HTS) to facilitate the drug discovery process, with its use being 
extended from direct interaction studies to complex enzymatic assays. 
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Figure 2-6: Basic principle of fluorescence polarization [299]. A fluorophore is excited with light that is 
linearly polarized by passing through an excitation polarizing filter; the polarized fluorescence is 
measured through an emission polarizer either parallel or perpendicular to the exciting light’s 
plane of polarization. Two intensity measurements are obtained (Iĵ and IŒ) and used for the 
calculation of FA or FP.
When a fluorophore in solution is exposed to plane-polarized light at its excitation
wavelength the resulting emission is depolarized. The depolarization results from the motion
of the fluorophore during the processes of excitation and emission. Because of this, the more 
rapid the motion of the fluorophore the more the emission is depolarized. The fluorescence 
emission can be segregated, using polarizers, into horizontal and vertical components, shown 
schematically in Figure 2-6. Quantitatively, FP/FA is defined as the difference of the emission 
light intensity parallel (IŒ) and perpendicular (Iĵ) to the excitation light plane normalized by 
the total fluorescence emission intensity (Equations 14 and 15, FP and FA are used 
interchangeably [300, 301]).
(14)
(15)
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It can be seen from Equations 14 and 15 that the FP value is independent of fluorophore 
concentration as it is not dependent on the absolute intensities of the emission light collected
at either orientation. On the other hand, the intrinsic fluorescence intensity of a fluorophore 
may change on binding to its cognate partner, thus resulting in significantly different 
contributions of the bound versus free forms of the fluorophore to the total fluorescence 
intensity of the sample, which in turn can complicate the interpretation of FP measurements
[302, 303]. As instruments may have unequal sensitivity in detecting light in the
perpendicular and the parallel orientations, a grating factor (commonly referred to as G factor)
[304]has been introduced to correct for that bias in order to calculate absolute polarization
values and for cases where data obtained from different instruments are to be compared [305].
Polarization relates a fluorophore’s lifetime (t) (defined as the average time lapse between 
excitation and emission of thH IOXRURSKRUHZLWK LWV URWDWLRQDO UHOD[DWLRQ WLPH ȝ the latter 
being defined as the time it takes for a molecule to rotate through an approximate 68.5eangle 
after excitation [298] (Equation 16):
(16)    
where R is the universal gas constant, V is the molar volume of the rotating molecule, T is the 
absolute temperature DQG Ș is the solvent viscosity. It can be seen from Equation 16 that 
rotational relaxation time is dependent on molar volume provided that temperature and 
viscosity remain constant. Therefore, as molecular size of the fluorescent species is being 
altered through dissociation/breakdown or association/binding events, the degree of 
depolarization of plane polarized light changes accordingly, thereby, directly affecting the FP
value. 
II.4.1.2 Fluorophore Rotation and Anisotropy
The utility of fluorescence polarization in the clinical and biomedical sciences ultimately 
rests on the dependence of the observed polarization on the rotational diffusion rate of
molecules. It is easy to imagine that the rotational rate will be slower as the molecule gets 
larger. For example, the rotational rate of a small molecule, e.g., of molecular weight 300 Da, 
will be much faster than the rotational rate of a large molecule, e.g., 100,000 Da. During the 
same fixed time interval, we would thus expect the small molecule to rotate through a larger
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angle than the large molecule and, hence, we would expect that the light emitted by the 
smaller molecule will be more equally distributed in all directions, compared to the case of
the larger molecule, whose emission will be oriented more or less in line with the original 
excitation direction. This scenario is illustrated in Figure 2-7.
Figure 2-7: Illustration of the rotation of a fluorophore free in solution as compared to a fluorophore 
attached to a protein or macromolecule [306]. As indicated in the figure, the fluorophore free in
solution can rotate rapidly (compared to its fluorescence lifetime) and hence gives rise to a low 
polarization value whereas a fluorophore attached to a protein (either covalently or 
noncovalently) rotates more slowly (relative to its fluorescence lifetime), due to the larger mass 
of the macromolecule, and hence gives rise to a high polarization.
In the case of fluorescent probes linked noncovalently to proteins (for example, porphryins, 
FAD, NADH, ANS, or fluorescent-antigen/antibody complexes), the probe is typically held to 
the protein matrix by several points of attachment, and hence, its “local” mobility, that is, its 
ability to rotate independently of the overall “global” motion of the protein, is restricted. In 
the case of a probe covalently attached to a protein, via a linkage through an amine or
sulfhydryl groups, for example, or in the case of tryptophan or tyrosine side chains, 
considerable “local” motion of the fluorophore can occur. Such local probe mobility will 
result in a lower polarization than expected from consideration of the probe lifetime and the 
size of the protein.
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II.4.1.3 Applications
FP is a homogeneous method that allows rapid and quantitative analysis of diverse 
molecular interactions and enzyme activities. This technique has been widely utilized in
clinical and biomedical settings, including the diagnosis of certain diseases and monitoring 
therapeutic drug levels in body fluids. It has also been applied to the analysis of molecular 
interactions including protein-protein, protein-DNA and protein-ligand binding events, 
separately. FP applications can be classified based on target class or molecular interaction. 
A FP assay can be configured through direct binding of the protein with its substrate in a 
design scheme similar to that applied in receptor-ligand binding (Figure 2-8A). In this case, 
the substrate is fluorescently labeled, and in the assay the FP value increases due to the 
formation of the larger enzyme-substrate complex [307]. In non-affinity-based methods, the 
substrate is usually labeled with a fluorophore and possesses a low rotational relaxation; thus, 
the readout almost always follows a decrease in polarization value as the enzymatic reaction, 
such as a proteolytic or hydrolysis process, leads to the breakdown of the fluorescently
labeled substrate and thus a decrease in its molecular size (Figure 2-8B) [308].
Fluorescence polarization immunoassay (FPIA) is an antibody-based technique that usually 
follows the competition between unlabeled antigen and labeled antigen for binding to an 
antibody. On the displacement of the labeled antigen by the unlabeled antigen, the rate of the 
tumbling motion is increased due to increased amount of free labeled antigen, resulting in a 
lower polarization (Figure 2-8C). This method requires a substantial degree of substrate 
phosphorylation [309], and assay sensitivity can be improved by switching to a competitive
FPIA format. In competitive FPIA [310], a fluorescently labeled phosphopeptide tracer 
representing the kinase reaction product is bound to an antibody, corresponding to a high FP
value. Displacement of the tracer by increased amount of reaction-generated phosphopeptide 
product causes higher molecular mobility of the tracer and, consequently, a decrease in FP 
value (Figure 2-8D).
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Figure 2-8: Schematic illustration of FP principle in relation to: A) Schematic illustration of FP principle in 
relation to receptor-ligand interaction [307] B) degradative enzymatic reactions (during hydrolysis,
breakdown of fluorophore-labeled substrate into smaller molecules produces species with lower 
FP, which can be used to measure enzymatic activity) [308], C) FPIA (binding of a labeled 
antigen to its antibody leads to an increase in FP; displacement of labeled antigen by unlabeled 
antigen reduces the FP value and the degree of FP reduction is correlated with the antigen
concentration in unknown samples) [309], D) competitive FPIA for kinase (displacement of a 
fluorescently labeled phosphopeptide tracer from phosphospecific antibodies by kinase 
reaction-generated phosphopeptide product (unlabeled) results in a decrease in FP, which can be 
used to measure kinase activity) [310].
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II.4.2 Experimental Section
II.4.2.1 Complementary strands (CS) displacement strategy
Despite its simplicity and sensitivity, direct (non-competitive) strategy is not widely 
applicable as it requires a sufficiently large aptamer conformational/structural change or the 
rational engineering of the aptameric element to produce detectable fluorescence anisotropy 
responses. The indirect format, on the other hand, takes advantage of the ability of nucleic 
acids to form duplex structures with their complementary sequences [311]. The fluorescence 
anisotropy signal of the duplex is expected to be greater than that of the free fluorescently 
labeled complementary strand (CS) since the molecular mass of the hybrid is higher than that 
of the CS probe alone. This indirect approach has advantages over the direct FP strategy. The 
aptamer does not have to be modified to obtain a significant signal, which does not depend on 
a large conformational change within the oligonucleotide. More importantly, the methodology 
displays a broad applicability [213].
A structure-switching aptamer assay based on a fluorescence polarization (FP) signal
transduction approach and dedicated to the L-tyrosinamide sensing was described and 
optimized by our group [312]. A fluorescently labeled complementary strand (CS) of the 
aptamer central region was used as a probe. The effects of critical parameters such as buffer 
composition and pH, temperature, aptamer:CS stoichiometry, nature of the dye (Fluorescein 
(F) or Texas Red (TR)) and length of the CS (15-, 12-, 9- and 6-mer) on the assay analytical 
performances were evaluated. 
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In  this  paper,  a  structure-switching  aptamer  assay based on  a  fluorescence  polarization (FP)  signal
transduction  approach  and dedicated  to the l-tyrosinamide sensing was described and optimized.  A
fluorescently labelled complementary  strand (CS) of the aptamer central  region  was used as a probe.  The
effects  of critical parameters  such  as buffer  composition  and pH,  temperature, aptamer:CS stoichiome-
try,  nature of the dye (Fluorescein (F) or  Texas  Red  (TR)) and  length  of the  CS  (15-,  12-,  9-  and 6-mer)
on  the  assay  analytical  performances were  evaluated.  Under  optimized  experimental conditions  (10 mM
Tris–HCl,  5  mM MgCl2 and 25  mM NaCl, pH 7.5  temperature of 22 ◦C and stoichiometry  1:1), the  results
showed  that, for a 12-mer  CS, the F  dye moderately  increased the  method  sensitivity  in comparison  to the
TR label.  The  F labelled  9-mer CS, however,  did not  allow  the hybrid  formation  with  the  functional  nucleic
acid,  thus  emphasizing the importance  of the  nature of the  fluorophore.  In  contrast,  the same  9-mer CS
labelled  with  the TR  dye  was  able  to  effectively  associate  with  the  aptamer and was easily  displaced  upon
target  binding as demonstrated  by a significant  improvement  of the  sensitivity  and a detection  limit of
250 nM,  comparable  to those  reported  with  direct aptasensing  methods.  The present  study  demonstrates
that  not  only the CS length  but  also  the  nature  of  the  dye  played  a preponderant role  in the performance
of  the  structure-switching  aptamer assay,  highlighting  the  importance  of  interdependently  controlling
these  two factors  for an optimal  FP-based  sensing  platform.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Aptamers are artificial oligonucleic acids selected in vitro
through SELEX (systematic evolution of ligands by exponential
enrichment) [1,2]. Aptamers display high affinity and specificity
to a wide range of  target molecules, including drugs, proteins
and other organic or inorganic species. Due to their numerous
advantages [1–3],  aptamers have become an attractive alterna-
tive to antibodies as molecular recognition elements in several
biosensor applications. A number of aptamer-based sensors have
been designed and optimized [4–6],  using fluorescent [7–14], col-
orimetric [15–19], magnetic [20,21],  electrochemical [22–24] or
mass sensitive [25–27] transduction systems. Among aptamer-
based sensors, fluorescent sensors are  particularly interesting, due
notably to their high intrinsic sensitivity and the capability for auto-
mated, high-throughput and multiplexed analysis.
The simplicity, speed and accuracy of the fluorescence polar-
ization (FP) approach has made it one of  the most appealing
and thus commonly used techniques for the routine analysis of
∗ Corresponding author.
E-mail address: eric.peyrin@ujf-grenoble.fr (E.  Peyrin).
small molecules in a variety of  areas [28]. Aptamers have recently
been employed for the quantitative determination of small target
molecules by measuring the change in the fluorescence anisotropy
signal using two different strategies. The first approach relies on
a direct (non-competitive) mechanism [29,30] while the second
is based on  an  indirect structure-switching mechanism [31]. In
the direct format, the target binding induces aptamer conforma-
tional and/or structural changes that affect precisely labelled sites
or regions of  the functional nucleic acid. These changes lead to
alter local dye motions, which are then monitored by variations
in the total fluorescence anisotropy signal [29,30].  Despite its sim-
plicity and sensitivity, such a  strategy is not widely applicable as
it requires a sufficiently large aptamer conformational/structural
change [30] or the rational engineering of  the aptameric element
to produce detectable fluorescence anisotropy responses [29]. The
indirect format, on the other hand, takes advantage of  the ability of
nucleic acids to form duplex structures with their complementary
sequences [10].  The fluorescence anisotropy signal of the duplex is
expected to be greater than that of the free fluorescently labelled
complementary strand (CS) since the molecular mass of  the hybrid
is higher than that of  the CS probe alone. In this indirect assay,
the aptamer is initially hybridized to its strand (CS), forming a
duplex. In the absence of the target, base pairing between the
0003-2670/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.aca.2011.09.022
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Fig. 1. Schematic representation of the indirect FP strategy for the design of the
small molecule aptasensor (aptamer in  blue, CS  in black, target as a  star). (For inter-
pretation of the references to color in this figure legend, the reader is referred to the
web  version of the article.)
complementary sequences is favoured. When the target is intro-
duced, it binds to the aptamer and the aptamer–CS hybridization
is disrupted, leading to the displacement of the complementary
strand [31] (Fig. 1) and thus resulting in an observable decrease
in the fluorescence anisotropy signal. This indirect approach has
advantages over the direct FP strategy. The aptamer does not
have to be modified to obtain a significant signal, which does
not depend on a large conformational change within the oligonu-
cleotide. More importantly, the methodology displays a broad
applicability [31].
However, compared to direct assays, this strategy suffers from
poor sensitivity that is directly related to the stability of the
CS–aptamer duplex [32].  As the target–aptamer association com-
petes with the CS–aptamer interaction (Fig. 1), a stable duplex
structure significantly alters the apparent binding affinity of the
target for the aptamer, causing performance deterioration of the
assay performances [10,11].
Improvement in the assay sensitivity is an important goal of the
method development since a  majority of biological events occur at
very low analyte levels. To date, no study has been performed to
identify and analyze the factors involved in the analytical perfor-
mances of the structure-switching-based FP aptasensor. The study
described here used the l-tyrosinamide 38-mer DNA aptamer (Apt-
Tym) as model system [9,30].  Under optimized binding conditions,
the FP biosensor titration curves with increasing target concen-
tration were generated for both the Fluorescein-tagged and the
Texas Red-tagged CS duplexes, and the assay performances were
compared.
2. Experimental
2.1. Chemicals and apparatus
l-Tyrosinamide (l-Tym), l-tyrosine (l-Tyr), and
tris(hydroxymethyl)aminomethane were obtained from Sigma
Aldrich (Saint-Quentin, France). NaCl and MgCl2 were obtained
from Chimie-Plus Laboratoires (Bruyères de  Pouilly, France) and
Panreac Quimica (Barcelona, Spain), respectively. Water was
obtained from a Purite Still Plus water purification system (Thame,
UK) fitted with a  reverse osmosis cartridge. The normal and
modified oligonucleotides listed in Table 1  were synthesized and
HPLC-purified by Eurogentec (Angers, France). The identity of  the
oligonucleotides was confirmed by MALDI-TOF mass spectrom-
etry. Fluorescence anisotropy was measured on a Tecan Infinite
F500 microplate reader (Männedorf, Switzerland) using black,
96-well Greiner Bio-One microplates (ref: 675086). Excitation was
set at 485 ± 20 nm or 585 ± 20 nm and emission was collected
with 535 ± 25 nm or 635 ± 30 nm bandpass filters in relation to the
wavelengths associated with the fluorescent dyes.
Table 1
Oligonucleotides utilized in  the  structure-switching aptamer-based fluorescence
polarization assays.a
Polarization homogeneous assay
Apt-Tym (38-mer) 5′-TGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC-3′
F-CS-15* (15-mer) 3′-CGAACCTAACTACAC-F-5′
F-CS-12* (12-mer) 3′-ACCTAACTACAC-F-5′
F-CS-9* (9-mer) 3′-TAACTACAC-F-5′
Apt-Tym (38-mer) 5′-TGGAGCTTGGATTGATGTGGTGTGTGAGTGCGGTGCCC-3′
TR-CS-12* (12-mer) 3′-ACCTAACTACAC-TR-5′
TR-CS-9* (9-mer) 3′-TAACTACAC-TR-5′
TR-CS-6* (6-mer) 3′-CTACAC-TR-5′
a F: fluorescein label; TR:  Texas red; complementary bases are in bold type.
2.2. Sample preparation
Unless otherwise stated, the binding buffer for fluorescence
polarization assay (FP) consisted of 10 mM Tris–HCl, pH 7.5, 5 mM
MgCl2 and 50 mM NaCl. The aptamer (Apt) and CS stock solutions
were prepared in  pure water at 10−6M and stored at −20 ◦C. The
working CS or CS–aptamer solutions were prepared from the stock
solutions by diluting 1.28× with concentrated binding buffer for
FP. The working solutions were heated at 90 ◦C for 5 min  and then
cooled at 4 ◦C for 30 min  in order to reach equilibrium prior to use.
The analyte solutions were prepared in water. For  l-Tym titration
curve, the analyte concentration varied from 25 mM to 2000 mM
(except for the TR-CS 9 mer). All  solutions were filtered before use
through 0.45 mm membrane filters.
To establish the titration curves, CS, Apt and analyte solutions
were mixed into individual wells (final volume = 100 mL) at room
temperature (22 ◦C, unless otherwise notified), resulting in both
Apt and CS oligonucleotide final concentrations of 10 nM.  Blank
wells of the microplate received 100  mL  of the binding buffer. All
experiments were done in triplicate. The microplate was placed
into the microplate reader for the measurement after 15 min  of
incubation in dark.
2.3. Parameter determination
The anisotropy (r) was  calculated by the instrument software,
as classically reported:
r  =
Iw − GIh
Iw + 2GIh
where Ivv and Ivh are the vertically and horizontally polarized com-
ponents of  the emission after excitation by vertically polarized
light. The instrumental correction factor G was determined from
standard solutions according to the manufacturer’s instructions.
Fluorescence anisotropy change 1r  was calculated as follows:
1r = r  − rf
where r  is the anisotropy of the hybrid (dye-labelled CS with
aptamer) and rf is the anisotropy of the free complementary strand.
1rmax is the maximal fluorescence anisotropy difference, obtained
in the absence of  target. Relative 1r  was  obtained as follows:
relative 1r  =
1r  × 100
1rmax
3.  Results and discussion
It is well established that the sensitivity of a  biosensor plat-
form is dependent on  both the affinity of the molecular recognition
element for the target analyte and the signal transduction tech-
nology employed [33]. The stability of the aptamer–CS duplex in
the structure-switching aptamer approach to biosensors is known
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to have a strong impact on  the sensitivity of the method [10,11].
Thus, the key factors in the development of  this type of biosen-
sor strategy are the hybridization conditions and the choice of  an
appropriate CS probe. To note, the core sequence (12-mer) of the
complementary strands utilized in this study (Table 1)  has been
previously described in the development of a structure-switching
aptamer assay for a multiplexed detection of  small analytes by
capillary electrophoresis [34].
3.1. Influence of the  buffer composition on the FP response
The influence of the salt concentration in the binding buffer on
the FP response was firstly studied. For the anti-l-tyrosinamide
aptamer, it has been previously shown that the magnesium concen-
tration played an essential role in both the 3D aptamer stabilization
and target binding [35]. Thus, in preliminary experiments, different
titration curves of  the aptamer-based Tym sensor were constructed
under four MgCl2 concentrations (NaCl concentration fixed at
50 mM)  (Fig. 2a). In the absence of aptamer, the fluorescence
anisotropy values of the F-CS-12 with all MgCl2 concentration were
equivalent (around 0.043 ± 0.001). The addition of the aptamer in
the absence of l-Tym resulted in  a  large increase in fluorescence
anisotropy values (0.083 ± 0.001, 0.094 ± 0.001, 0.106 ± 0.001 and
0.110 ± 0.001 for 2.5, 5,  10 and 15 mM  of MgCl2, respectively). The
presence of a high amount of  MgCl2 was favourable to the hybrid
species formation. The fluorescence anisotropy change upon target
binding was found to be slightly dependent on the MgCl2 concen-
tration. The optimal signal was attained between 2.5 and 10 mM
of MgCl2 with the best results for 5 mM.  The weaker fluorescence
anisotropy change was observed for higher MgCl2 concentration,
indicating the preponderant role of MgCl2 concentration in duplex
formation.
To determine whether the concentration of NaCl might affect
the assay response, a  series of aptamer-based indirect sensing
measurements were performed under different salt concentrations
(Fig. 2b). The 1r  value was also found to vary with the NaCl con-
centration. For an MgCl2 concentration set to 5 mM,  the response
was optimal for the 25 mM NaCl concentration. To note, the hybrid
species was formed even in absence of NaCl, showing that the pres-
ence of MgCl2 was sufficient to promote the duplex formation.
Lowering the salt concentration enhanced the structure-switching
aptamer mechanism (Fig. 2b). In contrast, the presence of a high
amount of NaCl favoured the hybridization so that displacement
by the target, and hence the formation of  target–aptamer complex,
was hindered under such salt conditions.
The role of the buffer pH on  the fluorescence anisotropy vari-
ation was also evaluated. No significant change was  observed
between pH 7 and pH 7.5 and 8 (data not shown). Thus, the buffer
pH was set to 7.5 for all experiments of the present study.
3.2. Influence of the  temperature and stoichiometry on the FP
response
As reported by previous FP studies on  the target–aptamer inter-
action [30,36],  temperature constitutes a preponderant parameter
in the signal response. As the rotational correlation time is inversely
related to the temperature, the effect of  increasing temperature
results in reduced FP changes [36]. Furthermore, the decrease in
the temperature typically improves the target binding to aptamer,
resulting in enhanced assay sensitivity for direct FP aptamer-based
assays [30,36].  To evaluate the effect of temperature on the current
displacement assay, mixed duplex-analyte samples were incubated
in a cold room (4 ◦C) or in controlled thermal bath (22 ◦C or 37 ◦C)
for a 15 min  period. The samples were then transferred into the
individual wells and the fluorescence anisotropy measurement was
immediately performed. The titration curves were constructed as
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Fig. 2. Fluorescence anisotropy change (relative 1r  %) of F-CS-12 and Apt-Tym with
increasing l-Tym (cognate ligand) under (a) 2.5 mM (blanck), 5 mM (black), 10  mM
(light  grey) and 15 mM (grey dark) MgCl2 concentration (50 mM NaCl). (b)  Fluo-
rescence anisotropy change (relative 1r  %) under 5 mM MgCl2 concentration and
various NaCl concentration conditions 0 mM (black), 25 mM (blanck), 50 mM (grey
dark),  100 mM (light grey). Probe concentration: 10 nM.  Aptamer concentration:
10  nM.  Binding buffer conditions: 10 mM Tris–HCl, pH =  7.5. Triplicate experiments.
shown in Fig. 3a. Similar FP responses were observed for 37 ◦C and
22 ◦C  while a  weaker fluorescence anisotropy change was obtained
for the 4 ◦C experiment. It can be suggested that the hybridized
form was more stable at lower temperature than higher tempera-
ture so that the fast displacement of  the CS upon target binding was
favoured at 22 or 37 ◦C. For convenience reasons, 22 ◦C was chosen
as standard temperature for subsequent experiments.
Finally, the influence of  the CS:aptamer stoichiometry were
investigated to fine-tune the FP response. The oligonucleotide
probe concentrations were optimized to 10 nM concentration in
a previous study to reach a fluorescence intensity signal-to-noise
ratio >10. [30]. In the present work, various aptamer concentra-
tions varying from 5 to 50 nM were tested). A weak fluorescence
anisotropy variation was observed for 50  nM aptamer concentra-
tion, indicating that a  large amount of  aptamer was unfavourable
to the CS displacement by the free target. When aptamer was in
insufficient concentration (5 nM), the sensitivity of the method was
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Fig. 3. Fluorescence anisotropy change (relative 1r  %) of F-CS-12 and Apt-Tym
with increasing l-Tym (cognate ligand) under (a) different temperature 4 ◦C (filled
square), 22 ◦C (open triangle) and  37 ◦C (filled triangle) (aptamer concentration:
10 nM). (b) 5  nM (filled square), 10  nM (filled triangle), 50 nM (open triangle). Probe
concentration: 10 nM.  Binding buffer conditions: 10 mM Tris–HCl, pH 7.5,  5 mM
MgCl2 , 25 mM NaCl.
affected. The best result was obtained for 1:1 stoichiometry (with
10 nM aptamer concentration).
3.3. Influence of the dye nature and CS  length on the FP response
Numerous studies have shown that the fluorophore nature
significantly influences the sensitivity of  the FP assays involving
labelled DNA species [30,36].  To  evaluate the impact of the dye
nature on the structure-switching aptamer based assay, two dif-
ferent dyes, i.e. F and TR, were used. The titration curves with
increasing l-Tym concentrations (from 25 to 2000 mM) were estab-
lished using the tagged complementary strands F-CS and TR-CS
under the optimized binding buffer conditions (10 mM Tris–HCl,
5  mM MgCl2 and 25 mM  NaCl, temperature of  22
◦C see above).
In  the absence of target, the fluorescence anisotropy values var-
ied from 0.045 ± 0.001 for the F-CS-12 probe to 0.091 ± 0.002 for
the TR-CS-12 probe under the binding buffer conditions. Such
behaviour could be attributed to the specific physico-chemical
features of the two dyes. FP measurements typically reflected
the contributions from (i) the local motional freedom of  the flu-
orescent reporter and (ii) the global rotational diffusion of the
entire species [37,38].  The rotation of  the anionic F moiety in
Fig. 4. Titration curves of (a) F-CS-15 (filled triangle), F-CS-12 (open triangle), TR-CS-
12  (open circle), (b) F-CS-9 (open square), TR-CS-9 (filled square) and Apt-Tym with
increasing l-Tym (cognate ligand) and l-Tyr (non-cognate ligand for TR-CS-12 (filled
circle)). Triplicate experiments. 1r  = r  − rf where rf is the  fluorescence anisotropy
in  absence of analyte. Probe concentration: 10 nM.  Aptamer concentration: 10 nM.
Binding buffer conditions: 10 mM Tris–HCl, pH 7.5, 5 mM MgCl2 , 25 mM NaCl.
an end-labelled CS  is largely uncoupled from the global motion
of the molecule, explaining the low anisotropy value of the F-
CS-12 probe. On the other hand, the TR on the TR-CS molecule
has been shown to exhibit a  higher degree of coupling to the
whole macromolecule as the result of  its  cationic character [39].
Moreover, the predicted fluorescence anisotropy value for the
CS was estimated to be 0.094 using the procedure previously
described by Gokulrangan et al. [36].  The r-value for the TR-
CS-12 probe was consistent with this theoretical data while the
measured fluorescence anisotropy of F-CS-12 was  significantly
lower. Upon aptamer addition, an increase in the fluorescence
anisotropy was observed for both probes. Fluorescence anisotropy
values of  0.105 ± 0.001 and 0.200 ± 0.002 were obtained for F-
CS-12 and TR-CS-12, respectively, consistent with the formation
of the duplex structure. The duplex formed with TR-CS-12 dis-
played a higher 1rmax value 0.109 ± 0.001 than that obtained
with the F-CS-12 probe (0.061 ± 0.001). With the two probes, l-
Tym could be detected between 25 mM and 100 mM  in a linear
pattern (Fig. 4a).  Detection limits (∼6 and ∼11 mM for F-CS-
12 and TR-CS-12, respectively), based on  a statistical analysis
by regression function were obtained (Table 2). The use of the
F-CS-12 probe was responsible for a greater assay sensitivity
(slope = −1.90 × 10−04± 2.65 × 10−05) as compared to the method
that used TR-CS-12 (slope = −1.05 × 10−04± 1.05 × 10−05)  (Fig. 4a).
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Table 2
Comparison of the l-tyrosinamide assay sensitivity for different methods.
Analytical method Label Detection limit Linear dynamic range Apparent Kd References
Structure switching
polarization fluorescence
Fluorophore labeled CS This work
F-CS-12 6 mM 25–100 mM 160 mM
TR-CS-12 11 mM 25–100 mM 260 mM
TR-CS-9 250 nM 0.5–2.5 mM 3 mM
Direct polarization
fluorescence
Fluorophorelabeled aptamer [30]
3′-F-9-Apt-Tym 200 nM at 25 ◦C 20 nM–1.5 mM 1.7 mM
100 nM at 4 ◦C 20–750 nM 0.7 mM
3′-F-15-Apt-Tym 280 nM at 25 ◦C 20 nM–2 mM 2.2 mM
Direct fluorescent intensity Fluorescent aptamer adduct ∼3 mMa 5–100 mMa 40 mM  [9]
a Graphically estimated.
These results correlated well with the values of the apparent disso-
ciation constants (Kd), which were estimated from the mid-point
of the maximum of the titration curves. Kd values of 160 mM
and 260 mM were observed for the F-CS-12-Apt and TR-CS-12-
Apt hybrids, respectively (Table 2). The higher assay sensitivity
obtained with F-CS-12 could be then explained by the ability of
the probe to be more easily displaced from the aptamer by the tar-
get binding. The negative charge on  the fluorescein was expected
to govern the dye-duplex backbone repulsion that could favour
the CS release. On the other hand, the duplex involving the TR-
CS-12 was assumed to be more stable due favourable electrostatic
and van der Waals interactions with DNA [36] such that the l-Tym
target molecule could not displace the labelled probe from Apt as
efficiently.
To investigate the specificity of the present structure switching
aptamer based FP assay, we further examined the aptamer binding
reaction with tyrosine. Fig. 4a shows the fluorescence anisotropy
changes in response to the addition of various concentrations of
l-tyrosine under the same experimental conditions used above.
No significant changes were observed upon l-tyrosine addition,
demonstrating the specificity of the sensing platform.
It is well established that the length of the CS constitutes one of
the main parameters that governs the stability of the duplex [10].
The effect of the CS  length on the structure-switching aptamer sys-
tem was thus subsequently evaluated. For a 15-mer CS, containing
the 12-mer core sequence CS-12 used above, the addition of the
aptamer in the absence of target resulted in a large increase in
fluorescence anisotropy value (0.110). As obviously expected, this
indicated that F-CS-15 annealed very efficiently to the aptamer.
However, a very slight variation was observed upon target binding
due to the too strong duplex stability (Fig. 4a). Ideally, the opti-
mized CS should be capable of hybridizing to the aptamer with
low/moderate strength in order to facilitate fast displacement upon
target binding. So, a truncated sequence of  CS-12 (12-mer) was
designed (CS-9, 9-mer) and the assay performances were again
evaluated. Both F and TR were used as reporters for CS-9 to eval-
uate the interdependent role of  the two factors. In the absence of
the target molecule, no variation in  the FP value was observed upon
aptamer addition to F-CS-9 (Fig. 4b), indicating that the duplex can-
not be effectively formed between F-CS-9 probe and the aptamer.
On the other hand, hybridization was effectively observed between
the TR-CS-9 probe and Apt. As reported above, such difference
observed for the two reporters can be attributed to the differ-
ent DNA-interacting features of the labels. Due to a lower hybrid
fraction formed, experiments involving TR-CS-9 exhibited a lower
1rmax value (0.017 ± 0.001) (Fig. 4a) than those performed with
the TR-CS-12 probe (0.109 ± 0.001) (Fig. 4b). The titration curve
obtained with the TR-CS-9 probe was characterized by a steep
slope (slope = −3.52 × 10−03± 8.87 × 10−04). This is attributed to
the weak stability of  the duplex structure, and implies great assay
sensitivity. Such sensitivity using TR-CS-9 was much higher than
the sensitivity obtained above with the F-CS-12-Apt and TR-CS-
12 probes, by a factor of about ∼20 and ∼30, respectively. With
TR-CS-9 probe, l-tyrosinamide could be detected in  a shorter lin-
ear range from 0.5 mM to 2.5 mM and a detection limit of  250 nM
was obtained (Table 2), comparable to that of the direct polariza-
tion l-tyrosinamide aptamer-based sensor [30] and better than that
obtained with direct fluorescent intensity measurement [9]. More-
over, the apparent Kd of the titration curve of TR-CS-9 probe was
estimated to be about 3 mM from the mid-point of the titration
curve, ∼50 or ∼90 times lower than the ones obtained for the two
other probe systems. Of particular interest is the fact that this Kd
value was  close to the dissociation constant of  the original l-Tym-
Apt complex determined by direct polarization assay (Table 2)  and
isothermal titration calorimetry [35],  suggesting that the associ-
ation between the TR-CS-9 probe and the aptamer did not alter
too much the binding ability of  the target. In order to try to further
improve the sensitivity of the FP assay, a 6-mer truncated sequence
of TR-CS-9 was subsequently evaluated. In the absence of the target
molecule, no variation in  the FP value was observed upon aptamer
addition to TR-CS-6. This shows that hybridization cannot occur
even with the cationic dye as label.
4. Conclusion
In summary, the structure-switching aptamer based FP assay
has been optimized through the study of the effects of the buffer
composition and pH, temperature, aptamer:CS stoichiometry, CS
length and label nature on the assay performances. For the same
length of a  12-mer CS, the anionic nature of F  dye constitutes an
advantage in  comparison to the cationic TR  label. On the other
hand, when the CS length was shortened, the use of the TR label
for the structure-switching aptasensing method resulted in great
sensitivity, with a detection limit comparable to the ones obtained
with direct aptamer-based assays. This study demonstrates that the
fluorescence anisotropy signal generation is dependent on the fine
interconnection between the dye nature and the length of the CS to
carefully control (i) the duplex stability and (ii) the relative affinity
between the aptamer–CS duplex and aptamer–target complexes.
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II.4.2.2 Single-stranded DNA binding protein (SSB)-assisted strategy
In indirect complementary strands displacement approaches, the FP signal results from the 
competition between the target and fluorescent complementary strand (CS) for the binding to 
aptamer. However, the ability of the fluorophore to rotate independently from the global 
motion of the tracer (classically referred as the “propeller effect”) can significantly reduce the 
FP signal for the bound state [305, 306]. In addition, as typically reported for the FP-based 
DNA hybridization monitoring [313, 314], the low molecular weight difference between the 
free CS and the CS-aptamer duplex limits the fluorescence anisotropy variation window in 
structure switching FP assay. 
Single-stranded DNA-binding protein, or SSB, binds to single-stranded regions of DNA to 
prevent premature annealing, to protect the single-stranded DNA from being digested by 
nucleases in cells. These unique binding features have been taken into account to develop 
SSB-based analytical tools for detecting DNA hybridization, single nucleotide 
polymorphisms and specific DNA-protein interaction. Our group described a new FP aptamer 
assay strategy which was based on the use of SSB protein from E. Coli as a strong FP signal 
enhancer tool. This approach relied on the unique ability of the SSB protein to bind the 
nucleic acid aptamer in its free state but not in its target-bound folded one [315], a large 
global diffusion difference between the target- and SSB-bound aptamer probes was expected 
due to the high molecular weight of the protein (~76 kDa). Furthermore, in this case, the 
interfering “propeller effect” could be restricted as the ssDNA strongly coiled around the SSB 
protein so that close contacts should occur between the aptamer and the protein.
Article published in the Analytical Chemistry (in press)
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ABSTRACT: Here, we describe a new ﬂuorescence polar-
ization aptamer assay (FPAA) strategy which is based on the
use of the single-stranded DNA binding (SSB) protein from
Escherichia coli as a strong FP signal enhancer tool. This
approach relied on the unique ability of the SSB protein to
bind the nucleic acid aptamer in its free state but not in its
target-bound folded one. Such a feature was exploited by using
the antiadenosine (Ade)−DNA aptamer (Apt-A) as a model
functional nucleic acid. Two ﬂuorophores (ﬂuorescein and
Texas Red) were introduced into diﬀerent sites of Apt-A to
design a dozen ﬂuorescent tracers. In the absence of the Ade
target, the binding of the labeled aptamers to SSB governed a
very high ﬂuorescence anisotropy increase (in the 0.130−0.200
range) as the consequence of (i) the large global diﬀusion diﬀerence between the free and SSB-bound tracers and (ii) the
restricted movement of the dye in the SSB-bound state. When the analyte was introduced into the reaction system, the formation
of the folded tertiary structure of the Ade−Apt-A complex triggered the release of the labeled nucleic acids from the protein,
leading to a strong decrease in the ﬂuorescence anisotropy. The key factors involved in the ﬂuorescence anisotropy change were
considered through the development of a competitive displacement model, and the optimal tracer candidate was selected for the
Ade assay under buﬀer and realistic (diluted human serum) conditions. The SSB-assisted principle was found to operate also with
another aptamer system, i.e., the antiargininamide DNA aptamer, and a diﬀerent biosensing conﬁguration, i.e., the sandwich-like
design, suggesting the broad usefulness of the present approach. This sensing platform allowed generation of a ﬂuorescence
anisotropy signal for aptamer probes which did not operate under the direct format and greatly improved the assay response
relative to that of the most previously reported small target FPAA.
F luorescence polarization (FP) is one of the most versatileand popular techniques used in clinical chemistry as
illustrated by the numerous applications reported in the
therapeutic drug monitoring and abused drug and toxic
screening. FP is a fast, homogeneous method, is insensitive to
the solution color, and is especially suitable for a high-
throughput format assay.1 Despite the large success of FP
immunoassay (FPIA), several eﬀorts have been carried out,
during the past couple decades, to couple the FP technique to
alternative aﬃnity tools. For example, FP molecular imprinted
sorbent assay (FPMIA) has also proved to be an eﬃcient
approach to detect small analytes such as propranolol or
ﬂuoroquinolones.2,3 However, at the present time, the
alternative selective binders most frequently used in FP
technology are nucleic acid aptamers for both protein and
small analyte sensing through FP aptamer assays (FPAAs).4−16
Compared to antibodies, aptamers present several attractive
features, including smaller size (especially advantageous for the
direct FP-based detection of proteins), enhanced stability,
chemical synthesis, and ease of incorporating modiﬁcations
and/or labels at precise locations.
For small molecule sensing, diﬀerent FPAA methodologies
have been established based on either direct or indirect
formats.11−16 However, these strategies typically yield a limited
FP signal. This constitutes a serious drawback that signiﬁcantly
aﬀects the analytical performances as well as the applicability of
such sensing platforms.17,18 It is well established that the
ﬂuorescence anisotropy of a probe (or tracer) results from its
global diﬀusion (dependent on its overall size) and the
ﬂuorophore local motion (dependent on the probe ﬂexibility
and dye movement freedom) contributions.19 In the direct
FPAA format, the FP signal depends on the target-induced
structural/conformational change of the aptamer tracer that
modiﬁes the local dye mobility.14,15 However, a restricted
modiﬁcation of the aptamer ﬂexibility and/or dye motion for
the target-bound aptamer complex can be responsible for a very
weak or nil assay response. Thus, the direct approach is not
easily generalizable, requiring a suﬃciently large induced-ﬁt
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mechanism or the knowledge of the secondary/tertiary
structure to engineer the aptameric probe.15 In indirect FPAA
approaches, the FP signal results from the competition between
the target and an additional species, i.e., a ﬂuorescent analogue
in “conventional” competitive assay,11 a ﬂuorescent comple-
mentary strand (CS) in structure switching assay,12,13 or an
enzyme in aptamer enzymatic cleavage protection assay,16 for
binding to the aptamer. However, the ability of the ﬂuorophore
to rotate independently from the global motion of the tracer
(classically referred as the “propeller eﬀect”) can signiﬁcantly
reduce the FP signal for the bound state.19,20 In addition, as
typically reported for FP-based DNA hybridization monitor-
ing,17,18 the low molecular weight diﬀerence between the free
CS and the CS−aptamer duplex limits the ﬂuorescence
anisotropy variation window in structure switching FPAA.
Due to the partial protection of the complexed DNA substrate
against enzymatic attack, the ﬂuorescence anisotropy change
can also be of weak magnitude using the aptamer enzymatic
cleavage protection strategy.16 Finally, the synthesis of the
ﬂuorescently labeled analogue in conventional competitive
FPAA can be laborious, with limited possibilities to function-
alize the small molecule target, leading to a poor capability to
manipulate both the binding aﬃnity and the ﬂuorescent
properties of the tracer. Very recently, two approaches based
on a mass amplifying strategy have been proposed to improve
the FP assay response.21,22 However, one method, coupling a
targeting aptamer to a molecular mass amplifying aptamer,21
does not ameliorate the FP signal change relative to that of the
Figure 1. (a) Schematic representation of the SSB-assisted FPAA: gray double arrows, global diﬀusion contribution; black double arrows, local dye
mobility contribution. (b) Titration curves of 5′-F-Apt-A with increasing Ade concentration under SSB-assisted (black symbols) and direct (white
symbols) FPAA modes. Gray symbols are for SSB-assisted FPAA using the scramble 5′-F-Apt-A. The probe concentration was 10 nM and the SSB
concentration 0.33 μM. Binding buﬀer conditions: 50 mM Tris−HCl, pH 7.5, 5 mM NaCl, 20 mM MgCl2. Δr = r − r0, where r0 is the ﬂuorescence
anisotropy in the absence of analyte.
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previously described FPAA. The other one, dependent on SiO2
nanoparticle-mediated mass enhancement,22 requires the time-
consuming preparation of the DNA−nanoparticle conjugates
and a careful design of the aptamer probe.
Single-stranded binding (SSB) proteins are essential proteins
for stabilization and access control to ssDNA within cells. One
of them, SSB from Escherichia coli, is involved in several
processes through interaction with enzymes as well as the
formation of RecA ﬁlaments on DNA. SSB exists as a stable
homotetramer, each subunit having an Mw of ∼19 000, that is
able to bind tightly to ssDNA but not to duplex DNA or stable
folded ssDNA conformations.23,24 These unique binding
features have been taken into account to develop SSB-based
analytical tools for detecting DNA hybridization, single
nucleotide polymorphisms, and speciﬁc DNA−protein inter-
action through electrochemical, surface plasmon resonance
imaging, ﬂuorescent molecular beacon, gold nanoparticle, or
capillary electrophoresis approaches.25−28
Here, we describe a new FPAA strategy utilizing the E. coli
SSB protein as a signal enhancer tool. The general concept is
illustrated in Figure 1a. In such a method, the ﬂuorescently
labeled aptamer is used as an FP probe. The ﬁrst objective of
the present approach was to establish a potentially general
methodology by exploiting the ability of the SSB protein to
bind the DNA aptamer in its free state but not in its target-
bound folded one (Figure 1a). The second objective of the
SSB-assisted strategy was to improve the FP signal by acting
rationally on both the global and local ﬂuorescence anisotropy
contributions. The SSB−DNA complex was assumed to exhibit
a much more important molecular size, due to the high
molecular weight of the protein (∼76 000), than the free
oligonucleotide. Thus, a large global diﬀusion diﬀerence
between the target- and SSB-bound aptamer probes was
expected, just like in conventional FPAA dedicated to protein
analysis.4−9 Furthermore, ssDNA is known to be strongly
coiled around the SSB protein so that close contacts should
occur between the aptamer and the protein.24 This would lead
to restricted DNA ﬂexibility and/or hindered label motion in
the SSB-bound state and then would limit the interfering
propeller eﬀect. Finally, due to the ease of synthesis and
modiﬁcation of oligonucleotides, diﬀerent kinds of ﬂuorophores
can be readily introduced into speciﬁc sites of aptamers. This
should allow the wide random screening of various labeled
aptamers to select the appropriate tracer with convenient
signaling features.
To test the feasibility of the SSB-assisted FPAA method and
establish the proof-of-principle, the antiadenosine (Ade)−DNA
aptamer (Apt-A) was ﬁrst used as a model functional nucleic
acid.29 A competitive displacement model was developed to
describe the mechanistic aspects of the SSB-assisted FPAA and
consider the critical factors involved in the FP response. The
optimal tracer was selected, and the methodology performances
were investigated under buﬀer and realistic medium conditions,
i.e., in diluted human serum. The general applicability of the
present strategy was subsequently appreciated using another
aptamer system, i.e., the antiargininamide (Rm) aptamer (Apt-
R).30 Finally, to further examine the broad usefulness of the
SSB-assisted approach, the possibility of applying the SSB-
assisted principle to a split aptamer biosensing platform31 was
also explored.
■ EXPERIMENTAL SECTION
Chemicals and Apparatus. Adenosine (Ade), arginina-
mide (Rm), inosine (Ino), tris(hydroxymethyl)aminomethane
(Tris), and human serum were obtained from Sigma-Aldrich
(Saint-Quentin, France). NaCl and MgCl2 were obtained from
Chimie-Plus Laboratoires (Bruyer̀es de Pouilly, France) and
Panreac Quimica (Barcelona, Spain), respectively. E. coli single-
stranded DNA binding protein (SSB) was obtained from Tebu-
bio (Le Perray en Yvelines, France). Water was obtained from a
Purite Still Plus water puriﬁcation system (Thame, U.K.) ﬁtted
with a reverse osmosis cartridge. All the unlabeled and
ﬂuorescein (F) or Texas Red (TR) labeled DNA oligonucleo-
tides were synthesized and HPLC-puriﬁed by Eurogentec
(Angers, France), and their identity was conﬁrmed by MALDI-
TOF mass spectrometry. The sequences of the aptamer,
scramble, and split aptamer oligonucleotides studied are listed
in Table IS (Supporting Information). Fluorescence anisotropy
readings were taken on a Tecan Inﬁnite F500 microplate reader
(Man̈nedorf, Switzerland) using black, 96-well Greiner Bio-One
microplates (Courtaboeuf, France). Excitation was set at 485 ±
20 or 585 ± 20 nm, and emission was collected with 535 ± 25
or 635 ± 30 nm bandpass ﬁlters in relation to the nature of the
ﬂuorescent dyes.
Assay Protocols. The binding buﬀer for the Ade assay
consisted of 50 mM Tris−HCl, pH 7.5, 5 mM NaCl, and 20
mM MgCl2. The binding buﬀer conditions for the Rm assay
were 10 mM Tris−HCl, pH 7.5, and 100 mM NaCl. The SSB
and diﬀerent aptamer stock solutions were prepared in pure
water and stored at −20 °C. The working aptamer solutions
were obtained by adequate dilution of the stock solution in
2.5× concentrated binding buﬀer. Prior to the ﬁrst use, the
working solutions were heated at 80 °C for 5 min and left to
stand at room temperature for 30 min. The analyte solutions
were prepared in water. All solutions were ﬁltered prior to use
through 0.2 μm membranes. To construct the SSB saturation
curve, the aptamer (10 nM) and SSB (from 0 to 0.84 μM)
solutions were mixed into the individual wells (ﬁnal volume
100 μL) at room temperature for 30 min. Blank wells of the
microplate received 100 μL of the binding buﬀer. To construct
the competition displacement curves, the oligonucleotides were
ﬁrst mixed with SSB for 5 min. The analyte was then added,
and the resulting solution was incubated for 30 min at room
temperature. These samples were transferred into the individual
wells (ﬁnal volume 100 μL). For the Ade titration curve, the
analyte concentration varied from 0 to 2000 μM (unless
otherwise stated), and for the Rm titration curve, the analyte
concentration varied from 0 to 5000 μM. The microplate was
immediately placed into the microplate reader for the
measurement. All experiments were done in triplicate.
Human serum samples were used to test the Ade assay
performances under biological conditions. Samples were diluted
in water spiked with the target and ﬁltered through 0.2 μm
membranes. Three replicate samples were then analyzed as
described above. For sandwich-like assay, the half-pieces of a
slightly modiﬁed version of Apt-A (St1* and St2; see Table IS,
Supporting Information) were mixed (10 nM St1* with an
St1*:St2 stoichiometry of 1:8) for a 5 min period at room
temperature, in the absence or presence of SSB, using the same
binding buﬀer used above. As St1* and St2 are shorter
oligonucleotides (13-mer), the SSB concentration in the
reaction mixture was increased relative to that of the full
aptamer experiments (St1*:SSB stoichiometry of 1:167) to
Analytical Chemistry Article
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obtain a suﬃcient fraction of the SSB-bound probe. The target
was then introduced into the reaction solution (0−2000 μM
Ade concentration range), and the resulting mixture was
incubated for 30 min at room temperature.
The measured ﬂuorescence anisotropy (r) was calculated by
the instrument software as follows:
=
−
+
r
I GI
I GI2
vv vh
vv vh (1)
Ivv and Ivh are the vertically and horizontally polarized
components of the emission after excitation by vertically
polarized light. The instrumental correction factor G was
determined from standard solutions according to the
manufacturer’s instructions. The model equations (Supporting
Information) were ﬁtted to the ﬂuorescence anisotropy data
using the software Table Curve 2D (SPSS Science Software
GmbH, Erkrath, Germany).
■ RESULTS AND DISCUSSION
Feasibility of SSB-Assisted FPAA. The proof-of-principle
of the SSB-assisted FPAA was ﬁrst investigated using the
antiadenosine (Ade)−DNA aptamer (Apt-A) couple. This
choice was motivated by the fact that the binding and structural
properties of Apt-A have been very well studied and
characterized in previous works.32 In the unbound state, Apt-
A is constituted of two short stems and a large, unstructured
internal bubble, while the target-bound aptamer folds into a
stabilized structure through the formation of base mismatches
and three-base platforms (Figure 1S, Supporting Information).
5′-End ﬂuorescein-labeled Apt-A (5′-F-Apt-A) was used as an
FP probe. In initial experiments, the FP titration curve of 5′-F-
Apt-A with increasing SSB concentration was constructed to
investigate the ability of SSB to bind DNA aptamer in its free
form. Under the binding buﬀer conditions used, the measured r
value of 5-F-Apt-A (10 nM) was ∼0.100, lower than the
theoretical one estimated previously (0.155).15 This diﬀerence
indicates that the ﬂuorescein label displayed a signiﬁcant degree
of local motional freedom that contributed to the total
ﬂuorescence anisotropy. When the SSB protein was added to
the medium, the r value of the probe was strongly increased to
reach 0.265 for the highest protein concentration (0.84 μM).
This signal enhancement can be typically attributed to the
expected increase in the molecular weight of 5′-F-Apt-A upon
SSB binding, theoretically from ∼7000 for the free oligonucleo-
tide to ∼84 000 for the complex. It has been previously
demonstrated that the association between short oligonucleo-
tides (in the 27−35-mer range) and the SSB protein follows
multiple stages.24 For low protein-to-DNA ratios, two
oligonucleotide molecules can interact with each SSB tetramer
(considering that one SSB subunit may bind a ∼15-mer-long
DNA),33 while only the 1:1 DNA−SSB complex can be stably
formed under excess protein conditions.24 In addition, the high
ﬂuorescence anisotropy value of the SSB−Apt-A complex
suggests that the local mobility of the dye (propeller eﬀect) was
signiﬁcantly reduced in the SSB-bound state of the aptameric
tracer. A previous work has reported that the ﬂuorescence
anisotropy of protein-bound DNA probes (Mw > 100 000)
displayed an r value higher than ∼0.240 when the local
motional freedom of the ﬂuorophore was hindered by close
contacts between the interacting partners.34 It is well
established that SSB binds to DNA by disrupting secondary
structures and inducing nucleic acid to wrap around the protein
so that close interactions occur between both the nucleic acid
backbone and bases and the protein.23,24 This would govern the
strong coupling of the ﬂuorophore with SSB, explaining the
very high FP signal increase for the tracer.
The feasibility of the SSB-assisted FPAA approach was
subsequently evaluated. The target was added to the mixture
containing the DNA−SSB complex (1:33 stoichiometry). The
solution was incubated for a 30 min period at room
temperature, and the ﬂuorescence anisotropy was then
measured. As shown in Figure 1b, the ﬂuorescence anisotropy
value decreased very signiﬁcantly, as exempliﬁed by the FP
change (Δr = r − r0, where r0 is the ﬂuorescence anisotropy in
the absence of analyte) of −0.135 observed in the presence of 5
mM Ade. This result reﬂects the decrease in the molecular size
of the probe upon target binding, conﬁrming that the
structured state of the target-bound aptamer allowed the
release of the DNA oligonucleotide from the SSB protein. Such
an eﬀect is in accordance with previous results from Krauss at
al., who have shown that stable folded conformations are
unfavorable for the binding to the SSB protein.23 A control
experiment was performed using a 5′-end ﬂuorescein-labeled
scramble sequence of Apt-A as the tracer. The r value did not
vary signiﬁcantly when the Ade concentration increased (Figure
1b), indicating that the ﬂuorescence anisotropy change was
dependent on the speciﬁc target binding to Apt-A.
FPAA experiments were performed under a direct format,
i.e., without SSB in the reaction medium, to examine the
eventual FP signal change attributable to the target-induced ﬁt
mechanism. The titration curve of the probe with increasing
target concentration showed that the addition of the target did
not change the r value for 5′-F-Apt-A (Figure 1b). These data
demonstrate the advantage of the present strategy relative to
the direct format one. In accordance with previous stud-
ies,15,32,35,36 the 25-mer Apt-A did not undergo, upon analyte
binding, a suﬃciently high structural change in the extremity
region (Figure 1S, Supporting Information) to trigger a direct
assay response. In contrast, the SSB-assisted FPAA allowed
generation of a great ﬂuorescence anisotropy signal due to the
strong modiﬁcation of the DNA structure between the protein-
induced unfolded state and the target-mediated folded one of
the aptameric probe. Such data reveal also that the FP signal
variation with increasing Ade concentration was dependent
solely on the target-promoted displacement of the probe from
the SSB protein.
Study of the SSB-Assisted FPAA Mechanism. An
important issue to address was how to quantitatively describe
the target-induced release of aptamer tracer from the SSB
protein to (i) consider the contributions of the key parameters
involved in the assay response and (ii) select a good tracer
candidate for Ade sensing. The SSB-assisted FPAA mechanism
was considered through the development of a competitive
displacement model. Model equations (eqs 1S−6S) and
simulated competitive displacement curves (Figure 2S) are
presented in the Supporting Information.
The insertion of a label on a DNA sequence as well as the
nature of the ﬂuorophore may aﬀect the aﬃnity of a nucleic
acid for interacting partners4,37,38 through various mechanisms
such as direct contact with the ﬂuorophore, change in
accessibility, modiﬁcation of the nucleic acid conformation,
steric hindrance eﬀects, etc. In addition, the photophysical
properties of a ﬂuorescent nucleic acid conjugate are highly
sensitive to the surrounding environment of the dye39,40 so that
signiﬁcant changes in the ﬂuorescence parameters typically
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occur upon molecular interactions.37,41 In this context, the Ade-
induced FP signal variation achieved with Apt-A labeled with
two ﬂuorophores at diﬀerent sites was explored. A wide set of
experimental data obtained from a dozen diﬀerent tracers were
faced to the theoretical model to appreciate the relevance of
this approach.
Five other Apt-A probes, terminally or internally labeled on
thymidine by ﬂuorescein (3′-end, T3, T11, T13, and T14
locations), were ﬁrst tested. The SSB titration curves were
constructed as reported for the 5′-F-Apt-A tracer (Figure 3S,
Supporting Information). The maximal variation range of
ﬂuorescence anisotropy (rb − rf, where rf and rb are the
respective ﬂuorescence anisotropy for the free and SSB-bound
tracers) and the g factor (the ratio of the total emission
intensity of the SSB-bound tracer to that of the free tracer)
varied with the dye position, from 0.130 to 0.200 and from 0.5
to 1.8, respectively (Figures 2a,b). Binding isotherms displayed
a sigmoid shape in all cases, in accordance with previous results
obtained for the interaction between short ﬂuorescently labeled
ssDNA and SSB.42 From such binding isotherms, the apparent
Kd values for the SSB−Apt-A complexes (Kdssb) were extracted
by the Hill model equation (4S, Supporting Information) ﬁtting
(Figure 3S). As can be seen in Figure 2c, Kdssb was in the 50−70
nM range (with an average Hill coeﬃcient of 2.25). This is in
agreement with the binding data of Webb and co-workers, who
reported a Kd value of 43 nM for the dT27−SSB complex.
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Ade titration curve experiments were then performed with
the diﬀerent probes for the DNA:SSB stoichiometry of 1:33. As
shown in Figure 4S (Supporting Information) for two
representative probes (T14- and T13-F-Apta-A), the r value
decreased when the target molecule was introduced into the
sample. No change in the r and total emission intensity values
was observed upon Ade addition in the direct format (without
SSB in solution) whatever the probe. In addition, for the most
displaced probe (T14-F-Apta-A), the r value returned roughly
to its original value in the presence of 2 mM Ade (0.079 versus
0.071). This reveals that the target-bound aptamer probe
interacted weakly, if at all, with the SSB protein. The
displacement model equation (6S, Supporting Information)
was then ﬁtted to the r versus Ade concentration plots.
Excellent agreement of the predicted ﬂuorescence anisotropy
signal with the experimentally obtained response was achieved
Figure 2. Summary of the ﬂuorescent and binding aﬃnity parameters extracted from the analysis of the SSB saturation and competitive displacement
curves obtained with the diﬀerent Apt-A probes tested: (a) rb − rf (rf and rb are the ﬂuorescence anisotropies for the free and SSB-bound probes,
respectively), (b) g factor (ratio of the total emission intensity of the SSB-bound probe to that of the free probe), (c) Kdssb (Kd for the SSB−Apt-A
complex), (d) Kdade (Kd for the Ade−Apt-A complex). All these parameters are presented in relation to the labeling site and ﬂuorophore nature of
the probes (the binding pocket is encircled).
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(Figure 4S). The Kd values for the Ade−Apt-A complex (Kdade)
were estimated from the nonlinear regression ﬁt. To note, these
values constitute solely apparent data as the system is known to
form a 1:2 stoichiometry complex.32 Kdade was in the 2−10 μM
range with an average value of 5 μM (Figure 2d). Such data are
in very good agreement with the previously reported apparent
dissociation constant for this aptamer−target couple observed
in solution and under label-free conditions (6 ± 3 μM),29
suggesting the suitability of the proposed model. These data
also indicate also that the labeling by the ﬂuorescein dye
roughly maintained the molecular recognition properties of the
aptamer for the attachment sites studied.
To further investigate the pertinence of the model, another
set of data was gathered using Apt-A labeled with Texas Red on
the same locations. Such a ﬂuorophore was chosen as its
electrostatic and photophysical properties diﬀer a lot from
those of ﬂuorescein.39 The six Texas Red-labeled probes were
titrated by SSB, and the target-induced displacement curves
were constructed. To note, as reported for the ﬂuorescein-
labeled tracers, both the r and total emission intensity values
did not change signiﬁcantly upon Ade addition under the direct
format. Two representative examples of such curves are
presented in Figure 4S (Supporting Information) with data
derived from the equation (6S, Supporting Information) ﬁtting
procedure. Theoretical data appeared in very good agreement
with the experimental ones, conﬁrming the results obtained
with the ﬂuorescein-labeled probes. The parameters extracted
from experimental results and ﬁtting processes are also reported
in Figure 2.
Figure 3. (a) First derivative (S) of the ﬁtted displacement curves as a function of the labeling site and dye type (black, F-Apt-A; gray, TR-Apt-A) of
the probes. (b) Calibration curve for Ade (black symbols) using the most eﬃcient T14-F-Apt-A probe. White symbols represent the data for the
noncognate ligand Ino. The probe concentration was 10 nM and the SSB concentration 0.25 μM. Binding buﬀer conditions: 50 mM Tris−HCl, pH
7.5, 5 mM NaCl, 20 mM MgCl2. Δr = r − r0, where r0 is the ﬂuorescence anisotropy in the absence of analyte.
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Some general trends were brought out from the data
collected for the 12 tested probes. The replacement of
ﬂuorescein by Texas Red had strong eﬀects on the apparent
Kdade value (Figure 2d). From an aggregate point of view, the
Texas Red-labeled probes displayed a mean value of about 75
μM, i.e., 15-fold higher than that observed for the ﬂuorescein-
labeled probes (5 μM). Such behavior could be attributed to
the fact that, in contrast to the anionic ﬂuorescein, the cationic
Texas Red dye is able to interact strongly with the DNA helix
through van der Waals and electrostatic interactions.39,40 This
would lead to some critical changes in the active conformation/
structure of the aptamer and/or steric hindrance eﬀects at the
binding site. For instance, an important loss of aﬃnity was
observed for the Texas Red labeling position ﬂanking the
central binding pocket of the aptamer, i.e., at the T3 and T11
locations (Figure 2d). Smaller diﬀerences were observed for the
sites located in the apical loop and at the 3′-end site, while no
signiﬁcant perturbation was reported at the 5′-end position
(Figure 2d).
The Kdssb values were also aﬀected by the nature of the
ﬂuorophore, but to less extent (Figure 2c). The average value
was 110 nM for the Texas Red-labeled tracers, i.e., about 2-fold
higher than that observed for the ﬂuorescein-labeled probes (60
nM). Previous works have demonstrated that the structure of
DNA labeled with the Cy3 cationic ﬂuorophore can be
stabilized through stacking interactions between the dye and
DNA base pairs.43 Thus, considering the positions of the
ﬂuorophore, it could be expected that interactions between
Texas Red and DNA bases would favor short base-paired
regions of the aptamer (Figure 1S, Supporting Information) to
the detriment of the single-stranded structure, reducing the
aﬃnity of SSB for the Texas Red-labeled probe.
Although the mean values of the maximal ﬂuorescence
anisotropy change were comparable for the two kinds of tracers
(0.167 versus 0.177), the signal variation ranges were almost
identical for the Texas Red-labeled probes, whereas they varied
more importantly for the ﬂuorescein-labeled probes (Figure
2a). This could result very likely from the well-known coupling
of Texas Red to the rotational dynamics of the aptamer, i.e., the
lower contribution of the dye local mobility to the total
ﬂuorescence anisotropy.40 Moreover, the higher r values
observed using the Texas Red-labeled probes (Figure 4S,
Supporting Information) were consistent with a dye motion
which was signiﬁcantly coupled to the rotational mobility of
DNA.
Finally, the g factor exhibited similar average values for the F-
and TR-Apt-A tracers (1.15 versus 1.25). However, as a result
of speciﬁc site-dependent changes in the ﬂuorophore local
environment from the free to SSB-bound states of tracers, a
signiﬁcant variability was reported in both cases (Figure 2b).
Performances of the Ade SSB-Assisted FPAA. Figure 3a
shows the ﬁrst derivative (S) of the ﬁtted displacement curves
as a function of the labeling site and dye type of the probes
studied. Such a parameter corresponds to the sensitivity of the
SSB-assisted FPAA, i.e., the ﬂuorescence anisotropy unit (rU)
per Ade concentration, attained with the various tracers. As a
consequence of the relative contributions of the binding aﬃnity
and ﬂuorescent parameters reported above (Figure 2), strong
diﬀerences in the S values were obtained for both ﬂuorescein-
and Texas Red-labeled probes. These ranged from −0.07 ×
10−3 to −1.06 × 10−3 rU/μM for TR-Apta-A and from −0.21 ×
10−3 to −3.65 × 10−3 rU/μM for F-Apta-A, i.e., a variation of
the assay sensitivity by a factor of ∼15−17 by modifying solely
the attachment position of the dye. The assay sensitivity can be
further enhanced by a factor as high as ∼50 when the nature of
the ﬂuorophore is also considered (T11-TR-Apt-A versus T14-
F-Apt-A).
The performances of the Ade SSB-assisted FPAA were then
analyzed using the most eﬃcient T14-F-Apta-A tracer. The
DNA:SSB complex stoichiometry was adjusted to 1:25 to
increase the assay sensitivity while maintaining a valuable signal
variation window. Under buﬀer conditions, a Δr value of
−0.120 was found over the 0−400 μM Ade concentration
range (Figure 3b). As a comparison, the ﬂuorescence
anisotropy changes reported previously for small target
molecule sensing did not exceed 0.065 whatever the format
used,11−16,21 except in a very recent case of nanoparticle-based
mass amplifying approach.22 It is also instructive to highlight
that even direct FPAA for protein determination displayed
typically lower assay responses, in the 0.050−0.100 range.4−8,10
The detection limit, based on a signal-to-noise ratio >3, was
equal to 1 μM with a linear range of 2−50 μM, R2 = 0.9833
(Figure 3b). This limit of detection was better than those
commonly obtained with most aptasensing methodologies
based on a simple and homogeneous format,36,44−50 i.e.,
excluding aptasensors that require a surface immobilization step
of aptamer or target or a sophisticated ampliﬁcation approach
(Table IIS, Supporting Information). Moreover, the Ade
detection limits attained under direct (using the previously
engineered, truncated 21-mer Apt-A probe)15 and enzymatic
cleavage protection16 FPAA formats were 10 and 5 μM,
respectively. The relative standard deviation ranged from 0.3%
to 3.0%, showing the high repeatability of the method. The
speciﬁcity of the assay was demonstrated using inosine (Ino) as
a structurally related compound (Figure 3b).
The ability of the SSB-assisted FPAA to function under
realistic conditions, i.e., in diluted human serum, was also
examined. The ﬂuorescence anisotropy was found to increase as
the dilution factor decreased. For example, the r0 values were
equal to 0.203, 0.216, 0.224, and 0.245 for the buﬀer and 50-,
10-, and 5-fold-diluted human serum conditions, respectively.
This behavior could be attributed, at least in part, to the matrix
proteins interacting nonspeciﬁcally with DNA as well as the
viscosity modiﬁcation of the reaction medium. Nevertheless, as
shown in Figure 5S (Supporting Information), the FP signal
change was roughly maintained, even in 5-fold-diluted serum,
suggesting the practical potential of the sensing methodology.
It is important to note that, in terms of analytical
performances, the main drawback of the present FPAA
approach was related to the signiﬁcant stability diﬀerence
observed between the SSB−aptamer and target−aptamer
complexes. Indeed, the value of the overall dissociation
constant for the competitive system, i.e., the Kdade/Kdssb ratio,
was found to be about 40 for the T14-F-Apta-A tracer (with a
mean value for the F- and TR-Apt-A probes equal to ∼90 and
∼650, respectively). As predicted by the competitive displace-
ment model (Supporting Information), this lowered the
sensitivity potentialities of the assay. The use of other SSB
proteins, which display features similar to those of E. coli SSB
but with a weaker binding aﬃnity for ssDNA,33 could possibly
overcome this limitation and further improve the performances
of the current aptasensor.
General Applicability of the SSB-Assisted Strategy. To
subsequently evaluate the general applicability of the SSB-
assisted strategy, the current approach was tested for (i)
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another target−aptamer couple and (ii) a diﬀerent aptasensing
platform.
First, the antiargininamide (Rm) aptamer (Apt-R)30 was
chosen as an alternative biorecognition element of the SSB-
assisted FPAA designed above (Figure 1a). The Apt-R structure
is characterized by a stem−loop domain (Figure 6S, Supporting
Information). The secondary structure stability of free Apt-R is
assumed to be higher than that of unbound Apt-A due to a
longer seven-base-pair stem.51 Apt-R was labeled at the 5′-end
by the ﬂuorescein dye. The ﬂuorescence anisotropy of the 5′-F-
Apt-R probe was strongly increased when the SSB protein was
added to the reaction medium, from 0.080 in the free state to
0.250 at the highest protein concentration tested. Under SSB-
assisted FPAA conditions, the ﬂuorescence anisotropy of the
aptamer probe decreased from 0.225 (1:33 stoichiometry for
DNA:SSB) to 0.110 with increasing Rm concentration,
conﬁrming the data reported above for the Ade−Apt-A system
(Figure 6S). The direct format of FPAA was also performed. In
the absence of SSB, the r value was not signiﬁcantly modiﬁed
when the Rm concentration increased (Figure 6S), conﬁrming
the usefulness of the present approach. A control experiment
with a 5′-end ﬂuorescein-labeled scramble sequence of Apt-R
was carried out using the same DNA:SSB stoichiometry. No
change in the ﬂuorescence anisotropy was observed, except at
high Rm concentration where the signal slightly diminished.
Second, the possibility to expand the SSB-assisted strategy to
another sensing design was evaluated by focusing our attention
on the sandwich-like platform. Initially introduced by
Stojanovic et al.,31 this mode consisted of the assembly of
split aptamer fragments mediated by the target (Figure 7S,
Supporting Information). Such a method has been widely
utilized to facilitate the transduction of the binding event into a
detectable signal using diﬀerent technologies such as optical or
electrochemical techniques.31,48,52 In initial experiments, the
feasibility to develop an FPAA based on the sandwich-like
design was explored using Apt-A as a model aptamer. It is of
interest to note that such an FP-based assay has not yet been
reported in the literature. The 25-mer Apt-A was cut in the
apical loop between the T13 and T14 sites, the T13 base was
deleted, and one A·T base pair was added at the extremities.32
A 13-mer DNA strand corresponding to half of such an Apt-A
sequence was labeled at the 5′-end by the ﬂuorescein dye (St1*,
10 nM). The addition of the second nonlabeled piece of Apt-A
(St2) at a 1:8 stoichiometry (St1*:St2) did not change the
ﬂuorescence anisotropy (r = 0.070) due to the lack of
association between the two DNA fragments in the absence
of Ade. When the target was introduced into the reaction
medium, the formation of the ternary complex (St1*−Ade−
St2) led to an increase in the FP signal. However, the FP
response was low (Δr = 0.025 at 2 mM Ade concentration),
dependent on the weak change in the molecular size between
the free St1* strand and the ternary complex (molecular weight
theoretically from 3500 to 7500), associated probably with
some propeller eﬀect (Figure 7S). The Ade assay displayed
linearity up to 200 μM with a limit of detection estimated at 15
μM. To work under SSB-assisted sandwich-like FPAA
conditions, the protein was added to the reaction medium
(ﬂuorescent DNA:SSB stoichiometry of 1:167) following the
same procedure described above (Figure 7S). In the absence of
target, single-strand DNA pieces interacted strongly with SSB
so that the FP signal increased from 0.070 to 0.195. Upon Ade
addition, the structured, ternary complex was formed, leading
to the release of the DNA fragments from the protein. Such
behavior was associated with a large reduction of the
ﬂuorescence anisotropy, as exempliﬁed by the Δr value of
−0.070 at 2 mM Ade concentration. This led to a wider
dynamic linear range up to 600 μM with a detection limit of 10
μM (Figure 7S).
In summary, we have described a novel FPAA approach
which is able to detect small target molecule binding through
an SSB-based competitive displacement strategy. This approach
presents several attractive features. First, as a consequence of
the strong structural changes between SSB-induced unfolded
and target-mediated folded states of the aptameric probe, the
present mode allows generation of a response for aptamer
probes which do not operate under the direct assay format.
Second, a strongly improved FP assay response is reached
relative to that obtained with the FPAA previously described
due to the combined eﬀects of the SSB protein on the
molecular size and the local dye motion of the tracer during the
interaction processes. Third, the assay is simple, homogeneous,
and potentially applicable to target sensing under biological
conditions. Finally, the strategy displays adaptability features as
demonstrated by the results obtained through the sandwich-like
assay conﬁguration.
■ ASSOCIATED CONTENT
*S Supporting Information
Tables IS and IIS, competitive displacement model, and Figures
1S−7S as noted in text. This material is available free of charge
via the Internet at http://pubs.acs.org.
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: eric.peyrin@ujf-grenoble.fr.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
This work was supported in part by a grant from the DGA
program (09C7001). Z.Z. was supported by the China
Scholarship Council fund from the Ministry of Education of
the People's Republic of China.
■ REFERENCES
(1) Smith, D. S.; Eremin, S. A. Anal. Bioanal. Chem. 2008, 391,
1499−1507.
(2) Hunt, C. L.; Pasetto, P.; Ansell, R. J.; Haupt, K. Chem. Commun.
2006, 1754−1756.
(3) Ton, X. A.; Acha, V.; Haupt, K.; Tse Sum Bui, B. Biosens.
Bioelectron. 2012, 36, 22−28.
(4) Potyrailo, R. A.; Conrad, R. C.; Ellington, A. D.; Hieftje, G. M.
Anal. Chem. 1998, 70, 3419−3425.
(5) Fang, X.; Cao, Z.; Beck, T.; Tan, W. Anal. Chem. 2001, 73, 5252−
5757.
(6) Gokulrangan, G.; Unruh, J. R.; Holub, D. F.; Ingram, B.; Johnson,
C. K.; Wilson, G. S. Anal. Chem. 2005, 77, 1963−1970.
(7) Li, W.; Wang, K.; Tan, W.; Ma, C.; Yang, X. Analyst 2007, 132,
107−113.
(8) Wang, M. S.; Black, J. C.; Knowles, M. K.; Reed, S. M. Anal.
Bioanal. Chem. 2011, 401, 1309−1318.
(9) Zou, M.; Chen, Y.; Xu, X.; Huang, H.; Liu, F.; Li, N. Biosens.
Bioelectron. 2012, 32, 148−154.
(10) Zhang, D.; Zhao, Q.; Zhao, B.; Wang, H. Anal. Chem. 2012, 84,
3070−3074.
(11) Wang, Y.; Killian, J.; Hamasaki, K.; Rando, R. R. Biochemistry
1996, 35, 12338−12346.
Analytical Chemistry Article
dx.doi.org/10.1021/ac301552e | Anal. Chem. XXXX, XXX, XXX−XXXH
(12) Cruz-Aguado, J. A.; Penner, G. Anal. Chem. 2008, 80, 8853−
8855.
(13) Zhu, Z.; Schmidt, T.; Mahrous, M.; Guieu, V.; Perrier, S.;
Ravelet, C.; Peyrin., E. Anal. Chim. Acta 2011, 707, 191−196.
(14) Ruta, J.; Perrier, S.; Ravelet, C.; Fize, J.; Peyrin, E. Anal. Chem.
2009, 81, 7468−7473.
(15) Perrier, S.; Ravelet, C.; Guieu, V.; Roy, B.; Perigaud, C.; Peyrin,
E. Biosens. Bioelectron. 2010, 25, 1652−1657.
(16) Kidd, A.; Guieu, V.; Perrier, S.; Ravelet, C.; Peyrin, E. Anal.
Bioanal. Chem. 2011, 401, 3229−3234.
(17) Walker, T. G.; Linn, C. P.; Nadeau, J. G. Nucleic Acids Res. 1996,
24, 348−353.
(18) Kumke, M. U.; Li, G.; McGown, L, B.; Walker, G. T.; Linn, C.
P. Anal. Chem. 1995, 67, 3945−3951.
(19) Jameson, D. M.; Ross, J. A. Chem. Rev. 2010, 110, 2685−2708.
(20) Moerke, N. J. Curr. Protoc. Chem. Biol. 2009, 1, 1−15.
(21) Cui, L.; Zou, Y.; Lin, N.; Zhu, Z.; Jenkins, G.; Yang, C. J. Anal.
Chem. 2012, 84, 5535−5541.
(22) Huang, Y.; Zhao, S.; Chen, Z. F.; Shi, M.; Liang, H. Chem.
Commun. 2012, 48, 7480−7482.
(23) Krauss, G.; Sindermann, H.; Schomburg, U.; Maass, G.
Biochemistry 1981, 20, 5346−5352.
(24) Kunzelmann, S.; Morris, C.; Chavda, A. P.; Eccleston, J. F.;
Webb, M. R. Biochemistry 2010, 49, 843−852.
(25) Kerman, K.; Morita, Y.; Takamura, Y.; Tamiya, E. Anal. Bioanal.
Chem. 2005, 381, 1114−1121.
(26) Tan, Y. N.; Lee, K. H.; Su, X. Anal. Chem. 2011, 83, 4251−4257.
(27) Tang, D.; Liao, D.; Zhu, Q.; Wang, F.; Jiao, H.; Zhang, Y.; Yu,
C. Chem. Commun. 2011, 47, 5485−5487.
(28) Berezovski, M.; Krylov, S. N. J. Am. Chem. Soc. 2003, 125,
13451−13454.
(29) Huizenga, D. E.; Szostak, J. W. Biochemistry 1995, 34, 656−665.
(30) Harada, K.; Frankel, A. D. EMBO J. 1995, 14, 5798−5811.
(31) Stojanovic, M. N.; de Prada, P.; Landry, D. W. J. Am. Chem. Soc.
2000, 122, 11547−11548.
(32) Lin, C. H.; Patel, D. J. Chem. Biol. 1997, 4, 817−832.
(33) Lohman, T. M.; Ferrari, M. E. Annu. Rev. Biochem. 1994, 63,
527−570.
(34) Wang, H.; Lu, M.; Tang, M. S.; Van Houten, B.; Ross, J. B. A.;
Weinfeld, M.; Le, X. C. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 12849−
12854.
(35) Nishihira, A.; Ozaki, H.; Wakabayashi, M.; Kuwahara, M.; Sawai,
H. Nucleic Acids Symp. Ser. 2004, 48, 135−136.
(36) Urata, H.; Nomura, K.; Wada, S.; Akagi, M. Biochem. Biophys.
Res. Commun. 2007, 360, 459−463.
(37) Jhaveri, S. D.; Kirby, R.; Conrad, R.; Maglott, E. J.; Bowser, M.;
Kennedy, R. T.; Glick, G.; Ellington, A. D. J. Am. Chem. Soc. 2000, 122,
2469−2473.
(38) Zhang, D.; Lu, M.; Wang, H. J. Am. Chem. Soc. 2011, 133,
9188−9191.
(39) Unruh, J. R.; Gokulrangan, G.; Wilson, G. S; Johnson, C. K.
Photochem. Photobiol. 2005, 81, 682−690.
(40) Unruh, J. R.; Gokulrangan, G.; Lushington, G. H.; Johnson, C.
K.; Wilson, G. S. Biophys. J. 2005, 88, 3455−3465.
(41) Merino, E. J.; Weeks, K. M. J. Am. Chem. Soc. 2005, 127,
12766−12767.
(42) Wan, Q. H.; Le, X. C. Anal. Chem. 2000, 72, 5583−5589.
(43) Spiriti, J.; Binder, J. K.; Levitus, M.; van der Vaart, A. Biophys. J.
2011, 100, 1049−1057.
(44) Cheng, X. H.; Bing, T.; Liu, X. J.; Shangguan, D. H. Anal. Chim.
Acta 2009, 633, 97−102.
(45) Xu, W.; Lu, Y. Anal. Chem. 2010, 82, 574−578.
(46) Xiang, Y.; Tong, A.; Lu, Y. J. Am. Chem. Soc. 2009, 131, 15352−
15357.
(47) Yoshida, W.; Sode, K.; Ibebukuro, K. Anal. Chem. 2006, 78,
3296−3303.
(48) Liao, D.; Jiao, H.; Wang, B.; Lin, Q.; Yu, C. Analyst 2012, 137,
978−982.
(49) Lu, N.; Shao, C.; Deng, Z. Chem. Commun. 2008, 6161−6163.
(50) Nishizawa, S.; Sato, Y.; Xu, Z.; Morita, K.; Li, M.; Teramae, N.
Supramol. Chem. 2010, 22, 467−476.
(51) Bishop, G. R.; Ren, J.; Polander, B. C.; Jeanfreau, B. D.; Trent, J.
O.; Chaires, J. B. Biophys. Chem. 2007, 126, 165−175.
(52) Chen, J.; Zhang, J.; Li, J.; Yang, H. H.; Fu, F.; Chen, G. Biosens.
Bioelectron. 2010, 25, 996−1000.
Analytical Chemistry Article
dx.doi.org/10.1021/ac301552e | Anal. Chem. XXXX, XXX, XXX−XXXI
1 
 
 
 
SUPPORTING INFORMATION 
 
 
 
 
Single-Stranded DNA Binding Protein-Assisted 
Fluorescence Polarization Aptamer Assay for Detection 
of Small Molecules 
 
 
Zhenyu Zhu, Corinne Ravelet, Sandrine Perrier, Valérie Guieu, Emmanuelle 
Fiore, Eric Peyrin* 
 
Département de Pharmacochimie Moléculaire UMR 5063, Institut de Chimie 
Moléculaire de Grenoble FR 2607, CNRS-Université Grenoble I (Joseph Fourier), 
38041 Grenoble cedex 9, France. 
 
 
 Tables I-IIS 
 Theoretical model 
 Figures 1-7S 
  
2 
 
Table IS. List of oligonucleotides used.a  
 
Oligonucleotides Sequences and labeling sites 
5’-F-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
3’-F-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T14-F-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T11-F-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T3-F-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T13-F-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
5’-TR-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
3’-TR-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T14-TR-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T11-TR-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T3-TR-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
T13-TR-Apt-A 5’-CCTGGGGGAGTATTGCGGAGGAAGG-3’ 
Scramble 5’-F-Apt-A 5’-AACGCGGAAGGGGTAGTTGTGGCGG-3’ 
Split 5’-F-Apt-A (St1*) 5’-ACCTGGGGGAGTA-3’ 
Split Apt-A (St2) 5’-TGCGGAGGAAGGT-3’ 
5’-F-Apt-R 5’-GATCGAAACGTAGCGCCTTCGATC-3’ 
Scramble 5’-F-Apt-R 5’-CGATGGCCAGGTATCACACATGCT-3’ 
 
aEach labeling site is underlined (green for fluorescein and red for Texas Red) 
 
 
 
Table IIS. Comparison of the Ade detection limits for the existing aptasensors.a  
 
Assay strategy Limit of detection Ref 
Fluorescence resonance energy transfer direct assay 10 µMb 36 
Label-free fluorescent direct assay 10 µM 44 
Label-free fluorescent direct assay 20 µM 45 
Label-free fluorescent direct assay 3 µM 46 
Enzymatic activity inhibition assay 25 µM 47 
Label-free fluorescent sandwich-like assay 12 µM 48 
G-quadruplex enzyme colorimetric direct assay 6 µM 49 
Label-free fluorescent direct assay 2 µM 50 
Direct FPAA 10 µM 15 
Enzymatic cleavage protection FPAA 5 µM 16 
SSB-assisted FPAA 1 µM This work 
 
aExcluding sensing platforms which involved heterogeneous format or sophisticated amplification approach 
bEstimated from the Ade titration curve 
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Theoretical model. A competitive displacement model was developed to describe the target-
induced FP signal change of the SSB-assisted FPAA. This is derived from the two following 
binding equilibria that involve the aptamer probe (Apt*), the protein (SSB) and the target (T): 
SSB + Apt*  SSB.Apt*         (1S) 
T + Apt*  T.Apt*          (2S) 
For the binding equilibrium between SSB and aptamer, i. e. Eq (1S), the fraction of the SSB-
bound aptamer (fb) is derived from the measured fluorescence anisotropy r as follows:S1 
)()(
)(
fb
f
b
rrrrg
rrf


          (3S) 
where rf and rb represent the anisotropy for the free and SSB-bound aptamer probe, 
respectively. The g factor is derived from the ratio of the total emission intensity (I) of the 
SSB-bound aptamer probe (Ib) to that of the free tracer (If), i. e. Ib/If.S1b It is introduced into Eq 
(3S) in order to consider possible change in the fluorescence quantum yield of the probe 
between the two states.S1a Both rb and Ib values can be estimated from the asymptote of the r 
and I versus SSB concentration curves. As frequently observed for DNA-protein 
associations,S2 fb can be linked to the average dissociation constant of the aptamer-SSB 
complex (Kdssb) and the free concentration of SSB ([SSB]) through the Hill binding model:S3 
 
  H
H
n
dssb
n
b SSBK
SSBf

           (4S) 
where nH corresponds to the Hill coefficient. Under conditions for which the total aptamer 
probe concentration (capt) is limiting (capt  Kdssb/5), the total concentration of SSB can closely 
approximate its free concentration. The presence of target in the reaction system can be 
accounted by introducing an additional competitive term into Eq (4S) as follows:S4 
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n
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
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        (5S) 
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where Kdtarget and [T] are the apparent dissociation constant of the target-aptamer complex and 
the free target concentration, respectively. Under limiting aptamer probe concentrations, the 
total concentration of target can be used in place of its free concentration into Eq (5S). In this 
relation, the interaction between the folded target-bound aptamer and the SSB protein is 
considered to be sufficiently weak to be neglected. Thus, combining Eqs (3S) and (5S), and 
assuming that the fluorescence anisotropy and total emission intensity values are similar for 
the free and target-bound aptamer states, the change of the probe fluorescence anisotropy 
when the target concentration varies is described by the following expression: 
   	    
    )1(
)1(
arg
arg
etdt
dssb
n
n
etdt
dssbffb
n
K
TKSSBg
SSB
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




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
      (6S) 
Figure 2S (see below) presents theoretical data, at a given SSB concentration, created from Eq 
(6S) for various Kdssb, Kdtarget, (rb-rf) and g factor values (all other parameters being held 
constant). The increase in Kdssb and (rb-rf) values and/or the decrease in Kdtarget and g factor 
values govern an enhancement of the displacement curve slope, i. e. an increase in the assay 
sensitivity. This is achieved at the expense of the FP signal variation range for the Kdssb and g 
factor effects.  
 
 
 
 
 
--------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
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Figure 1S. Predicted secondary structures for the Apt-A probe and Apt-A-Ade complex 
(adapted from ref 32). 
 
 
  
6 
 
Figure 2S. Theoretical data created from Eq (6S) for different values of (a) Kdssb: 50 nM 
(triangles), 100 nM (diamonds) and 150 nM (squares); fixed parameters: rb = 0.250, rf = 
0.100, Kdtarget = 10 µM, g factor = 1. (b) Kdtarget: 40 µM (triangles), 10 µM (diamonds) and 2.5 
µM (squares); fixed parameters: rb = 0.250, rf = 0.100, Kdssb = 50 nM, g factor = 1. (c) (rb-rf): 
0.200 (triangles), 0.150 (diamonds) and 0.100 (squares); fixed parameters: rf = 0.100, Kdssb = 
50 nM, Kdtarget = 10 µM, g factor = 1. (d) g factor: 2.5 (triangles), 1 (diamonds) and 0.4 
(squares); fixed parameters: rb = 0.250, rf = 0.100, Kdssb = 50 nM, Kdtarget = 10 µM. Total SSB 
concentration and nH are fixed to 300 nM and 2, respectively. 
 
(a) 
 
(b) 
 






     


	







     


	

7 
 
(Continued) 
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Figure 3S. SSB titration curve using the 5’-F-Apt-A probe. The theoretical curve () is 
recreated using equation parameters (see Figure 2 in the manuscript) obtained by fitting Eq 
(4S) to fb. Probe concentration = 10 nM. Binding buffer conditions: 50 mM Tris-HCl, pH = 
7.5, 5 mM NaCl, 20 mM MgCl2. 
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Figure 4S. Representative competitive displacement curves using T14-F-Apt-A (black 
circles), T13-F-Apt-A (white circles), 3’-TR-Apt-A (black squares) and T11-TR-Apt-A 
(white squares). The theoretical curves () are recreated using equation parameters (see 
Figure 2 in the manuscript) obtained by fitting Eq (6S) to r. Probe concentration = 10 nM. 
SSB concentration = 0.33 µM. Binding buffer conditions: 50 mM Tris-HCl, pH = 7.5, 5 mM 
NaCl, 20 mM MgCl2. 
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Figure 5S. Calibration curves for Ade using the T14-F-Apt-A probe under 50-fold (squares), 
10-fold (triangles) and 5-fold (diamonds) diluted human serum conditions. Probe 
concentration = 10 nM. SSB concentration = 0.25 µM. r = r - r0 where r0 is the fluorescence 
anisotropy in absence of analyte. 
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Figure 6S. (a) Predicted secondary structure for the Apt-R probe (adapted from ref 51). (b) 
Titration curves of 5’-F-Apt-R with increasing Rm concentration under SSB-assisted (black 
symbols) and direct (white symbols) FPAA modes. Grey symbols for SSB-assisted FPAA 
using the scramble 5’-F-Apt-R. Probe concentration = 10 nM. SSB concentration = 0.33 µM. 
Binding buffer conditions: 10 mM Tris-HCl, pH = 7.5, 100 mM NaCl. r = r - r0 where r0 is 
the fluorescence anisotropy in absence of analyte. 
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Figure 7S. (a) Schematic representation of the sandwich-like FPAA design with the SSB-
assisted format. (b) Titration curves of split 5’-F-Apt-A (St1*:St2, 1:8 stoichiometry) with 
increasing Ade concentration in presence (circles) and absence (diamonds) of SSB protein. 
St1* concentration = 10 nM. SSB concentration = 1.67 µM. Binding buffer conditions: 50 
mM Tris-HCl, pH = 7.5, 5 mM NaCl, 20 mM MgCl2. r = r - r0 where r0 is the fluorescence 
anisotropy in absence of analyte. 
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II.4.3 Conclusions
In summary, aptamer-based fluorescence polarization/anisotropy offers significant 
advantages for some applications in clinical chemistry and bioassays and its use in
biotechnology and drug discovery will no doubt continue to expand. First, polarization assays 
are homogeneous; that is, there is no necessity for separation of free and bound ligands.
Second, polarization assays are reproducible and facilely automated. More importantly, 
because FP is less affected by environmental interferences, aptamer-based SSB assisted 
strategy can be successfully applied under realistic conditions, i. e. in diluted human serum,
which made a big progress toward clinical diagnosis compare to the former aptamer-based
methodologies.
However, several challenges still exist. For CS displacement strategy, FA signal generation 
is highly dependent on the length of the CS and the nature of the dye. Although SSB assisted 
strategy has greatly improved the assay response relatively to the previously reported small 
target assays, this method also has limitations since the affinity of SSB is too high for long 
aptamers. By careful consideration of experimental design, these limitations will be overcome 
and fluorescence polarization methods will become firmly entrenched, particularly for
bioanalytical applications in the near future.
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Since the discovery of the aptamers in 1990, the field of aptamer research is continuing to 
progress at a rapid rate. In vitro selection has undoubtedly bought this field to flourish; we 
have seen the creation of hundreds of aptamers, each with a unique target specificity. These 
aptamers can bind substances ranging from small molecule to proteins to cells. Exploring in
this avenue of aptamer research will not only emphasize the specific ability of aptamers to 
fold into distinct three-dimensional structures and interact with selected targets, they will also 
focus on the utility and practicality of aptamer research.
We have already witnessed the potential of using aptamers for various applications in
medical diagnostics and therapeutics. On the therapeutic front, aptamers have been 
successfully used to sequester viral or defective proteins in cells as decoys. One example of 
this kind of molecule is “Macugen” (Pegaptanib), developed by EyTech Pharmaceuticals, 
USA, for the treatment of age-related macular degeneration. Archemix, a company 
specializing in the development of aptamer-based therapeutics, has developed anti-cancer 
aptamers that have been shown to be active in patients with renal carcinoma and acute
myeloid leukemia in phase one and phase two clinical trials, respectively
(www.archemix.com). On the diagnostic front, aptamers are now widely accepted as 
substitutes for antibodies in immunodiagnostics. In contrast to antibodies, aptamers are 
smaller and less complex and consequently are easier to manufacture and modify. The 
commercialization of some of these aptamer-based technologies was also achieved. For 
example, SomaLogic manufactures platforms containing aptamer arrays that enables for 
simultaneous detection of multiple biomarkers (www.somalogic.com). The affinities 
displayed by the aptamers are comparable to the affinities of antibodies for antigens; therefore, 
their utility as a fundamental molecular recognition element in biosensors has been realized.
In the past few years, more and more aptamer-based biosensors have been reported via 
elegant design. The principle of these biosensors is quite simple, they may be created by 
joining an existing aptamer, which serves as the molecular recognition element, to a signal 
transducer. This modular design is used to create different type of aptamer biosensors, 
whether they signal by optical, acoustic, mechanical, or electrical means. For certain targets, 
we can select sensors with signaling motifs that best suit our needs and convenience. However, 
one major challenge for the current aptamer-base biosensors is that most of the assays are 
confined to macromolecules such as proteins since the binding event leads to a significant 
structure change which can be easily converted into a detectable signal. Aptamer-based small 
molecule detections are not widely investigated.
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In our studies, small biomolecule detection has been successfully achieved through various 
aptamer-based approaches. The first work of structure-switching aptamer-based CE makes it 
possible for multiple small molecule detection in a single run, which expands significantly the 
potential of small molecule analysis in terms of simplicity, adaptability, generalizability, and 
high-throughput analysis capability. The second aptamer-based gold nanoparticle colorimetric 
sensing allows a rapid, homogeneous, sensitive analysis which can be observed by naked eyes. 
Aptamer-based FP assay is a versatile and powerful method for the study of biomolecular 
binding interactions. The results described above greatly improve the response relatively to 
the previously reported small target assays, and as a significant progress, the SSB-assisted FP 
strategy can operate also under realistic (diluted human serum) conditions, which leads to a 
bright future for the aptamer-base clinical application.
Several problems related to the practical application of aptamers are still under study. 
When considering the role of aptamer arrays for the analysis of complex biological samples,
any problems arising from cross-reactivity between targets and aptamers have to be scaled 
against the limitations of current analytical technologies. For example, aptamers configuration 
is sensitive to the salt composition; therefore, medium composition may affect the aptasensor 
properties. Several proteins may interact with DNA aptamers nonspecifically. They could 
bind to the sugar-phosphate backbone of DNA, and thus hinder the specific binding of analyte. 
The presence of nucleic acid in the biological liquids may cause hybridization with aptamers, 
and thus affect the aptamers conformation and maintaining the proper binding site. 
Furthermore, currently only approx. 250 aptamers are available to apply, while the number of 
various antibodies is much larger. Thus, despite the advantages of aptamers over antibodies, 
further effort is required for wide spreading aptamers-based technology in practical 
applications. It should be also noted that SELEX is still a highly specialized process and is not 
as popular amongst the wider scientific community as would be expected.
Future direction of the aptamer-based assay will probably see growth of microchips and 
nanochips. In the past two decades, there is strong interest in developing miniaturized
bioanalytical systems that integrate various biochemical analysis components on a single chip.
The development of microarrays based on aptamers used as receptors can be seen as a logical 
continuation of the DNA-chip technology. In the near future, aptamer microarrays are 
expected to play a dominant role in proteomics, thus extending the use of aptamer-based 
microarrays. Meanwhile, improved detection technique is another key in the future 
aptamer-based assay. The advantages of development for large-scale multiplexed aptamer 
arrays and the label-free target quantification methods are obvious. Given the commercial 
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opportunities and recent innovations in surface based analysis techniques, large scale 
molecular diagnostic arrays may not be too far away.
Overall, with the continuous improvement of the stability and reliability, more and more 
aptamer-based biosensors with excellent performances will be manufactured via smart 
designing strategies, which will endow them great opportunity to be applied in the fields of 
bioassay, biomedical diagnostic or environmental monitoring in the near future.
Développement de nouveaux outils analytiques à base d'acides nucléiques aptamères 
pour la détection de petites molécules
 
Résumé : La détection de petites molécules est d'un grand intérêt dans les domaines 
pharmaceutique, environnemental, alimentaire et de la biologie clinique. Les 
aptamères, sélectionnés par la méthode SELEX (pour Systematic Evolution of Ligands 
by Exponential Enrichment), sont des oligonucléotides qui se lient à une cible donnée 
avec une affinité et une spécificité importantes. L'objectif de ce travail est d'établir de 
nouvelles méthodologies analytiques basées sur l’utilisation des aptamères pour la 
détection de petites molécules. Dans un premier temps, une méthodologie par 
électrophorèse capillaire, dérivée du concept de déplacement du brin complémentaire 
de l’aptamère, est décrite pour la détection simultanée de plusieurs analytes dans un 
seul capillaire. La deuxième étude se focalise sur le développement d’un aptacapteur 
colorimétrique simple, rapide et peu coûteux, qui utilise le concept général de 
protection enzymatique de l’aptamère et les nanoparticules d’or en tant que système 
de transduction. Enfin, deux méthodes par polarisation de fluorescence, basées sur le
concept de déplacement (du brin complémentaire ou de l’aptamère lui-même), sont 
présentées afin d’accroitre les potentialités des aptacapteurs dédiés à la détection des 
petites molécules.
Mots clés: Acide nucléique aptamères, SELEX, petites molécules, électrophorèse 
capillaire, nanoparticules d'or, polarisation de fluorescence, aptacapteurs.
Development of novel analytical tools based on nucleic acid aptamers for the 
detection of small molecules
 
Abstract: Small biomolecule detection is of great interest and importance in the 
pharmaceutical, environmental, food and clinical fields. Aptamers, selected by 
SELEX (Systematic Evolution of Ligands by Exponential Enrichment), are
oligonucleotides that bind to a target with high affinity and specificity. The objective 
of the work is to establish novel methodologies of aptamer-based assays for the small 
biomolecule detection. In the first work, a rationalized capillary electrophoresis
strategy, derived from the structure-switching aptamer concept, is described for the 
design of simultaneous detection of multiple analytes. The second work based on a 
gold nanoparticle colorimetric sensing strategy allows a rapid, label-free, 
homogeneous assay for small molecule using an aptamer enzymatic cleavage 
protection strategy. In the third work, two aptamer-based fluorescence polarization
approaches, using the displacement concept, are described to improve the 
potentialities of the small molecule-dedicated aptasensors.
Key words: Nucleic acid aptamers, SELEX, small molecules, capillary 
electrophoresis, gold nanoparticles, fluorescence polarization, aptasensors. 
